Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
CB-7921220 | 115453-99-1 | C14H12N2O2 | 240.26 | 6-[(E)-2-(4-aminophenyl)ethenyl]pyridine-2-carboxylic acid |
CB7646 | 104880-54-8 | C8H16N6O2 | 228.25 | CB-7646;Methanol, ((6-(methylamino)-1,3,5-triazine-2,4-diyl)bis(methylimino))bis-;[[4-[Hydroxymethyl(methyl)amino]-6-(methylamino)-1,3,5-triazin-2-yl]-methylamino]methanol |
CB-52 | 869376-90-9 | C26H43NO3 | 417.6 | CB52;CB 52 |
CB5083 | 1542705-92-9 | C24H23N5O2 | 413.4 | CB5083; CB-5083; CB 5083. |
CB4091 | 3447-95-8 | C19H18O7 | 358.34 | 4-[1-[3-methyl-5-(5-oxo-2H-furan-3-yl)-1-benzofuran-2-yl]ethoxy]-4-oxobutanoic acid |
CB-403 | 302356-18-9 | C17H16O2 | 252.11 | |
CB-3988 | 112888-26-3 | C26H23F3N4O6 | 544.48 | CB3988;(2S)-2-[2-Trifluoromethyl-4-[N-[(3,4-dihydro-2-methyl-4-oxoquinazolin)-6-ylmethyl]-N-(2-propynyl)amino]benzoylamino]glutaric acid;N-[2-Trifluoromethyl-4-[2-propynyl[(3,4-dihydro-4-oxo-2-methylquinazolin)-6-ylmethyl]amino]benzoyl]-L-glutamic acid;(2 |
CB-3705 | 5854-11-5 | C21H21N5O6 | 439.42 | 5,8-Dideazafolic acid;CB3705;Glutamic acid, N-(p-(((2-amino-4-hydroxy-6-quinazolinyl)methyl)amino)benzoyl)-, L- (2S)-2-[[4-[(2-amino-4-oxo-1H-quinazolin-6-yl)methylamino]benzoyl]amino]pentanedioic acid |
CB30900 | 145788-82-5 | C31H32FN5O9 | 637.61 | CB 30900; CB30900; CB-30900; N-(N-(4-(N-((3,4-Dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl)-N-prop-2-ynylamino)-2-fluorobenzoyl)-L-gamma-glutamyl)-D-glutamic acid |
CB30865 | 206275-15-2 | C26H22BrN5O2 | 516.39 | ZM242421; CB-30865; CB 30865; ZM-242421; ZM 242421 |
CB-25 | 869376-63-6 | C25H41NO3 | 403.6 | CB25; CB 25 |
CB1-IN-1 | 1429239-98-4 | C33H31Cl2F3N6O3S2 | 751.67 | 1-(2,4-dichlorophenyl)-N-piperidin-1-yl-4-[(pyrrolidin-1-ylsulfonylamino)methyl]-5-[5-[2-[4-(trifluoromethyl)phenyl]ethynyl]thiophen-2-yl]pyrazole-3-carboxamide CB1-IN-1 SCHEMBL14816497 CS-5144 HY-12790 N-Piperidino-1-(2,4-dichlorophenyl)-4-(pyrroliz |
CB181963 | 635292-67-0 | C19H24FN11O5S2 | 569.59 | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-3-[(E)-[methyl(piperazine-1-carboximidoyl)hydrazinylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;CB-181963;5-Thia-1-azabicyclo(4.2.0)oct-2- |
CB10-277 | 7203-91-0 | C9H11N3O2 | 193.206 | CB10-277; 1-p-carboxy-3,3-dimethylphenyltriazine. |
CB 966 | 128312-71-0 | C30H50O3 | 458.72 | (1R-(1alpha(R*),3abeta,4E(1R*,3S*,5Z),7aalpha))-5-((1-(6-ethyl-6-hydroxy-1-methyloctyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-Cyclohexanediol |
CB 65 | 913534-05-1 | C22H28ClN3O3 | 417.93 | N-Cyclohexyl-7-chloro-1-[2-(4-morpholinyl)ethyl]quinolin-4(1H)-one-3-carboxamide |
CB 3731 | 80015-07-2 | C23H24FN5O6 | 458.47 | N-(4-((N-(2-Amino-4-hydroxy-6-quinazolinyl)methyl)-N-(fluoroethyl)amino)benzoyl)glutamic acid |
CB 3703 | 32093-09-7 | C22H24N6O5 | 452.18 | N-(p-(((2,4-Diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-L-glutamic acid; L-Glutamic acid, N-(4-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-; |
CB 300919 | 289715-28-2 | C32H34ClN7O2 | 584.11 | CB-300919; CB300919 |
CB 1837 | 27141-65-7 | C8H7N3O4 | 209.159 | 1-(2,4-dinitrophenyl)aziridine; CB 1837; CB1837; CB-1837; AI3-51871; NSC 3375 |
CAY10734 | 635701-59-6 | C23H25N3O3 | 391.5 | CAY 10734; CAY-10734 |
CAY10723 | 2095107-57-4 | C24H27FN6O3 | 466.5 | CAY 10723; CAY-10723 |
CAY10722 | 388086-13-3 | C21H14Cl2N2O2 | 397.3 | CAY 10722; CAY-10722 |
CAY10721 | 848688-62-0 | C18H13N3O3S | 351.4 | CAY 10721; CAY-10721 |
CAY10719 | 1942919-63-2 | C25H20Cl2N2O2 | 451.3 | CAY 10719; CAY-10719 |
CAY10717 | 1240322-54-6 | C29H25F3N6O3 | 562.5 | CAY 10717; CAY-10717 |
CAY10711 | 1666171-29-4 | C41H54N6S2 | 695 | CAY 10711; CAY-10711 |
CAY10704 | 101784-44-5 | C18H20Cl2N2 | 335.3 | CAY 10704; CAY-10704 |
CAY10700 | 1381846-21-4 | C16H19ClN4O2 | 334.8 | mPGES-1 Inhibitor-1; CAY 10700; CAY-10700 |
CAY10698 | 684236-01-9 | C17H17N3O4S2 | 391.5 | CAY 10698; CAY-10698 |
CAY10685 | 1613116-16-7 | C17H16ClN3S | 329.8 | CAY 10685; CAY-10685 |
CAY10684 | 493035-81-7 | C27H32ClNO4 | 470 | CAY 10684; CAY-10684; 7-((2R)-2-((E)-3-(4'-Chloro-2'-methyl-[1,1'-biphenyl]-3-yl)-3-hydroxyprop-1-en-1-yl)-5-oxopyrrolidin-1-yl)heptanoic acid |
CAY10683 | 1477949-42-0 | C15H22N2O3 | 278.35 | Santacruzamate A |
CAY10682 | 1542066-74-9 | C30H25BrFN5O | 570.5 | CAY 10682; CAY-10682 |
CAY10681 | 1542066-69-2 | C30H26BrN5O | 552.5 | CAY 10681; CAY-10681 |
CAY10680 | 1439488-21-7 | C18H16N2O2S | 324.4 | CAY 10680; CAY-10680 |
CAY10678 | 1268709-57-4 | C23H34N4O | 382.5 | mPGES-1 Inhibitor III; CAY 10678; CAY-10678 |
CAY10677 | 1443253-20-0 | C25H37N5 | 407.6 | Icmt Inhibitor 15; CAY 10677; CAY-10677 |
CAY10669 | 1243583-88-1 | C20H22O4 | 326.4 | CAY 10669; CAY-10669 |
CAY10650 | 1233706-88-1 | C28H25NO6 | 471.5 | CAY 10650; CAY-10650 |
CAY10649 | 1272519-89-7 | C17H12ClNO2S | 329.8 | CAY 10649; CAY-10649 |
CAY10640 | 1208549-68-1 | C17H20F3N3O3 | 371.4 | sEHi; Soluble Epoxide Hydrolase Inhibitor; CAY 10640; CAY-10640 |
CAY10638 | 1221413-57-5 | C16H13NO3S2 | 331.4 | CAY 10638; CAY-10638 |
CAY10626 | 1202884-94-3 | C31H35F3N8O3 | 624.7 | CAY 10626; CAY-10626 |
CAY10622 | 1038549-25-5 | C25H25N5O3 | 443.5 | CAY 10622; CAY-10622 |
CAY10621 | 120005-55-2 | C26H45NO4 | 435.6 | SKI 5C; SPHK1 Inhibitor 5C; CAY 10621; CAY-10621 |
CAY10614 | 1202208-36-3 | C42H78INO2 | 756 | CAY 10614; CAY-10614 |
CAY10608 | 457897-92-6 | C18H22Cl2N2O4S | 433.4 | CAY 10608; CAY-10608 |
CAY10606 | 1159576-98-3 | C22H18ClNO3 | 379.8 | CAY 10606; CAY-10606 |
CAY10603 | 1045792-66-2 | C22H30N4O6 | 446.5 | |
CAY10602 | 374922-43-7 | C22H15FN4O2S | 418.4 | CAY 10602; CAY-10602 |
CAY10599 | 1143573-33-4 | C38H41NO5 | 591.7 | CAY 10599; CAY-10599 |
CAY10597 | 916046-55-4 | C20H14ClFN2O5 | 416.8 | CAY 10597; CAY-10597 |
CAY10595 | 916047-16-0 | C20H13Cl2FN2O5 | 451.2 | CAY 10595; CAY-10595 |
CAY10594 | 1130067-34-3 | C26H28N4O2 | 428.5 | CAY 10594; CAY-10594 |
CAY10592 | 685139-10-0 | C23H17Br2ClO3S | 568.7 | CAY 10592; CAY-10592 |
CAY10591 | 839699-72-8 | C20H25N5O2 | 367.5 | SIRT1 Activator 3; Sirtuin 1 Activator 3; CAY 10591; CAY-10591 |
CAY10590 | 1101136-50-8 | C21H33NO3 | 347.5 | CAY 10590; CAY-10590 |
CAY10589 | 1077626-52-8 | C25H28ClN3O2S | 470 | CAY 10589; CAY-10589 |
CAY10583 | 862891-27-8 | C25H25NO3 | 387.5 | CAY 10583; CAY-10583 |
CAY10581 | 1018340-07-2 | C22H21NO4 | 363.41 | CAY10581; 1018340-07-2; CHEMBL407954 |
CAY10580 | 64054-40-6 | C19H35NO4 | 341.5 | CAY 10580; CAY-10580 |
CAY10578 | 19231-60-8 | C10H3I4NO4 | 708.8 | CAY 10578; CAY-10578 |
CAY10577 | 300675-28-9 | C10H5Cl2NO3 | 258.1 | CAY 10577; CAY-10577 |
CAY10575 | 916985-21-2 | C22H21N3O6S2 | 487.6 | CAY 10575; CAY-10575 |
CAY10574 | 140651-18-9 | C9H10N6O | 218.2 | CAY 10574; CAY-10574; Cdk9 Inhibitor II |
CAY10573 | 853652-40-1 | C33H31NO5 | 521.6 | CAY 10573; CAY-10573 |
CAY10571 | 152121-46-5 | C21H16FN3O2S | 393.4 | CAY 10571; CAY-10571 |
CAY10570 | 875014-22-5 | C25H32N2OS | 408.6 | CAY 10570; CAY-10570 |
CAY10567 | 32387-96-5 | C21H14N2O2 | 326.4 | BML-257 |
CAY10566 | 944808-88-2 | C18H17ClFN5O2 | 389.8 | CAY 10566; CAY-10566 |
CAY10561 | 933786-58-4 | C22H17Cl2FN4O2 | 459.3 | Pyrazolylpyrrole ERK Inhibitor; CAY 10561; CAY-10561 |
CAY10502 | 888320-29-4 | C30H37NO7 | 523.6 | CAY10502; CAY-10502 |
CAY10499 | 359714-55-9 | C18H17N3O5 | 355.3 | CAY-10499; CAY 10499 |
CAY10498 | 863202-33-9 | C18H20N6 | 320.4 | 2-phenyl-amino-N6-endo-norbornyladenine |
CAY10486 | 615264-52-3 | C19H19NO4 | 325.4 | 4-Hydroxycinnamic acid (L-phenylalanine methyl ester) amide |
CAY10485 | 615264-62-5 | C27H27NO7 | 477.5 | 3,4-dihydroxy Hydrocinnamic acid (L-Aspartic acid dibenzyl ester) amide |
CAY10471 | 627865-18-3 | C21H21FN2O4S | 416.5 | CAY-10471; CAY 10471; TM-30089; TM 30089 |
CAY10465 | 688348-33-6 | C15H9Cl2F3 | 317.1 | CAY 10465; CAY-10465 |
CAY10464 | 688348-37-0 | C15H12Cl2O | 279.2 | CAY 10464; CAY-10464 |
CAY10462 | 502656-68-0 | C17H25N3O·2HCl | 360.3 | CAY 10462; CAY-10462 |
CAY10448 | 1177195-52-6 | C18H28INO3 | 433.3 | CAY 10448; CAY-10448 |
CAY10444 | 298186-80-8 | C15H29NO2S | 287.5 | BML-241; CAY 10444; CAY-10444; BML 241 |
CAY10443 | 582314-48-5 | C17H15Cl2NO2 | 336.2 | (S)-Indan-1-yl 3,4-dichlorobenzylcarbamate |
CAY10435 | 288862-73-7 | C18H26N2O2 | 302.4 | CAY 10435; CAY-10435 |
CAY10434 | 769917-29-5 | C17H25N3O | 287.4 | CAY 10434; CAY-10434 |
CAY10416 | 443919-96-8 | C29H29FN2O5S | 536.6 | CHEMBL423638 ; 43919-96-8; 3-[[3-fluoro-5-(tetrahydro-4-methoxy-2H-pyran-4-yl)phenoxy]methyl]-1-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole; 3-((3-fluoro-5-(4-methoxytetrahydro-2H-pyran-4-yl)phenoxy)methyl)-1-(4-(methylsulfonyl)phenyl)-5-phenyl-1H- |
CAY10412 | 390824-17-6 | C25H36O2S | 400.6 | CAY 10412; CAY-10412 |
CAY10404 | 340267-36-9 | C17H12F3NO3S | 367.4 | 3-[4-(methylsulfonyl)phenyl]-4-phenyl-5-(trifluoromethyl)-isoxazole |
CAY10401 | 288862-89-5 | C24H34N2O2 | 382.5 | CAY 10401; CAY-10401; 1-oxazolo[4,5-b]pyridin-2-yl-9-octadecyn-1-one |
CAY10398 | 193551-00-7 | C15H23N3O3 | 293.4 | MD 85; PX 089274 |
CAY10397 | 78028-01-0 | C17H16N2O5 | 328.3 | CK47A |
Cavidine | 32728-75-9 | C21H23NO4 | 353.41 | Cavidine |
Cavaol E | 1233044-20-6 | C25H36O9 | 480.555 | |
Caustic Soda | 68988-74-9 | |||
Cauloside F | 60451-47-0 | C59H96O27 | 1237.4 | |
Cauloside D | 12672-45-6 | C53H86O22 | 1075.2 | Hederacoside D; Kizuta Saponin K10 |
Cauloside C | 20853-58-1 | C41H66O13 | 766.95 | Hederoside D2; Akebia saponin C; Calthoside D |
Caulophyllogenin | 52936-64-8 | C30H48O5 | 488.70 | Segetalic acid |
Caulophylline B | 1359978-55-4 | C19H21NO5 | 343.379 | 1-[2-(dimethylamino)ethyl]-4,5-dihydroxy-3,6-dimethoxyfluoren-9-one |
Caulilexin C | 30536-48-2 | C11H10N2O | 186.2 | 1-Methoxy-3-indoleacetonitrile;1-Methoxyindoleacetonitrile;2-(1-methoxyindol-3-yl)acetonitrile |
Caudatin | 38395-02-7 | C28H42O7 | 490.6 | (3beta,12beta,14beta,17alpha)-12-[[(2E)-3,4-Dimethyl-1-oxo-2-pentenyl]oxy]-3,8,14,17-tetrahydroxypregn-5-en-20-one; |
Catuabine A | 65862-78-4 | C24H30N2O7 | 458.50400 | |
Cathepsin L Inhibitor | 167498-29-5 | C26H26N2O5 | 446.5 | SB 412515 |
Cathepsin Inhibitor 1 | 225120-65-0 | C20H24ClN5O2 | 401.89 | Cathepsin-Inhibitor-1; CTS-IN-1; CTS IN 1 |
CATHARANTHINE TARTRATE | 4168-17-6 | C25H30N2O8 | 486.51 | CATHARANTHINE TARTRATE; 7-ETHYL-9,10,12,13-TETRAHYDRO-6,9-METHANO-5H-PYRIDO[1',2':1,2]AZEPINO[4,5-B]INDOLE-6(6AH)-CARBOXYLIC ACID METHYL ESTER TARTRATE; (2alpha,5beta,6alpha,18beta)-3,4-Didehydroibogamine-18-carboxylic acid methyl ester (2R,3R)-2,3-dihydr |
Catharanthine sulfate | 70674-90-7 | C21H26N2O6S | 434.5 | |
Catharanthine | 2468-21-5 | C21H24N2O2 | 336.43 | Catharanthine |
Catestatin | 142211-96-9 | C107H173N37O26S | 2425.84 | Chromogranin A344-364 |
Catechu (resin) | 8001-76-1 | W99 | ||
Catecholborane | 274-07-7 | C6H4BO2 | 119.91 | Catecholborane;1,3,2-Benzodioxaborole;274-07-7;Benzo[d][1,3,2]dioxaborole;1,3,2$l^{2}-benzodioxaborole;CENMEJUYOOMFFZ-UHFFFAOYSA-N |
Catechin 7-xyloside | 42830-48-8 | C20H22O10 | 422.4 | (2S,3R,4S,5R)-2-[[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-3,4,5-triol |
Catechin 3-rhamnoside | 103630-03-1 | C21H24O10 | 436.4 | a-L-Mannopyranoside,2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyr an-3-yl6-deoxy-, (2R-trans)-; Catechin 3-O-a-L-rhamnopyranoside |
Catechin | 154-23-4 | C15H14O6 | 290.27 | (+)-Catechin; Cianidanol; D-Catechin; Cyanidanol; Catechuic acid |
Catalposide | 6736-85-2 | C22H26O12 | 482.45 | Catalpin; (1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-hexahydro-6-[(4-hydroxybenzoyl)oxy]-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl-b-D-glucopyranoside; Hydroxybenzoyl catalpol |
Catalponol methylthiomethyl ether | 1432057-74-3 | C17H22O2S | 290.42 | (2R,4S)-2-(3-methylbut-2-en-1-yl)-4-((methylthio)methoxy)-3,4-dihydronaphthalen-1(2H)-one |
Catalponol | 34168-56-4 | C15H18O2 | 230.3 | |
Catalpol | 2415-24-9 | C15H22O10 | 362.33 | Catalpinoside; (1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl-b-D-glucopyranoside |
Catalpin | 1390-72-3 | C16H18O7 | 322.3 | |
Catalpalactone | 1585-68-8 | C15H14O4 | 258.3 | 3-(2,2-dimethyl-6-oxo-3H-pyran-5-yl)-3H-2-benzofuran-1-one |
Castoryl Maleate | 68308-83-8 | |||
Castoroil, sulfated, sodium salt | 68187-76-8 | 0 | MONOPOLOEL 100/23; Rizinusl, sulfatiert, Natriumsalz; Castor oil sodium sulfate; (Hydrolysis products of sulfated castor oil), sodium salts; Castor oil, sulfate, sodium salt; Castor oil, sulfated sodium salts; Castor oil, sulfated, sodium salts; Einecs 26 | |
Castoreum oil | 8023-83-4 | 0 | Castoremoil; Castoreumextract; Castoreumoil; CastoreumResinoid; Castoreumtincture; Hyperabsolutecastoreum; Oils,castoreum; CASTOREUM | |
Castor oil, oxidized,sulfurized | 189200-44-0 | |||
Castor oil, acetylated | 84929-62-4 | |||
Castor oil, 2,4-toluene diisocyanate, 2,6-toluene diisocyanate polymer | 67700-43-0 | |||
CASTOR OIL GLYCIDYL ETHER | 74398-71-3 | C66H116O12 | 1101.62004 | 1,2,3-propanetriylesterof12-(oxiranylmethoxy)-9-octadecenoicacid; 9-octadecenoicacid,12-(oxiranylmethoxy)-,1,2,3-propanetriylester,homopolym; 9-Octadecenoicacid,12-(oxiranylmethoxy)-,1,2,3-propanetriylester,homopolymer; Poly9-octadecenoicacid-12(oxymethyl |
Castor Oil | 8001-79-4 | |||
Casticin | 479-91-4 | C19H18O8 | 374.34 | 5,3'-DIHYDROXY-3,6,7,4'-TETRAMETHOXYFLAVONE; |
Casopitant | 414910-27-3 | C30H35F7N4O2 | 616.625 | GW679769; Rezonic; Zunrisa; |
CASIN | 425399-05-9 | C20H22N2O | 306.4 | 2-[(2,3,4,9-Tetrahydro-6-phenyl-1H-carbazol-1-yl)amino]ethanol; 2-[(6-phenyl-2,3,4,9-tetrahydro-1H-carbazol-1-yl)amino]ethanol |
Caseins, ammoniumcomplexes | 9005-42-9 | |||
Casein from bovine milk | 9000-71-9 | |||
Casegravol | 74474-76-3 | C15H16O5 | 276.288 | 8-[(E)-3,4-dihydroxy-3-methylbut-1-enyl]-7-methoxychromen-2-one |
Cascaroside A | 53823-08-8 | C27H32O14 | 580.53458;g/mol | CascarosideA; UNII-AI50I7OZY7; 53823-08-8; (10S)-1-HYDROXY-3-(HYDROXYMETHYL)-10-[(2S,3R,4R,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]-8-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}-9,10-DIHYDROANTHRACEN-9-ONE; AC1L9DAW; AI5 |
CASCARA SAGRADA | 8007-06-5 | 0 | Cascarillaabsolutecolourlessmd; Cascarillaoleoresin; Oils,cascarilla; CASCARA SAGRADA EXTRACT; CASCARA SAGRADA AROMATIC FLUID EXTRACT; CASCARA EXTRACT; CASCARA SAGRADA; CASCARA SAGRADA, FLUID EXTRACT | |
CASANTHRANOL | 8024-48-4 | CASANTHRANOL; CASANTHRANOL,USP | ||
Carzelesin | 119813-10-4 | C41H37ClN6O5 | 729.22 | |
CARYOPHYLLENE ALCOHOL | 472-97-9 | C15H26O | 222.37 | 4,4,8-trimethyltricyclo(6.3.1.0'2,5)dodecan-1-ol; 5]dodecan-1-ol,4,4,8-trimethyl-,(1R,2S,5R,8S)-Tricyclo[6.3.1.02; 8beta)]-bet; tricyclo[6.3.1.02,5]dodecan-1-ol,4,4,8-trimethyl-,[1theta-(1alpha,2alpha,5; CARYOPHYLLENE ALCOHOL; beta-caryophyllene alcohol; |
Caryophyllene | 87-44-5 | C15H24 | 204.35 | (1R,9S)-8-METHYLEN-4,11,11-TRIMETHYL-BICYCLO[7.2.0]UNDEC-4-ENE; 8-METHYLENE-4,11,11-TRIMETHYLBICYCLO[7.2.0]UNDEC-4-ENE; B-CARYOPHYLLENE; BETA-CARYOPHYLLEN; BETA-CARYOPHYLLENE; CARYOPHYLLENE, (-)-TRANS-; CARYOPHYLLENE NATURAL; CARYOPHYLLENE |
Carvedilol Related Compound F | 1246820-73-4 | C24H30N2O4 | 410.52 | 1-[[2-(2-Methoxyphenoxy)ethyl]amino]-3-[(2,3,4,9-tetrahydro-1H-carbazol-5-yl)oxy]-2-propanol; |
Carvedilol Phosphate | 610309-89-2 | C24H29N2O8P | 504.47 | 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol;phosphoric acid;hydrate |
Carvedilol Impurity C | 72955-94-3 | C31H32N2O4 | 496.61 | 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](phenylmethyl)amino]-2-propanol; |
Carvedilol Impurity B | 918903-20-5 | C39H39N3O6 | 645.76 | 1,1'-[[2-(2-Methoxyphenoxy)ethyl]imino]bis[3-(9H-carbazol-4-yloxy)-2-propanol; USP Carvedilol Related Compound B; |
Carvedilol Impurity A | 1076199-79-5 | C36H43N3O7 | 629.76 | 1-[[4-(2-Hydroxy-3-[[2-(methoxyphenoxy)ethyl]amino]propyl]-9H-carbazol-4-yl]oxy]-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol; 1-(9H-Carbazol-4-yloxy)-3-[[2-hydroxy-3-[[2-(2-methoxyphenoxy)ethyl]amino]propyl][2-(2-methoxyphenoxy)ethyl]amino]-2-propanol |
Carvedilol Impurity 2 | 1801551-41-6 | C14H11NO2 | 225.25 | 2-(9H-Carbazol-4-yloxy)-ethenol |
Carvedilol EP impurity E | 64464-07-9 | C9H14ClNO2 | 203.67 | Carvedilol Impurity E; Carvedilol USP E |
Carvedilol D5 | 929106-58-1 | C24H21D5N2O4 | 411.51 | 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol-d5; Artist-d5; BM 14190; Cadilan-d5; Carca-d5; Cardivas-d5; Carloc-d5; Carvas-d5; Carvedilol-d5; Carvediol-d5; Coreg-d5; DQ 2466-d5; Dilatrend-d5; Dimitone-d5; Eucardic-d5; Korvasan-d |
Carvedilol Bisalkylpyrocatechol derivative | 1346602-98-9 | C40H42N4O6 | 674.8 | 3,3-{2,2-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol); |
Carumonam | 87638-04-8 | C12H14N6O10S2 | 466.407 | CARUMONAM; Acetic acid, [[(Z)-[2-[[(2S,3S)-2-[[(aminocarbonyl)oxy]methyl]-4-oxo-1-sulfo-3-azetidinyl]amino]-1-(2-amino-4-thiazolyl)-2-oxoethylidene]amino]oxy]-; Acetic acid, [[[2-[[2-[[(aminocarbonyl)oxy]methyl]-4-oxo-1-sulfo-3-azetidinyl]amino]-1-(2-amin |
Carubicin HCl | 52794-97-5 | C26H28ClNO10 | 549.95 | (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,6,8,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; Carubicin HCl; Carubicin hydrochloride; Karminomycin hydrochloride; NSC 275649. |
Carubicin | 50935-04-1 | C26H27NO10 | 513.5 | Antibiotic R 588A; Carminomicin I; Carminomycin I; carminomycin; Demethyldaunomycin; Karminomitsin; karminomycin; CMM |
Carteolol Impurity H HCl | 53371-79-2 | C16H22N2O3. HCl | 290.37 36.46 | |
Carteolol HCl EP Impurity G | 54945-72-1 | C12H15NO4 | 237.26 | |
Carteolol HCl EP Impurity E | 56660-90-3 | C21H22N2O5 | 382.42 | |
Carteolol HCl EP Impurity D | 51781-13-6 | C12H14ClNO3 | 255.7 | |
Carteolol HCl EP Impurity C | 51781-14-7 | C12H13NO3 | 219.24 | 3,4-Dihydro-5-(2-oxiranylmethoxy)-2(1H)-quinolinone |
Carteolol HCl EP Impurity B | 30389-33-4 | C9H9NO2 | 163.18 | 5-Hydroxy-3,4-dihydro-2(1H)-quinolinone |
Carteolol HCl EP Impurity A | 5057-12-5 | C9H11NO2 | 165.19 | 4,6,7,8-Tetrahydro-3,4,5,6,7,8-hexahydrocarbostyril-5-one; NSC 160504; |
Carteolol HCl | 51781-21-6 | C16H25ClN2O3 | 328.83 | Carteolol Hydrochloride ; Carteolol HCl; Arteoptic; Cartrol; Mikelan; Abbott-43326; Hydrochloride, Carteolol; Monohydrochloride, Carteolol; OPC 1085; OPC-1085; OPC1085; |
Cartap HCl | 15263-52-2 | C7H15N3O2S2. HCl | 237.34 36.46 | CADAN(R) HYDROCHLORIDE; CARTAP HYDROCHLORIDE; PADAN(R); S,S'2-DIMETHYLAMINOTRIMETHYLENE BIS-(THIOCARBAMATE) HYDROCHLORIDE; SUNTAP(R); SUNVEX(R); VEGETOX(R) HYDROCHLORIDE; 1,3-bis(carbamoylthio)-2-(n,n-dimethylamino)propanemonohydrochloride |
CART (62-76) (rat, human) | 210978-19-1 | C64H99N17O23S3 | 1570.77 | |
CART (55-102) (rat) | 209615-79-2 | C226H367N65O65S7 | 5259.21 | |
CART (55-102) (human) | 214050-22-3 | C225H365N65O65S7 | 5245.18 | |
Carsalam | 2037-95-8 | C8H5NO3 | 163.13 | beaprine;carsalam;oxophenhydroxazine;ruhmal;TIMTEC-BB SBB003929;1,3-BENZOXAZINE-2,4-DIONE;2 H-1,3-BENZOXAZINE-2,4(3 H)-DIONE;1,3-Benzoxazine-2,4-(3H)-dione |
Carrot Seed oil | 8015-88-1 | CARROT OIL; CARROT OLEO RESIN; CARROT SEED OIL; FEMA 2244; daucusoil; Oils,carrot; DAUCUS CAROTA SATIVA (CARROT) SEED OIL; Cafrot seed oil | ||
Carrageenan | 9000-07-1 | |||
Carquejol | 23734-06-7 | C10H14O | 150.22 | 2-Cyclohexen-1-ol,5-methylene-6-(1-methylethenyl)-, (1S-cis)-; Carquejol (6CI); o-Mentha-1(7),4,8-trien-3-ol, (2R,3S)- (8CI) |
Carpropamide | 104030-54-8 | C15H18Cl3NO | 334.67 | CARPROPAMID; 2,2-DICHLORO-N-[1-(4-CHLOROPHENYL)ETHYL]-1-ETHYL-3-METHYLCYCLOPROPANECARBOXAMIDE; CARPROPAMID <)>97 %; CARPROPAMIDE; carpropamid (bsi,paiso); CARPROPAMID STANDARD |
Carprofen-D3 | 1173019-42-5 | 2-(6-Chloro-9H-carba- zol-2-yl)-propionic acid- D3 | ||
Carpinontriol B | 473451-73-9 | C19H20O6 | 344.363 | |
Carpinontriol A | 473451-72-8 | C19H20O6 | 344.364 | |
Carphenazine Dimaleate | 2975-34-0 | C32H39N3O10S | 657.73 | (Z)-but-2-enedioic acid;1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]propan-1-one;Wy 2445; |
Carpaine | 3463-92-1 | C28H50N2O4 | 478.7076;g/mol | Carpaine; (+)-Carpaine; 3463-92-1; AC1L9D45; C10135; UNII-VLR223H4QP |
Carpaine | 5853-21-4 | C28H50N2O4 | 478.71 | |
Carpachromene | 57498-96-1 | C20H16O5 | 336.34 | 1. 5-hydroxy-8-(4-hydroxyphenyl)-2,2-dimethyl-pyrano[3,2-g]chromen-6-one |
Caroverine HCl | 55750-05-5 | C22H28N3O2Cl | 401.94 | (R)-BIS[(3-CARBOXY-2-HYDROXYPROPYL) TRIMETHYL AMMONIUM] L-TARTRATE; L-(-)-CARNITINE-L-(-)-TARTRATE; L-CARNITINE L-TARTRATE; L-CARNITINE TARTRATE; L-CARNITINE-1-TARTRATE; L-CARNITINETARTRATE,POWDER; L-Carnitine L-Tartrate (factory standard); L-Carnipure(R) |
Caroverine | 23465-76-1 | C22H27N3O2 | 365.474 | CAROVERINE; spadon; 1-[2-(Diethylamino)ethyl]-3-[(4-methoxyphenyl)methyl]quinoxalin-2(1H)-one; Spasmium; 1-(2-(Diethylamino)ethyl)-3-(p-methoxybenzyl)-2(1H)-quinoxalinone; 1-Diethylaminoethyl-3-(p-methoxybenzyl)quinoxalone-2 |
Carotene | 7488-99-5 | C40H56 | 536.88 | A-CAROTENE; ALPHA/BETA-CAROTENE MIX; ALPHA-CAROTENE; CAROTENE, A-; ALPHA-CAROTENE FROM CARROTS; .beta.,.epsilon.-Carotene, (6R)-; (1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-1-(2,6,6-trimethyl-1-cyclohexenyl)-18-(2,6,6-trimethyl-1-cyclohex-2-en |
Carotegrast | 401904-75-4 | C27H24Cl2N4O5 | 555.41 | (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[6-(dimethylamino)-1-methyl-2,4-dioxoquinazolin-3-yl]phenyl]propanoic acid |
Carnosol | 5957-80-2 | C20H26O4 | 330.42 | 2H-9,4a-(Epoxymethano)phenanthren-12-one,1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-,(4aR-(4aalpha,9alpha,10abeta))-;(5beta)-11,12-dihydroxy-7,20-epoxyabieta-8(14),9(11),12-trien-20-one;(5beta,7alpha)-11,12-dihydroxy-7,20-epo |
Carnosic Acid | 3650-09-7 | C20H28O4 | 332.43 | CARNOSOLIC ACID;CARNOSIC ACID;4a(2H)-Phenanthrenecarboxylic acid, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4aR,10aS)-;(4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic ac |
Carnidazole | 42116-76-7 | [2-(2-Methyl-5-nitro- imidazol-1-yl)-ethyl]- thiocarbamic acid O- methyl ester | ||
Carnauba Wax | 8015-86-9 | Palm wax; Brazil wax | ||
Carnallite | 1318-27-0 | 0 | KCl·MgCl2·6H2O | |
Carmustine | 154-93-8 | C5H9Cl2N3O2 | 214.05 | 1,3-Bis(2-chloroethyl)-1-nitrosourea; BCNU; Carmustin |
Carmoxirole hydrochloride | 115092-85-8 | C24H26N2O2.HCl | 410.94 | 3-[4-(3,6-Dihydro-4-phenyl-1(2H)-pyridinyl)butyl]-1H-indole-5-carboxylic acid hydrochloride |
Carmoterol | 147568-66-9 | C21H24N2O4 | 368.43 | Carmoterol;8-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone |
Carmoisine | 3567-69-9 | C20H12N2Na2O7S2 | 502.43 | Acid red 14; Azo Rubine |
Carmofur | 61422-45-5 | C11H16FN3O3 | 257.26 | HCFU |
Carminomycin | 39472-31-6 | C26H27NO10 | 513.49 | Carminomicin; NSC 180024 |
Carminic acid | 1260-17-9 | C22H20O13 | 492.39 | 7-b-D-Glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-2-anthracenecarboxylic acid |
Carmichaenine E | 2065228-63-7 | C31H43NO8 | 557.684 | |
Carmichaenine D | 2065228-62-6 | C29H39NO7 | 513.631 | |
Carmichaenine C | 2065228-61-5 | C30H41NO7 | 527.658 | |
Carmichaenine B | 2065228-60-4 | C23H37NO7 | 439.549 | |
Carmichaenine A | 2065228-59-1 | C31H43NO7 | 541.685 | |
Carmegliptin | 813452-18-5 | C20H28FN3O3 | 377.45300 | |
CARM1-IN-1 | 1020399-49-8 | C26H21Br2NO3 | 555.26 | |
Carlinoside | 59952-97-5 | C26H28O16 | 596.491 | |
Carisoprodol-d7 | 1218911-70-6 | C12H17N2O4D7 | 267.38 | N-(1-Methylethyl)carbamic Acid 2-[[(Aminocarbonyl)oxy]methyl]-2-methylpentyl-3,3,4,4,5,5,5-d7 Ester; Domarax-d7; N-Isopropyl-2-methyl-2-propyl-1,3-propanediol-d7 Dicarbamate; Flexal-d7; Isomeprobamate-d7; NIH 10966-d7; NSC 172124-d7; Somalgit-d7; Stialgin |
Carisoprodol-d3 | 1215602-82-6 | C12H21N2O4D3 | 263.35 | N-(1-Methylethyl)carbamic Acid 2-[[(Aminocarbonyl)oxy]methyl]-2-(methyl-d3)pentyl Ester; Domarax-d3; N-Isopropyl-2-(methyl-d3)-2-propyl-1,3-propanediol Dicarbamate; Flexal-d3; Isomeprobamate-d3; NIH 10966-d3; NSC 172124-d3; Somalgit-d3; Stialgin-d3 |
Carisoprodol isopropyl impurity | 1729-14-2 | C15H30N2O4 | 302.42 | Isopropylcarbamic Acid 2-Methyl-2-propyltrimethylene Ester |
Carisoprodol impurity C | 78-26-2 | C7H16O2 | 132.2 | 2-Methyl-2-propyl-1,3-propanediol |
Carisoprodol impurity B | 7148-50-7 | C8H14O3 | 158.2 | Carbonic acid 2-methyl-2-propyltrimethylene ester; NSC 65885; |
Carisbamate-d4 | 1292841-50-9 | C9H6ClNO3D4 | 219.66 | (1S)-1-(2-Chlorophenyl-d4)-1,2-ethanediol 2-Carbamate; JNJ 10234094-d4; RWJ 333369-d4; YKP 509-d4 |
Cariprazine-d6 | 1308278-67-2 | C21H26Cl2N4OD6 | 433.46 | |
Cariprazine hydrochloride | 1083076-69-0 | C21H33Cl3N4O | 463.87 | Cariprazine HCl; Vraylar; 3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea hydrochloride |
Cariprazine D8 | 1308278-50-3 | C21H24D8Cl2N4O | 435.46 | 3,3-dimethyl-1-[(1r,4r)-4-{2-[4-(2,3- dichlorophenyl)(D8)piperazin-1- yl]ethyl}cyclohexyl]urea |
Cariprazine | 839712-12-8 | C21H32Cl2N4O | 427.41 | Urea, N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N -diMethyl-;N'-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethylurea;RGH 188;3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1 |
Cariporide | 159138-80-4 | C12H17N3O3S | 283.35 | N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide; 4-isopropyl-3-(methylsulfonyl)benzoyl-guanidine methanesulfonate; cariporide; HOE 642; HOE-642; HOE642 |
caricotamide | 64881-21-6 | C8H11N3O2 | 181.1918 | |
Carfilzomib Impurity 2 | 1541172-75-1 | C40H59N5O8 | 737.94 | |
Carfilzomib | 868540-17-4 | C40H57N5O7 | 719.9 | Kyprolis; PR171; PR-171; PR 171; (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide |
Carfentrazone-Ethyl | 128639-02-1 | C15H14Cl2F3N3O3 | 412.19 | AFFINITY; ETHYL 2-CHLORO-3-[2-CHLORO-4-FLUORO-5-[4-(DIFLUOROMETHYL)-4,5-DIHYDRO-3-METHYL-5-OXO-1H-1,2,4TRIAZOL-1-YL]PHENYL]PROPANOAT; ETHYL-ALPHA,2-DICHLORO-5-[4-(DIFLUOROMETHYL)-4,5-DIHYDRO-3-METHYL-5-OXO-1H-1,2,4-TRIAZOL-1-YL]-4-FLUOROBENZENEPROPANOATE; |
Carfentrazone | 128621-72-7 | C13H10Cl2F3N3O3 | 384.14 | Affinty; ethyl (RS)-2-chloro-3-(2-chloro-5-(4-difluirimethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)-4-fluorophenyl)propionate; ethyl-2-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)-4-fluorobenzenepropanate; ca |
Carfenazine | 2622-30-2 | C24H31N3O2S | 425.587 g/mol | |
Cardol triene | 79473-24-8 | C21H30O2 | 314.5 | |
Cardol diene | 79473-25-9 | C21H32O2 | 316.5 | |
Cardionogen 1 | 577696-37-8 | C13H14N4OS | 274.34 | 6-Cyclohexyl-3-(2-furanyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole |
Cardiogenol C hydrochloride | 1049741-55-0 | C13H16N4O2·HCl | 296.75 | 2-[[2-(4-methoxyanilino)pyrimidin-4-yl]amino]ethanol hydrochloride |
Cardiogenol C | 671225-39-1 | C13H16N4O2 | 260.297 | Ethanol, 2-[[2-[(4-methoxyphenyl)amino]-4-pyrimidinyl]amino]-; 2-(4-Methoxyanilino)-4-(1-hydroxyethylamino)pyrimidine |
Carbuterol-d9 | 1346747-24-7 | C13H12N3O3D9 | 276.38 | N-[5-[2-[(1,1-Dimethylethyl-9)amino]-1-hydroxyethyl]-2-hydroxyphenyl]urea; Bronsecur-d9; Pirem-d9; SKF 40383-d9; SKF 40383A-d9 |
Carbuterol acetate hydrate | 1613439-57-8 | [5-(2-tert-Butylamino-1-hydroxyethyl)-2-hydroxyphenyl]-urea acetate hydrate | ||
Carbuterol | 34866-47-2 | C13H21N3O3 | 267.33 | [5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxyphenyl]urea; 34866-46-1 (Mono-hydrochloride); Carbuterolum; Carbuterolum [inn-latin]; Einecs 252-257-5; Unii-0N12jr32mr |
Carboxytolbutamide-d9(butyl-d9) | 1219802-95-5 | C12H7D9N2O5S | 309.38 | 1-Butyl-3-(4-carboxyphenylsulfonyl)urea |
Carboxy-PTIO, potassium salt | 148819-94-7 | C14H16KN2O4 | 315.38 | 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, potassium salt |
Carboxypolystyrene resin | 120246-33-5 | N/A | 0 | CARBOXYLIC ACID POLYSTYRENE RESIN; CARBOXYPOLYSTYRENE RESIN; 4-CARBOXYLIC ACID POLYSTYRENE RESIN; POLYSTYRENE CARBOXYLIC ACID; Carboxypolystyreneresin1%crosslinkedwithdvb1.4-1.6mmolg100-200mesh; Carboxypolystyrene resin, 1% crossl with DVB, 0.8-1.2 mmol/g |
CARBOXYPEPTIDASE P | 9075-64-3 | C8H17N2O5P | 0 | PROLINE CARBOXYPEPTIDASE; PENICILLOCARBOXYPEPTIDASE S-1; AMINOACYLPROLINE CARBOXYPEPTIDASE; CARBOXYPEPTIDASE P; CPP; EC 3.4.17.16; Carboxypeptidase P from Penicillium janthinellum; carboxypeptidase P from penicillium jan-thinellum |
Carboxypeptidase G2 (CPG2) Inhibitor | 192203-60-4 | C13H15NO6S | 313.33 | CPG2 Inhibitor; L-Glutamic acid, N-[[(4-methoxyphenyl)thio]carbonyl]- |
Carboxymethyl curdlan | 114732-86-4 | CM-curdlan | ||
Carboxymethyl chitosan | 83512-85-0 | N-Carboxymethyl chitosan | ||
Carboxymethyl cellulose sodium - Viscosity 100 - 300 mPa.s | 9004-32-4 | |||
Carboxymethyl cellulose | 9000-11-7 | |||
Carboxymefloquine | 35853-50-0 | C12H5F6NO2 | 309.1640192 | Carboxymefloquine; 2,8-bis-(Trifluoromethyl)-4-quinolin carboxylic acid |
Carboxylic acid celecoxib | 170571-01-4 | C17H12F3N3O4S | 411.36 | 4-[1-[4-(Aminosulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoic Acid; Celebrex Carboxylic Acid; |
Carboxy Gliclazide | 38173-52-3 | C15H19N3O5S | 353.40 | 4-[[[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)aMino]carbonyl]aMino]sulfonyl]benzoic Acid; S 2574 |
Carboxyethylsilanetriol sodium salt; 25% in water | 18191-40-7 | C3H7O5Si.Na | 174.159 | CARBOXYETHYLSILANETRIOL NA SALT 25% IN WATER; 25% IN WATER; CARBOXYETHYLSILANETRIOL, SODIUM SALT: 25% IN WATER |
Carboxyatractyloside potassium salt | 35988-42-2 | C31H44O18S2·2K | 847 | |
Carboxyatractyloside | 33286-30-5 | C31H46O18S2 | (2beta,15alpha)-15-Hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioic acid | |
Carboxyamidotriazole orotate | 187739-60-2 | C22H16Cl3N7O6 | 580.763 | Carboxyamidotriazole orotate; CTO; |
Carboxy Tolperisone Hydrochloride | 446063-44-1 | C16H21NO3.HCl | 311.81 | Tolperisone 4-Carboxylic Acid Hydrochloride Hydrate; 4-[2-Methyl-1-oxo-3-(1-piperidinyl)propyl]benzoic Acid Hydrochloride Hydrate |
Carboxin | 5234-68-4 | C12H13NO2S | 235.3 | |
Carbovir Triphosphate Triethylamine Salt | 1391048-07-9 | 487.19 | rel-P-[[(1R,4S)-4-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl]methyl] Ester Triphosphoric Acid Triethylamine Salt; Abacavir - In House Impurity;cis-(±)-P-[[4-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl]methyl] Ester Triph | |
Carbovir Monophosphate | 144490-73-3 | C11H14N5O5P | 327.23 | rel-2-Amino-1,9-dihydro-9-[(1R,4S)-4-[(phosphonooxy)methyl]-2-cyclopenten-1-yl]-6H-purin-6-one; cis-(±)-2-Amino-1,9-dihydro-9-[4-[(phosphonooxy)methyl]-2-cyclopenten-1-yl]-6H-purin-6-one; Carbovir 5'-Phosphate; Abacavir - In House Impurity; Abacavir Impur |
Carbovir | 118353-05-2 | C11H13N5O2 | 247.25 | rel-2-Amino-1,9-dihydro-9-[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]-6H-purin-6-one; (+/-)-Carbovir; cis-Carbovir; GR 90352X; NSC 614846; |
Carbosulfan | 55285-14-8 | C20H32N2O3S | 380.54 | POSSE(R);((dibutylamino)thio)methylcarbamicacid,2,2-dimethyl-2,3-dihydro-7-benzofura;2,2-Dimethyl-2,3-dihydro-1-benzofuran-7-yl (dibutylamino)sulfanyl(methyl)carbamate;2,3-dihydro-2,2-dimethyl-7-benzofuranyl((dibutylamino)thio)methylcarbamate;2,3-dihydro |
Carbosperse K 776 | 97953-25-8 | C10H17NNa2O9S2 | 0 | Carbosperse K 776; Copolymer of acrylic acid and 2-acrylamido-2-methylpropyl sulfonic acid |
Carboset XPD 1234 | 25086-15-1 | C9H14O4 | 186.2051 | 2-methyl-2-propenoicacipolymerwithmethyl2-methyl-2-propenoate; 2-Propenoicacid,2-methyl-,polymerwithmethyl2-methyl-2-propenoate; eudispert; Methacrylicacid,polymerwithmethylmethacrylate; Methyl2-methyl-2-propenoate,2-methyl-2-propenoicacidcopolymer; Methy |
Carboprost tromethamine | 58551-69-2 | C25H47NO8 | 489.65 | Hemabate; Carboprost Trometanol; 2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid |
Carboprost | 35700-23-3 | C21H36O5 | 368.51 | |
Carboplatin Impurity B (Cyclobutane-1,1-dicarboxylic acid) | 5445-51-2 | C6H8O4 | 144.13 | 1,1-Cyclobutanedicarboxylic acid |
Carboplatin Impurity 1 | 903630-03-5 | C6H14N2O5Pt | 389.29 | |
Carboplatin | 41575-94-4 | C6H12N2O4Pt | 371.25 | JM-8; JM 8; JM8; CBDCA, NSC 241240; NSC241240; NSC-241240 |
Carbophenothion-methyl | 953-17-3 | C9H12ClO2PS3 | 314.81 | TRITHION METHYL; Dimethyl (((p-chlorophenyl)thio)methyl) dithiophosphate; dimethylp-chlorophenylthiomethyldithiophosphate; ENT 25,599; ENT 25586; ent25,599; ent25586; G-29288 |
carbonyl dibromide | 593-95-3 | CBr2O | 187.818 g/mol | carbonyldibromide; Carbonyldibromide; Carbonicdibromide; 593-95-3; bromoketone; Bromophosgene |
Carbonochloridic acid,5-methyl-2-(1-methylethyl)cyclohexyl ester, (1S,2R,5S)- | 7635-54-3 | C11H19 Cl O2 | 218.72 | (+)-MENTHYL CHLOROFORMATE; (+)-CHLOROFORMYLOXY-P-MENTHANE; (+)-(1S)-MENTHYL CHLOROFORMATE; (1S)-(+)-MENTHYL CHLOROFORMATE; (+)-MENTHYL CHLOROFORMATE (97% EE/GLC); (+)-MENTHYL CHLOROFORMATE 97%; (R)-(-)-Menthyl Chloroformate; (1S)-(+)-Menthylchloroformate, |
Carbonimidodithioicacid, cyano-, 4-methoxyphenyl methyl ester (9CI) | 152381-97-0 | C10H10 N2 O S2 | 238.33 | (4-METHOXYPHENYL) METHYL CYANOCARBONIMIDODITHIOATE |
Carbonimidodithioicacid, cyano-, 3-fluorophenyl methyl ester (9CI) | 152382-01-9 | C9H7 F N2 S2 | 226.29 | (3-FLUOROPHENYL) METHYL CYANOCARBONIMIDODITHIOATE; (Fluorophenyl) methyl cyanocarbonimidodithioate |
Carbonimidodithioicacid, cyano-, 3,4-dichlorophenyl methyl ester (9CI) | 152382-17-7 | C9H6 Cl2 N2 S2 | 277.19 | (3,4-DICHLOROPHENYL) METHYL CYANOCARBONIMIDODITHIOATE; (3,4-Dichlorophenyl) methyl |
Carbonimidodithioicacid, cyano-, 2-chlorophenyl methyl ester (9CI) | 152381-98-1 | C9H7 Cl N2 S2 | 242.75 | 152381-98-1;CARBONIMIDODITHIOICACID,CYANO-,2-CHLOROPHENYLMETHYLESTER(9CI);(2-Chlorophenyl)methylcyanocarbonimidodithioate;ZINC04290414;AC1MC4IR;MolPort-000-159-881 |
Carbonic Anhydrase from bovine erythrocytes | 9001-03-0 | Carbonate Dehydratase, Carbonate Hydrolyase | ||
Carbonic acid,trithio-, dipotassium salt, monohydrate (8CI) | 19086-12-5 | CH2 S3 . H2 O . 2 K | 204.42 | |
Carbonic acid, magnesium salt | 7757-69-9 | CH2MgO4 | 102.32918 | Magnesiumcarbonatehydrate,Puratronic,99.996%(metalsbasis); Carbonic acid/magnesium,(1:x) salt; Carbonic acid, magnesium salt (1:); Einecs 231-817-2 |
Carbonic acid 4-nitrophenyl 5-thiazolylmethyl ester | 144163-97-3 | C11H8N2O5S | 280.26 | (4-nitrophenyl)1,3-thiazol-5-ylmethylcarbonate; 144163-97-3; ((5-THIAZOLYL)METHYL)-(4-NITROPHENYL)CARBONATE; 4-Nitrophenyl(thiazol-5-ylmethyl)carbonate; Thiazolylmethyl-4-nitrophenylcarbonate; Carbonicacid4-Nitrophenyl5-thiazolylmethylester |
Carbonic acid | 463-79-6 | CH2O3 | 62.0248 g/mol | |
Carbon-13C disulfide | 30860-31-2 | CS2 | 77.13 | methanedithione;Carbon-13Cdisulfide;30860-31-2;CARBONDISULFIDE;486434_ALDRICH;AKOS015913073 |
Carbon fluoride | 51311-17-2 | (CF)mult | 31.009 | CEFBON; GRAPHITE FLUORIDE; GRAPHITE, FLUORINATED; GRAPHITE, FLUORINATED, POLYMER; Fluorinatedcarbon; GRAPHITE FLUORINATED, 3.35A PARTICLE SIZE -100 MESH 99% |
CARBON DIOXIDE | 1111-72-4 | CO2 | 45.002155;g/mol | methanedione; Carbon-13Cdioxide; 1111-72-4; 13CLabeledcarbondioxide; 364592_ALDRICH; 486418_ALDRICH |
Carbon Black | 1333-86-4 | C | 12.01 | |
Carbomethoxyethylthioethyl 4-O-(4-O-[6-O-{a-D-glucopyranosyl}-a-D-glucopyranosyl]-a-D-glucopyranosyl)-b-D-glucopyranoside | 90214-99-6 | C30H52O23S | 812.79 | |
Carbomethoxyethylthioethyl 2-acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranoside | 87019-31-6 | C20H35NO13S | 529.56 | |
Carbomer 980 | 139637-85-7 | C8H8O2 | 136.15 | |
Carbomer 940 | 76050-42-5 | C3H4O2 | 72.06 | Acrylic acid; 2-Propenoic acid; Propenoic acid; prop-2-enoic acid; acritamer 940; Acrypol 940; Carbopol 940; Carbopol cv 940 |
Carbomer 934 | 9007-16-3 | C5H10O2 | 102.13 | Carbopol 934; 2-Methylbutanoic acid |
Carbomer 1342 | 96827-24-6 | |||
Carbomer | 54182-57-9 | Carbopol | ||
Carbomer | 9007-20-9 | C3H4O2 | 72.06270 | |
Carbogen | 8063-77-2 | CO4 | 0 | CARBOGEN; Carbon dioxide, mixt. with oxygen; CARBON DIOXIDE-OXYGEN MIXTURE); carbogen - carbon dioxide/oxygen mixture, > 25% oxygen; BOC Carbogen; CARBONDIOXIDEMIXEDWITHOXYGEN |
Carbofuran-D3 | 1007459-98-4 | 2,2-Dimethyl-7-methyl- D3-carbamoyloxy-2,3- dihydro-benzofuran | ||
Carbodenafil-d5 | 1324230-58-1 | C24H27N6O3D5 | 457.59 | 5-[2-Ethoxy-5-[(4-ethyl-d5-1-piperazinyl)carbonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; Fondenafil-d5 |
Carbodenafil | 944241-52-5 | C24H32N6O3 | 452.55 | 5-[2-Ethoxy-5-[(4-ethyl-1-piperazinyl)carbonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; Fondenafil |
Carbocloral | 541-79-7 | C5H8Cl3NO3 | 236.48 | CI-336;CN-16146;NSC-33077;N-(2,2,2-trichloro-1-hydroxy-ethyl)carbamic acid ethyl ester;Chloralurethane;Prodorm;Uraline;Uralium;ethyl N-(2,2,2-trichloro-1-hydroxyethyl)carbamate;HY185;HY-185;NSC33077;(2,2,2-Trichloro-1-hydroxyethyl)carbamic acid ethyl este |
Carbocisteine-13C3 | 1391068-19-1 | C5H9NO4S | 182.16 | S-Carboxymethyl-L-cysteine-13C3; (2R)-2-Amino-3-[(carboxymethyl)thio]propionic Acid-13C3; (R)-S-(Carboxymethyl)cysteine-13C3; (L)-2-Amino-3-(carboxymethylthio)propionic Acid-13C3; 3-[(Carboxymethyl)thio]-L-alanine-13C3; AHR 3053-13C3; Bronchokod-13C3; Car |
Carbocisteine Sulfoxide (Mixture of diastereomers) | 5439-87-2 | C5H9NO5S | 195.19 | 3-[(Carboxymethyl)sulfinyl]-L-alanine; Carboxymethyl-L-cysteine Sulfoxide; NSC 15388; S-Carboxymethyl-L-cysteine Sulfoxide |
Carbocisteine Lactam Sodium Salt | 88933-48-6 | C5H6NNaO3S | 183.16 | (3R)-5-Oxo-3-thiomorpholinecarboxylic Acid Monosodium Salt; (R)-5-Oxo-3-thiomorpholinecarboxylic Acid Sodium Salt; (3R)-3-Carboxy-5-oxothiomorpholine Sodium Salt |
Canusesnol A | 816456-90-3 | C15H22O3 | 250.3 | (4aS,7S)-7-Hydroxy-7-(2-hydroxy-2-propanyl)-1,4a-dimethyl-5,6,7,8 -tetrahydro-2(4aH)-naphthalenone |
Carbinoxamine Maleate | 3505-38-2 | C16H19ClN2O. C4H4O4 | 290.80 116.07 | 2-[(4-Clorophenyl)-2-pyridinylmethoxy]-N,N-dimethylethanamine Maleate Salt; Allergefon; Clistin; Ciberon; Lergefin; |
Carbinoxamine Impurity B | 14159-57-0 | C12H11NO | 185.23 | |
Carbinoxamine | 486-16-8 | C16H19ClN2O | 290.79 | 2-[(4-Clorophenyl)-2-pyridinylmethoxy]-N,N-dimethylethanamine; |
Carbimazole | 22232-54-8 | C7H10N2O2S | 186.23 | Carbimazole |
Carbidopa Impurity F | 1458640-32-8 | C12H18N2O4 | 254.29 | |
Carbidopa Hydrate | 38821-49-7 | C10H14N2O4.H2O | 244.247 | Carbidopa Monohydrate; Carbidopa-1-wasser |
Carbidopa | 28860-95-9 | C10H14N2O4 | 226.23 | Carbidopa |
Carbetocin | 37025-55-1 | C45H69N11O12S | 988.16 | Duratocin; Pabal; Lonactene |
Carbetamide | 16118-49-3 | C12H16N2O3 | 236.27 | (R)-()-1-(Ethylcarbamoyl)ethyl N-phenylcarbamate |
Carbenicillin Disodium | 4800-94-6 | C17H16N2Na2O6S | 422.36 | (2S,5R,6R)-6-[(2-Carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium Salt; N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-6-yl)-2-phenylmalonamic Acid Disodium Salt; Anabactyl; Carbap |
Carbenicillin | 4697-36-3 | C17H18N2O6S | 378.4 | Geocillin |
Carbendazim-d4 | 291765-95-2 | C9H5N3O2D4 | 195.22 | N-1H-(Benzimidazol-d4)-2-yl-carbamic Acid Methyl Ester; 2-(Benzimidazole-d4)carbamic Acid Methyl Ester; Carbendazole-d4; BMC-d4; MBC-d4; BCM-d4; BAS-3460-d4; BAS-67054-d4; CTR-6669-d4 |
Carbendazim-d3 | 1255507-88-0 | C9H6N3O2D3 | 194.21 | Methyl-d3 2-benzimidazolecarbamate |
Carbazole-d8,NH | 38537-24-5 | 175.255854;g/mol | 1,2,3,4,5,6,7,8-octadeuterio-9H-carbazole; Carbazole-d8,NH; CARBAZOLE(RING-D8); SCHEMBL1923220; 38537-24-5; 97960-57-1 | |
Carbazochrome sodium sulfonate (AC-17) | 51460-26-5 | C10H11N4NaO5S | 322.27 | |
Carbazochrome | 69-81-8 | C10H12N4O3 | 236.23 | 2-(1,2,3,6-Tetrahydro-3-hydroxy-1-methyl-6-oxo-5H-indol-5-ylidene)hydrazinecarboxamide; 3-Hydroxy-1-methyl-5,6-indolinedione 5-Semicarbazone; Adrenochrome Semicarbazone; Adchnon; Adedolon; Adrenochrome Monosemicarbazone; Adrenostazin; Adrenoxyl; Adrezon; |
CARBAZINE | 92-81-9 | C13H11N | 181.23 | 9,10-dihydro-acridin; Acridane; CARBAZINE; ACRIDAN; 9 10-DIHYDROACRIDINE; AI3-09022; ms-Dihydroacridine; Acridine, 9,10-dihydro- |
Carbazeran citrate | 153473-94-0 | C18H24N4O4.C6H8O7 | 552.53 | Ethyl 1-(6,7-dimethoxy-1-phthalazinyl)-4-piperidinyl carbamate citrate |
Carbazeran | 70724-25-3 | C18H24N4O4 | 360.41 | N-Ethylcarbamic Acid 1-(6,7-Dimethoxy-1-phthalazinyl)-4-piperidinyl Ester; Ethylcarbamic Acid 1-(6,7-Dimethoxy-1-phthalazinyl)-4-piperidinyl Ester; UK 31557;153473-94-0(Carbazeran citrate) |
Carbasalate Calcium | 5749-67-7 | C18H14CaO8.CH4N2O | 458.434 | Carbaspirin calcium; Carbaspirin; Carbasalate calcium |
Carbaryl-D3 | 1433961-56-8 | 1-Naphthol-N-methyl-D3- carbamate | ||
Carbaprostacyclin methyl ester | 69552-55-2 | C22H36O4 | 364.5 | |
CARBAMYL PHOSPHATE DILITHIUM SALT | 1866-68-8 | CH2Li2NO5P | 152.89 | LITHIUM CARBAMOYLPHOPHATE, DIBASIC; CARBAMYL PHOSPHATE DILITHIUM SALT; CARBAMYL PHOSPHORIC ACID DILITHIUM SALT; CARBAMOYLPHOSPHATE DILITHIUM SALT; CAP-LI2; carbamyl phosphate dilithium; Lithium carbamoylphosphate dibasic; dilithium carbamoyl phosphate |
Carbamoyl-DL-aspartic acid | 923-37-5 | C5H8N2O5 | 176.13 | Carbamoyl-DL-aspartic acid; N-Carbamoyl-DL-aspartic acid |
carbamoyl chloride | 463-72-9 | CH2ClNO | 79.48568 | carbamoyl chloride; carbamic chloride; carbamyl chloride; chloroformamide |
Carbamodithioic acid,ethyl ester | 625-61-6 | C3H7 N S2 | 121.22400 | |
Carbamimidothioic acid, nitro-methylester | 2986-25-6 | C2H5N3O2S | 135.145;g/mol | N-Nitro-S-methylisothiourea; 2986-25-6; S-Methyl-N-nitroisothiourea[14C]; N-Nitro-S-methylisothiourea; N-Nitro-S-methylpoundinvertedquestionmarkisothiourea; methylN'-nitrocarbamimidothioate |
Carbamimidic acid,N,N'-bis(1-methylethyl)-, (4-nitrophenyl)methyl ester | 2978-11-2 | C14H21 N3 O3 | 279.3348 | NBDI; O-(4-NITROBENZYL)-N,N'-DIISOPROPYLISOUREA; O-P-NITROBENZYL N,N'-DIISOPROPYLISOUREA; O-(P-NITROBENZYL)-N,N'-DIISOPROPYLUREA; O-(P-NITROPHENYL)-N,N'-DIISOPROPYLUREA; N,N'-DIISOPROPYL-O-(4-NITROBENZYL)ISOUREA; PNBDI; n,n'-bis(1-methylethyl)-carbamimidi |
Carbamicacid, ethyl(4-piperidinylmethyl)-, 1,1-dimethylethyl ester (9CI) | 158958-41-9 | C13H26 N2 O2 | ||
Carbamicacid, [cis-4-(2-aminoethyl)cyclohexyl]-, 1,1-dimethylethyl ester (9CI) | 509143-12-8 | C13H26 N2 O2 | ||
Carbamicacid, (2-cyclopropyl-2-hydroxyethyl)-, 1,1-dimethylethyl ester (9CI) | 121102-91-8 | C10H19 N O3 | 201.26276;g/mol | tert-butylN-(2-cyclopropyl-2-hydroxyethyl)carbamate; 121102-91-8; Carbamicacid,(2-cyclopropyl-2-hydroxyethyl)-,1,1-dimethylethylester(9CI); ACMC-20mpaj; SCHEMBL571099; CTK4B2180 |
Carbamic acid,N-[2-(2-aminophenyl)ethyl]-, 1,1-dimethylethyl ester | 180147-34-6 | C13H20 N2 O2 | 236.31 | [2-(2-AMINO-PHENYL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER |
Carbamic acid,N,N-bis(2-chloroethyl)-, phenylmethyl ester | 72791-76-5 | C12H15 Cl2 N O2 | 276.16 | N-CBZ-N,N-BIS(2-CHLOROETHYL)AMINE; benzyl bis(2-chloroethyl)carbamate |
Carbamic acid,N-(2-aminoethyl)-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-,1,1-dimethylethyl ester | 120131-72-8 | C14H29 N3 O4 | 303.4 | 1,4-BIS-BOC-1,4,7-TRIAZAHEPTANE |
Carbamic acid,[(4-cyano-3-fluorophenyl)methyl]-, 1,1-dimethylethyl ester (9CI) | 229623-55-6 | C13H15 F N2 O2 | 250.2688032 | TERT-BUTYL 4-CYANO-3-FLUOROBENZYLCARBAMATE |
Carbamic acid, N-[2-[(R)-(3-chlorophenyl)(3R)-3-piperidinylmethoxy]ethyl]-, methyl ester | 942142-80-5 | C16H23ClN2O3 | 326.81800 | |
Carbamic acid, N-[1-[4-(2-phenylacetyl)phenyl]cyclobutyl]-, 1,1-dimethylethyl ester | 1032349-98-6 | C23H27NO3 | 365.46538;g/mol | tert-butylN-[1-[4-(2-phenylacetyl)phenyl]cyclobutyl]carbamate; TERT-BUTYL(1-(4-(2-PHENYLACETYL)PHENYL)CYCLOBUTYL)CARBAMATE; 1032349-98-6; SCHEMBL361871; CXYVWHPPHMMIFX-UHFFFAOYSA-N; MolPort-035-757-628 |
Carbamic acid, N-[(1S)-1-(aminomethyl)-2-[(3R)-tetrahydro-2H-pyran-3-yl]ethyl]-N-methyl-, 1,1-dimethylethyl ester | 942145-27-9 | C14H28N2O3 | 272.38400 | |
Carbamic acid, 5-hexenyl-, 1,1-dimethylethyl ester (9CI) | 202926-14-5 | C11H21NO2 | 199.28994 | Carbamic acid, 5-hexenyl-, 1,1-dimethylethyl ester (9CI) |
Carbamic acid, 3-butynyl-, 1,1-dimethylethyl ester (9CI) | 149990-27-2 | C9H15NO2 | 169.2209 | tert-butylN-but-3-ynylcarbamate; tert-Butylbut-3-yn-1-ylcarbamate; 149990-27-2; TERT-BUTYL3-BUTYN-1-YLCARBAMATE; tert-butylbut-3-ynylcarbamate; TERT-BUTYLN-(BUT-3-YN-1-YL)CARBAMATE |
Carbamic acid, [3-(dimethylamino)propyl]-, 1,1-dimethylethyl ester (9CI) | 216659-47-1 | C10H22N2O2 | 202.29388 | tert-butylN-[3-(dimethylamino)propyl]carbamate; 216659-47-1; TERT-BUTYL3-(DIMETHYLAMINO)PROPYLCARBAMATE; CARBAMICACID,[3-(DIMETHYLAMINO)PROPYL]-,1,1-DIMETHYLETHYLESTER(9CI); AmbkkkkK578; SCHEMBL285008 |
Carbamic acid, (2-amino-2-iminoethyl)-, 1,1-dimethylethyl ester (9CI) | 251294-65-2 | C7H15N3O2 | 173.2129 | tert-butylN-(2-amino-2-iminoethyl)carbamate; tert-Butyl(2-amino-2-iminoethyl)carbamate; 251294-65-2; Tert-butylN-(carbamimidoylmethyl)carbamate; CARBAMICACID,(2-AMINO-2-IMINOETHYL)-,1,1-DIMETHYLETHYLESTER(9CI); SCHEMBL1394865 |
Carbamic acid isopropyl ester | 1746-77-6 | C4H9NO2 | 103.14 | CARBAMIC ACID ISOPROPYL ESTER; ISOPROPYL CARBAMATE; carbamicacid,1-methylethylester; Isopropylester kyseliny karbaminove; isopropylesterkyselinykarbaminove; Carbamic acid isopropyl |
Carbamazepine-d10 | 132183-78-9 | C15H2N2OD10 | 246.33 | [D10]-Carbamazepine; [2H10]-Carbazepine; DTXSID30497060; AN-32203 |
Carbamazepine-10,11-epoxide | 36507-30-9 | C15H12N2O2 | 252.28 | 1a,10b-Dihdyro-6H-dibenzo[b,f]oxireno[d]azepine-6-carboxamide; 10,11-Dihydro-10,11-epoxycarbamazepine; 10,11-Epoxycarbamazepine; Carbamazepine 10,11-oxide; GP 49-023 |
Carbamazepine-10, 11-epoxide-d10 | 1219804-16-6 | C15H2N2O2D10 | 262.33 | 10,11-Epoxycarbamazepine |
Iminostilbene | 256-96-2 | C14H11N | 193.24 | 5H-Dibenz[b,f]azepine; 2,2'-Iminostilbene; 5-Azadibenzo[a,e]cycloheptatriene; 5H-Dibenzo[b,f]azepine; NSC 123458; RP 9989; Carbamazepine EP Impurity D |
Carbamazepine Impurity C | 1219170-51-0 | C16H13N3O2 | 279.3 | N-Carbamoyl Carbamazepine |
Carbamazepine EP Impurity G | 59690-97-0 | C15H11BrN2O | 315.17 | 10-Bromo-5H-dibenzo[b,f]azepine-5-carboxamide; 5-bromobenzo[b][1]benzazepine-11-carboxamide |
Carbamazepine | 298-46-4 | C15H12N2O | 236.27 | NSC 169864; NSC169864; NSC-169864 |
Carbadox | 6804-07-5 | C11H10N4O4 | 262.22 | |
Carazolol-D7 | 1173021-02-7 | 1-(9H-Carbazol-4-yloxy)- 3-isopropyl-D7-amino- propan-2-ol | ||
Carazolol | 57775-29-8 | C18H22N2O2 | 298.386 | 1-(9H-Carbazol-4-yloxy)-3-isopropylaminopropan-2-ol |
Caraphenol A | 354553-35-8 | C42H28O9 | 676.7 | (2S,2aS,7R,7aR)-2,7,12-Tris(4-hydroxyphenyl)-2,2a,7,7a-tetrahydro bis[1]benzofuro[3',4':4,5,6,3'',4'':7,8,9]cyclonona[1,2,3-cd][1]b enzofuran-4,9,14-triol |
CARAMEL FURANONE (3% IN TRIACETIN) | 28664-35-9 | C6H8O3 | 128.13 | 2(5H)-Furanone, 3-hydroxy-4,5-dimethyl- [28664-35-9] in 1,2,3-Propanetriol, triacetate [102-76-1], 4,5-Dimethyl-3-hydroxy-2,5-dihydrofuran-2-one in Triacetin, CARAMEL FURANONE (3% IN TRIACETIN), Contains 3% FEMA/GRAS # 3634 |
Caramel | 8028-89-5 | |||
Caracemide | 81424-67-1 | C6H11N3O4 | 189.17 | NSC 253272;N-(methylcarbamoyl)-N-((methylcarbamoyl)oxy)acetamide |
Carabrolactone B | 1187925-31-0 | C15H22O4 | 266.3 | (3aS,4S,4aS,5S,7aS,8R,9aS)-decahydro-4,5-Dihydroxy-4a,8-dimethyl-3-methyleneazuleno[6,5-b]furan-2(3H)-one |
Carabrolactone A | 1187925-30-9 | C15H22O5 | 282.3 | |
Carabersat | 184653-84-7 | C20H20FNO4 | 357.38 | N-[(3R,4S)-6-acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-4-fluorobenzamide; SB 204269; SB-204269 |
Captopril-d3 | 1356383-38-4 | C9H12NO3SD3 | 220.31 | (2S)-1-(3-Marcapto-2-methyl-1-oxopionyl]-L-proline-2,5,5-d3; SQ-14225-d3 |
Captopril Impurity N | 65134-74-9 | C8H14O4S2 | 238.33 | |
Captopril Impurity G | 33325-40-5 | C6H10O3S | 162.21 | 3-(Acetylthio)-2-methylpropanoic Acid; 3-Mercapto-2-methylpropionic Acid Acetate (RS)-3-Acetylthio-2-methylpropionic Acid; (±)-3-Acetylthio-2-methylpropionic Acid; 2-(Acetylthiomethyl)propanoic Acid; 3-(Acetylthio)-2-methylpropanoic Acid; 3-Acetylsulfanyl |
Captopril Impurity F | 63250-36-2 | C9H15NO3S | 217.29 | 1-[(2R)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline; 2-D-Methyl-3-mercaptopropanoyl-L-proline; SQ 14534; Epicaptopril |
Captopril EP Impurity E | 23500-15-4 | C9H15NO3 | 185.22 | (2S)-1-(2-Methylpropanoyl)pyrrolidine-2-carboxylic acid, 1-Isobutyryl-L-proline |
Captopril EP Impurity B | 80629-35-2 | C9H14BrNO3 | 264.12 | (S)-1-(3-bromo-2-methyl-1-oxopropyl)-L-proline |
Captopril EP Impurity A (Captopril disulfide) | 64806-05-9 | C18H28N2O6S2 | 432.56 | 1,1'-[Dithiobis[(2S)-2-methyl-1-oxo-3,1-propanediyl]]bis-L-proline CAPTOPRDS; SQ 14551; Captopril Imp. A (BP) |
Captopril | 62571-86-2 | C9H15NO3S | 217.29 | ISF 2522; ISF2522; ISF-2522; Captopril, Capoten, SQ14225, SQ 14225, SQ-14225, SQ14,225, SQ 14,225, SQ-14,225 |
Captan solution | 133-06-2 | C9H8Cl3NO2S | 300.58932;g/mol | CAPTAN; 133-06-2; Amercide; Orthocide; Vondcaptan; Captaf |
Captamine | 108-02-1 | C4H11NS | 105.2 | (2-mercaptoethyl)dimethylamine; (dimethylamino)ethylmercaptan; 2-(Dimethylamino)-1-ethanethiol; 2-(dimethylamino)-ethanethio; captamine; n,n-dimethylcysteamine |
Capsicum annuum annuum, longum group, cayenne, ext. | 84603-55-4 | |||
Capsiconiate | 946572-73-2 | C20H28O4 | 332.4 | Coniferyl (E)-8-methyl-6-nonenoate |
Capsiate | 205687-01-0 | C18H26O4 | 306.39700 | |
Capsazepine | 138977-28-3 | C19H21ClN2O2S | 376.91 | N-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide |
Capryloyl salicylic acid | 78418-01-6 | C15H20O4 | 264.32 | Capryloyl salicylic acid; 5-Octanoylsalicylic acid |
Capryloyl Glycine | 14246-53-8 | C10H19NO3 | 201.27 | N-Octanoylglycine; N-(1-Oxooctyl)glycine; Capryloylglycine; Lipacide C 8G; 2-Octanoylaminoacetic acid |
Caprospinol | 4952-56-1 | C33H52O4 | 512.76 | Diosgenin caproate; Diosgenin, hexanoate; SP-233 |
Caprooyl tetrapeptide-3 | 1012317-71-3 | C28H51N9O7 | 625.761 | L-Lysyl-N-hexanoylglycyl-L-histidyl-L-lysinamide acetate |
Capromorelin Tartrate | 193273-69-7 | C32H41N5O10 | 655.7 | N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamide;(2R,3R)-2,3-dihydroxybutanedioic acid; Capromorelin (Tartrate); Capromorelin tartrate [USAN]; 4150VMF5EP |
Capric Acid Cholesterol Ester | 1183-04-6 | C37H64O2 | 540.9 | |
Capric acid | 334-48-5 | C10H20O2 | 172.27 | CAPRIC ACID (NATURAL), Decanoic acid, Kortacid 1099 |
Capreomycin sulfate | 1405-37-4 | C24H42N14O8.H2SO4 | 752.8 | Kapreomycin; Capostatin; HSDB 3211; HSDB-3211; HSDB3211; (2S)-2,5-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec- |
Capreomycin | 11003-38-6 | C50H88N28O15 | 1321.41 | Capromycin, Caprolin, Capastat, Capostatin, L 29275 |
Caprarioside | 1151862-69-9 | C22H28O11 | 342.29 | 8-O-Benzoylharpagide |
Capobenic-Acid | 21434-91-3 | C16H23NO6 | 325.35692;g/mol | 6-[(3,4,5-trimethoxybenzoyl)amino]hexanoicacid; CAPOBENICACID; Trifartine; ATBAC; 21434-91-3; UNII-3R77T835TA |
Capmatinib | 1029712-80-8 | C23H17FN6O | 412.43 | INCB28060; INC-280; INC280 |
Capillarisin | 56365-38-9 | C16H12O7 | 316.26 | Capillarisin |
Capecitabine Related Compound C | 921769-65-5 | C16H20FN3O7 | 385.35 | 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine Cyclic 2',3'-Carbonate; |
Capecitabine impurity D | 910129-15-6 | C15H22FN3O6 | 359.36 | |
Capecitabine Impurity 3 (Defluoro Capecitabine) | 216450-02-1 | C15H23N3O6 | 341.37 | 5'-Deoxy-N-[(pentyloxy)carbonyl]cytidine |
Canthin-6-one | 479-43-6 | C14H8N2O | 220.2 | 6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one |
Cantharidic acid sodium salt | 1465-77-6 | C10H12O5·2Na | 258.2 | |
CANTHARIDIC ACID | 28874-45-5 | C8H10O5 | 186.16 | 5'-3'2,3-DICARBOXY-2,3-DIMETHYL-1,4-EPOXYCYCLOHEXANE; CANTHARIDIC ACID; CANTHARIDIC ACID DISODIUM SALT; EXO-1,6-DICARBOXY-ENDO-1,6-DIMETHYL-7-OXABICYCLO[2,2,1]HEPTANE; EXO-1,6-DICARBOXY-ENDO-1,6-DIMETHYL-7-OXABICYLCO[2,2,1]HEPTANE |
Canagliflozin alpha-Isomer Impurity | 1589590-87-3 | C24H25FO5S | 444.53 | (1R)-1,5-Anhydro-1-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-D-glucitol; |
Canophyllal | 14440-40-5 | C30H48O2 | 440.712 | 3-oxofriedelan-28-al; Friedelane-3-one-28-al |
Canola oil | 120962-03-0 | Rapeseed oil | ||
Canniprene | 70677-47-3 | C21H26O4 | 342.4 | 3-[2-(3-Hydroxy-5-methoxyphenyl)ethyl]-6-methoxy-2-(3-methyl-2-butenyl)phenol |
Cannabivarin | 33745-21-0 | C19H22O2 | 282.383 | Cannabivarol; CBV |
Cannabispirenone A | 63213-00-3 | C15H16O3 | 244.29 | (3R)-4-hydroxy-6-methoxyspiro[1,2-dihydroindene-3,4'-cyclohex-2-ene]-1'-one |
Cannabigerol | 25654-31-3 | C21H32O2 | 316.48 | |
Cannabidiol dimethyl ether | 1242-67-7 | C23H34O2 | 342.5 | CBDD; Cannabidiol-2',6'-dimethyl ether |
Cangrelor tetrasodium | 163706-36-3 | C17H21Cl2F3N5Na4O12P3S2 | 864.274 | AR-C69931MX; AR C69931MX; N6-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)-betagamma-dichloromethylene-ATP tetrasodium salt |
Cangrelor Metabolite (Cangrelor Impurity 3) | 163706-58-9 | C16H22F3N5O4S2 | 469.51 | |
Cangrelor Impurity 8 | 1830294-25-1 | C11H14F3N5S2 | 337.39 | |
Cangrelor Impurity 6 | 43157-50-2 | C10H13N5O4S | 299.31 | |
Cangrelor Impurity 5 | 163706-51-2 | C13H16F3N5O4S | 395.36 | |
Cangrelor Impurity 4 | 1830294-26-2 | C22H28F3N5O7S2 | 595.62 | |
Cangrelor Impurity 2 | 847460-53-1 | C16H23F3N5O6PS2 | 533.49 | |
Cangrelor Impurity 1 | 1054332-15-8 | C19H25F3N7O5PS2 | 583.55 | |
Cangrelor | 163706-06-7 | C17H25Cl2F3N5O12P3S2 | 776.37 | Kengreal; UNII-6AQ1Y404U7; AR-C69931XX; AR-C69931MX; [dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid |
Canfosfamide Hydrochloride | 439943-59-6 | C26H41Cl5N5O10PS | 823.93 | Telcyta; TER 286; TLK 286; N5-(((2-((bis(bis(2-chloroethyl)amino)phosphoryl)oxy)ethyl)sulfonyl)-D-alanyl)-N5-((R)-carboxy(phenyl)methyl)-L-glutamine hydrochloride; |
Canfosfamide | 158382-37-7 | C26H40Cl4N5O10PS | 787.465 | TELCYTA; TLK286; |
Canertinib dihydrochloride | 289499-45-2 | C24H27Cl3FN5O3 | 558.86 | N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide; CI1033PD183805 |
Canertinib | 267243-28-7 | C24H25ClFN5O3 | 485.94 | PD183805,CI-1033 |
Candicidin complex | 1403-17-4 | C59H84N2O18 (for Candicidin D) | 1109.3 | Levorin |
Candesartan Ethyl Ester | 139481-58-6 | C26H24N6O3 | 468.52 | 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid Ethyl Ester; |
Candesartan D4 | 1346604-70-3 | C24H16D4N6O3 | 444.48 | 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1-(phenyl-d4)-1'-phenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid; CV-11974-d4; Candesartan M1-d4; 3-[[2'-(1H-Tetrazol-5-yl)[1-(phenyl-d4)-1'-phenyl]-4-yl]methyl]-2-ethoxy-3H-benzimidazole-4-carboxylic Acid |
Candesartan Cilexetil Impurity D | 1185256-03-4 | C33H34N6O6 | 610.68 | 2-Hydroxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester; Candesartan Cilexetil Impurity D; (RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl-3-[[2'- (2-ethyl-2H-tetraz |
Candesartan Cilexetil Impurity C | 1185255-99-5 | C33H34N6O6 | 610.68 | 2-Hydroxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester; Candesartan Cilexetil Impurity C; (RS)-1-[[Cyclohexyloxy)carbonyl]oxy]ethyl-3-[[2'-(1-ethyl- 1H-tetrazo |
Candesartan Cilexetil | 145040-37-5 | C33H34N6O6 | 610.66 | TCV-116; TCV 116; TCV116; Candesartan cilexetil |
Candesartan | 139481-59-7 | C24H20N6O3 | 440.45 | Candesartan, CV11974, CV-1197, CV 11974, Trade names: Blopress, Atacand, Amias, and Ratacand |
candelilla wax | 8006-44-8 | CANDELILLA WAX; CANDELILLA WAX, NATURAL; FEMA 3479; EUPHORBIA CERIFERA (CANDELILLA) WAX; CANDELLILAWAX; Candeliila wax | ||
Canagliflozin Related Impurity 9 | 32384-65-9 | C18H42O6Si4 | 466.86 | (3R,4S,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2h-pyran-2-o |
Canagliflozin Related Impurity 14 | 58861-48-6 | C10H7FS | 178.23 | |
Canagliflozin Related Impurity 10 | 1799552-91-2 | C24H25FO6S | 460.53 | |
Canagliflozin hemihydrate | 928672-86-0 | C24H25FO5S | 444.52 | (3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol hemihydrate; JNJ 28431754; JNJ-28431754; JNJ28431754; TA 7284; TA-7284; TA7284; JNJ-24831754-ZAE; JNJ-28431754-AAA; Canagliflozin |
Canagliflozin Defluoro Impurity | 842133-16-8 | C24H26O5S | 426.54 | |
Canagliflozin D4 | 1997338-61-0 | C24H21D4FO5S | 448.54 | (2S,3R,4R,5S,6R)-2-[3-({5-[4-fluoro(2,3,5,6-D4)phenyl]thiophen-2-yl}methyl)-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
Canagliflozin | 842133-18-0 | C24H25FO5S | 444.52 | JNJ-24831754; TA-7284; JNJ 24831754; TA 7284; JNJ24831754; TA7284; (1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol |
Canadine | 5096-57-1 | C20H21NO4 | 339.4 | (13As)-5,8,13,13A-tetrahydro-9,10-dimethoxy-6H-benzo[G]-1,3-benzodioxolo[5,6-A]quinolizine; |
Camylofine dihydrochloride | 5892-41-1 | C19H34Cl2N2O2 | 393.393 | 3-Methylbutyl {[2-(diethylamino)ethyl]amino}(phenyl)acetate dihydrochloride |
Camylofine | 54-30-8 | C19H32N2O2 | 320.477 | Camylofine; Acamylophenine; Adopon; Avacan; Novospasmin; 3-methylbutyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate |
Camstatin | 1002295-95-5 | C122H203N39O34 | 2760.19 | |
Campestanol | 474-60-2 | C28H50O | 402.71 | 5a-Cholestan-24(RS)-methyl-3b-ol (3b,5a,24R)-Ergostan-3-ol 24b-Ethylcholestanol |
cAMP-Bn | 62742-71-6 | C17H18N5O6P | 419.3 | Adenosine- 3', 5'- monophosphate, benzyl ester |
cAMP-AM | 159764-93-9 | C13H16O8N5P | 401.3 | Adenosine- 3', 5'- monophosphate, acetoxymethyl ester |
Camostat Mesylate | 59721-29-8 | C20H22N4O5.CH4O3S | 494.52 | 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate methanesulfonate; Camostat Mesilate; Camostat Mesylate; FOY 305; FOY-305; FOY305 |
Camostat | 59721-28-7 | C20H22N4O5 | 398.42 | Camostat |
CaMKII-IN-1 | 1208123-85-6 | C29H30ClN5O2S | 548.1 | CaMKII-IN-1 |
Camiverine | 54063-28-4 | C19H30N2O2 | 318.458 | Camiverine;Sanaspasmina;Camiverinum[INN-Latin];Camiverina[INN-Spanish];54063-28-4;FC4/58 |
CAM-IN-1 | 251994-14-6 | C15H11BrN2O2S | 363.23 | Thieno[2,3-c]pyridine-2-carboxamide, 4-(4-bromophenoxy)-N-methyl- |
Camelliaside B | 131573-90-5 | C32H38O19 | 726.63 | |
Camelliaside A | 135095-52-2 | C33H40O20 | 756.66 | Kaempferol-3-O-[2-O-b-D-galactose-6-O-a-L-rhamnose]-b-D-glucoside |
Camellianin A | 109232-77-1 | C29H32O15 | 620.56 | |
CAMEK DH | 42370-07-0 | C11H18O | 166.26 | CAMEK DH; NORBORNANE, 2-ACETYL-3,3-DIMETHYL; 1-(3,3-dimethylbicyclo[2.2.1]hept-2-yl)-ethanon; 1-[3,3-dimethylbicyclo[2.2.1]hept-2-yl]-Ethanone; 1-(3,3-dimethylbicyclo[2.2.1]hept-2-yl)ethan-1-one; 2-ACETYL-3,3-DIMETHYLBICYCLO(2.2.1)HEPTANE; 1-(3,3-Dimethyl |
Cambinol | 14513-15-6 | C21H16N2O2S | 360.43 | 2,3-dihydro-5-[(2-hydroxy-1-naphthalenyl)methyl]-6-phenyl-2-thioxo-4(1H)-pyrimidinone; Cambinol; NSC 112546; SIRT1 Inhibitor II; SIRT2 Inhibitor VI; SIRT 1/2 inhibitor IV; NSC112546; NSC-112546; NSC 112546 |
Cambendazole-D7 | 1228182-48-6 | (2-Thiazol-4-yl-1H- carbamic acid isopropyl- D7- ester |
||
Cambendazole | 26097-80-3 | (2-Thiazol-4-yl-1H- benzimidazol-5-yl)- carbamic acid isopropyl ester | ||
Camaric acid | 146450-83-1 | C35H52O6 | 568.8 | (+)-22beta-(Angeloyloxy)lantanolic acid |
Camaldulenic acid | 71850-15-2 | C30H46O4 | 470.694 | |
Calyxin H | 202596-22-3 | C35H34O7 | 566.65 | (E)-1-[2,4-dihydroxy-3-[(E,1S,5S)-5-hydroxy-1-(4-hydroxyphenyl)-7-phenylhept-2-enyl]-6-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one |
Calyxin B | 164991-53-1 | C35H34O8 | 582.7 | |
Calyxamine B | 150710-72-8 | C12H21NO | 195.3 | 1-(2,2,6,6-Tetramethyl-4-piperidinylidene)acetone |
Calystegine B4 | 184046-85-3 | C7H13NO4 | 175.18 | |
Calystegine B3 | 178231-95-3 | C7H13NO4 | 175.19 | |
Calystegine B2 | 127414-85-1 | C7H13NO4 | 175.19 | (1R,2S,3R,4S,5R)-8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol; Nortropanoline |
Calystegine B1 | 127414-86-2 | C7H13NO4 | 175.18 | |
Calystegine A5 | 165905-26-0 | C7H13NO3 | 159.18 | |
Calystegine A3 | 131580-36-4 | C7H13NO3 | 159.18 | |
CALYCULIN A | 101932-71-2 | C50H81N4O15P | 1009.17 | CALYCULIN A;CALYCULIN A, DISCODERMIA CALYX;calyculin A from discodermia calyx;CALYCULIN A FROM DISCODERMIA CALYX, 10 U G;N-[(3S)-[4-(1E)-3-[(2R,3R,4R,7S,8S,9R)-2-[(1S,3S,4S,5R,7E,9E,11E,13Z)-14-Cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentam;L-Ribonamide |
Calycotomine | 4356-47-2 | C12H17NO3 | 223.26828 | Calycotomine; (6,7-Dimethoxy-1,2,3,4-tetrahydro-isoquinolin-1-yl)methanol |
Calycosin-7-O-beta-D-glucoside | 20633-67-4 | C22H22O10 | 446.40 | 3-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one calycosin-7-O-beta-D-glucopyranoside Calycosin 7-o-beta-D-glucoside 20633-67-4 Calycosin-7-O-beta-D-glucoside UNII-247AW3A88 |
Calycosin | 20575-57-9 | C16H12O5 | 284.26 | 7,3'-DIHYDROXY-4'-METHOXYISOFLAVONE;3'-HYDROXYFORMONONETIN;3',7-DIHYDROXY-4'-METHOXYISOFLAVONE;3-(3-Hydroxy-4-methoxyphenyl)-7-hydroxy-4H-1-benzopyran-4-one;7-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; |
Calyciphylline A | 596799-30-3 | C23H31NO4 | 385.5 | Methyl (1R,2S,3R,5R,6S,8R,10S,16R,17R)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.11,5.02,10.03,8.016,19]icos-13(19)-ene-17-carboxylate 8-oxide |
Calycanthine | 595-05-1 | C22H26N4 | 346.478 | (1S,2R,10S,11R)-21,24-dimethyl-3,12,21,24-tetraazahexacyclo[9.7.3.3(2,10).0(1,10).0(4,9).0(13,18)]tetracosa-4,6,8,13,15,17-hexaene; (4bS,5R,10bS,11R)-13,18-dimethyl-5,6,11,12-tetrahydro-5,10b:11,4b-di(epiminoethano)dibenzo[c,h]-2,6-naphthyridine |
Calphostin C | 121263-19-2 | C44H38O14 | 790.8 | UCN 1028 C, PKF 115-384 |
Calpeptin | 117591-20-5 | C20H30N2O4 | 362.46 | N/A |
Calpain Inhibitor XII | 181769-57-3 | C26H34N4O5 | 482.6 | Z-L-Nva-CONH-CH2-2-Py |
Calpain Inhibitor VI | 190274-53-4 | C17H25FN2O4S | 372.5 | SJA 6017 |
Calpain Inhibitor II | 110115-07-6 | C19H35N3O4S | 401.6 | Ac-Leu-Leu-Met-H; ALLM |
CALP3 | 261969-05-5 | C44H68N10O9 | 881.08 | Calcium-like peptide 3 |
CALP2 | 261969-04-4 | C68H104N14O13S | 1357.72 | Calcium-like peptide 2 |
CALP1 | 145224-99-3 | C40H75N9O10 | 842.09 | Calcium-like peptide 1 |
Calmidazolium chloride | 57265-65-3 | C31H23Cl7N2O | 687.70 | 1-[Bis(4-chlorophenyl)methyl]-3-[2-(2,4-dichlorophenyl)-2-(2,4-dichlorobenzyloxy)ethyl]-1H-imidazolium chloride |
Calindol hydrochloride | 729610-18-8 | C21H20N2·HCl | 336.9 | Calindol |
Californium dioxide | 12015-10-0 | CfO2 | ||
californium | 7440-71-3 | Cf | 251.08 g/mol | |
Calhex 231 hydrochloride | 652973-93-8 | C25H27ClN2O.HCl | 443.41 | 4-Chloro-N-[(1S,2S)-2-[[(1R)-1-(1-naphthalenyl)ethyl]amino]cyclohexyl]-benzamide hydrochloride |
Calendula officinalis oil | 70892-20-5 | |||
Calendula officinalis | 85409-12-7 | |||
Calendula extract | 84776-23-8 | Mixture | Calendula Officinalis Extract | |
Calciumsilicide (Ca2Si) (6CI,7CI,8CI,9CI) | 12049-73-9 | Ca2Si | 108.2415;g/mol | Dicalciumsilicide; EINECS234-989-7; IN007577; CALCIUMSILICIDE(CA2SI)(6CI,7CI,8CI,9CI); 12049-73-9 |
Calcium-Sensing Receptor Antagonists I | 478963-79-0 | C23H24N2O2 | 360.45 | 2(1H)-Quinazolinone, 1-(1-methylethyl)-4-[4-(1-methylethyl)phenyl]-6-(2-propyn-1-yloxy)- |
CALCIUMPOLYSTYRENESULPHONATE | 37286-92-3 | C8H7CaO3S+ | ||
Calcium-lignin sulfonate | 8062-15-5 | C20H26O10S2 | 490.56 | |
Calcium-D-arabonate | 22373-09-7 | C5H9O6 Ca | 205.20 | |
calcium3-[[(2R)-2-hydroxy-4-[hydroxy(oxido)phosphoryl]oxy-3,3-dimethylbutanoyl]amino]propanoate | 55816-28-9 | C9H16CaNO8P | 337.277 g/mol | calcium; 3-[[(2R)-2-hydroxy-4-[hydroxy(oxido)phosphoryl]oxy-3,3-dimethylbutanoyl]amino]propanoate; Calcium4-phosphopantothenate; 55816-28-9; beta-Alanine,N-(2-hydroxy-3,3-dimethyl-1-oxo-4-(phosphonoxy)butyl)-,calciumsalt(1:1),(R)-; AC1L266P |
calcium(2+) 12-hydroxyoctadecanoate | 3159-62-4 | C36H70CaO6 | 639.0154 | calcium(2+) 12-hydroxyoctadecanoate; Calcium 12-hydroxystearate; Octadecanoic acid, 12-hydroxy-, calcium salt (2:1); 12-hydroxy-octadecanoic aci calcium salt; Octadecanoic acid,12-hydroxy-,calcium salt; 12-HYDROXYOCTADECANOIC ACID, CALCIUM SALT; 12-Hydrox |
Calcium undecylenate | 1322-14-1 | C11H20 O2 . 1/2 Ca | 406.6127 | 10-undecenoicacid,calciumsalt; ca.undecylenate(calciumundecylenate); calciumdiundec-10-enoate; CALCIUM UNDECENOATE; CALCIUM UNDECYLENATE; 10-UNDECANOIC ACID CALCIUM SALT; Bis(10-undecenoic acid)calcium salt; calcium undec-10-enoate |
Calcium trisodium pentetate | 12111-24-9 | C25H35CaNa3O10 | 604.58671 | calcium trisodium pentetate; CALCIUMDTPA; Calciate(3-), [N,N-bis[2-[bis(carboxymethyl) amino]ethyl]glycinato(5-)]-, trisodium |
Calcium triple superphosphate | 65996-95-4 | 370.11 | Calcium triple superphosphate; Triple Super Phosphate; Superphosphates, concd.; TSP,granulated(fert.); Superphosphate (triple); TREBLE SUPERPHOSPHATE; superphosphates, concentrated | |
Calcium titanate | 12049-50-2 | CaTiO3 | 135.94 | Calciumtitaniumtrioxide; ct; rc17; titanate(tio32-),calcium(1:1); titanatecalcium(1:1); titaniumcalciumoxide; CALCIUM TITANIUM OXIDE; CALCIUM TITANATE |
Calcium thiosulfate | 10124-41-1 | CaS2O3 | 152.2062 | calcium thiosulphate; Thiosulfuric acid (H2S2O3), calcium salt (1:1); Calcium thiosulfate hexahydrate.; calcium hyposulfite; calcium thiosulfate [ca(s2o3)]; tecesal; thiosulfuric acid, calcium salt; Calcium thiosulfate, 50% solution |
Calcium sulfonate | 61789-86-4 | Calcium sulfonate; Petroleum sulfonic acids calcium salts | ||
Calcium sulfide | 20548-54-3 | CaS | 72.14 | CALCIUM SULFIDE; Calcium sulfide (CaS); calciumsulfide(cas); Calcium-sulphide-; Calcium sulfide, #325 mesh, 99.9+% metals basis; Calcium sulfide, -325 mesh, pure, 99.9+%; CALCIUM SULFIDE, 99.99%; Calciumsulfide(99.9+%-Ca) |
Calcium Sulfate dihydrate | 10101-41-4 | CaSO4.2H2O | 172.164 | Sulfuric Acid Calcium Salt (1:1) Dihydrate; Gypsum Dihydrate |
Calcium Sulfate 0.5-hydrate | 10034-76-1 | CaH2O5S | 154.15600 | |
Calcium Stearate | 1592-23-0 | C36H70CaO4 | 607.03 | Stearic Acid Calcium Salt; Lubrical 48 |
Calcium silicide | 12013-56-8 | CaSi2 | 96.25 | |
Calcium silicate | 10101-39-0 | O3SiCa | 116.17 | SILICIC ACID CALCIUM SALT; VANFRE IL-2; VANSIL W-20; VANSIL W30; VANSIL(R) G; VANSIL(R) W10; VANSIL W-10; CALCIUM SILICATE |
Calcium salicylate | 824-35-1 | C14H10CaO6 | 314.3 | 2-hydroxy-benzoicacicalciumsalt(2:1); Benzoicacid,2-hydroxy-,calciumsalt(2:1); Calcium2-hydroxybenzoate; calciumdisalicylate; CALCIUM SALICYLATE; CALCIUM SALICYLATE DIHYDRATE; 2-hydroxy-benzoic aci calcium salt; Benzoic acid, 2-hydroxy-, calcium salt |
Calcium Saccharate | 5793-88-4 | C6H8CaO8 | 248.2 | D-Saccharic Acid Calcium Salt |
Calcium Pyruvate | 52009-14-0 | C6H6CaO6 | 214.19 | calcium; 2-oxopropanoate; Calciumpyruvate; 52009-14-0; calciumpyruvic; Calcium2-oxopropanoate |
Calcium polysulfides;Lime sulfur | 1344-81-6 | 74.1598 | Calcium sulfide (Ca(Sx)); CALCIUMPOLYSULPHIDE; LIMESULPHURMIXTURE; LIME-SULPHUR; neviken; orthorix; Calcium polysulfides | |
Calcium Polycarbophil | 9003-97-8 | (C20H18Ca4O18)mult | 0 | Polycarbophil; CARBOPOLEX55; polycarbophil calcium; Carbofil; Policarbofila; Policarbofila [inn-spanish]; Polyacrylic acid calcium salt cross-linked with divinyl glycol; Polycarbofil |
Calcium polycarbophil | 126040-58-2 | Calcium polycarbophil; Colonel | ||
Calcium Phytate | 3615-82-5 | C6H6Ca6O24P6 | calcium-magnesiumphytate; eviunis; forglesan; fosforodeangeli; hexakis(dihydrogenphosphate),calciummagnesiumsalt,myo-inosito; inophosphan; inositocalcium; Myo-inositol,hexakis(dihydrogenphosphate),calciummagnesiumsalt | |
CALCIUM PHTHALATE HYDRATE | 5793-85-1 | C8H6CaO5 | 222.21 | CALCIUM PHTHALATE HYDRATE; PHTHALIC ACID CALCIUM SALT HYDRATE; calcium phthalate; phthalic acid calcium salt; 1,2-Benzenedicarboxylic acid calcium salt; Einecs 227-332-0 |
Calcium phosphate, tribasic | 12167-74-7 | HCa5O13P3 | 1004.64 | calciumhydroxidephosphate(ca5(oh)(po4)3); PENTA-CALCIUM HYDROXIDE TRIPHOSPHATE; TERT-CALCIUM PHOSPHATE; TRI-CALCIUM DI-ORTHOPHOSPHATE; TRI-CALCIUM (ORTHO)PHOSPHATE; TRI-CALCIUM PHOSPHATE; TRI-CALCIUM PHOSPHATE (BETA-FORM); CELLULOSE HYDROXYAPATIT |
Calcium Phosphate Dibasic Dihydrate | 7789-77-7 | Ca.HO4P.2.H2O | 172.09 | |
Calcium Oxide | 73018-51-6 | CaO | 56.077 | Lime Oxide |
Calcium nitrate tetrahydrate | 13477-34-4 | Ca(NO3)2.4(H2O) | 236.15 | Lime nitrate; CALCIUM NITRATE TETRAHYDRATE; CALCIUM NITRATE 4H2O; CALCIUM NITRATE, 4-HYDRATE; CALCIUM NITRATE HYDRATED; CALCIUM (II) NITRATE, HYDROUS |
Calcium N5-methyltetrahydrofolate | 26560-38-3 | C20H23CaN7O6 | 497.52 | NSC173328 |
Calcium myristate | 15284-51-2 | 494.809 | ||
Calcium methoxide | 2556-53-8 | Ca.(oCH3)2 | 102.15 | CALCIUM METHOXIDE; CALCIUM DIMETHOXIDE; methanol,calciumsalt; calcium dimethanolate; Calciummethoxidecontainsmethanol; Calciummethoxideminbalancemethanoloffwhitepowder |
Calcium metasilicate | 13983-17-0 | CaHO3Si | 117.17 | Aedelforsite; cab-o-lite; cab-o-lite100; cab-o-lite130; cab-o-lite160; cab-o-litef1; cab-o-litep4; casiflux |
Calcium lignosulfonate | 8061-52-7 | C20H24CaO10S2 | 528.61 | LIGNOSULFONIC ACID, CA; LIGNOSULFONIC ACID, CALCIUM SALT; CALCIUM LIGNOSULFONATE; calciumligninsulphonate; ligninsulfonicacid,calcium; ligninsulfonicacid,calciumsalt; Calcium lignosulphonate; Ligninesulfonicacidcalciumsalt |
Calcium Levomefolate | 151533-22-1 | C20H23N7O6.Ca | 499.53 | Levomefolate calcium |
Calcium Levofolinate | 80433-71-2 | C20H21CaN7O7 | 511.5 | Saponins |
Calcium L-cystinate | 74263-37-9 | C6H12 N2 O4 S2 . x Ca | 278.3626 | |
Calcium laurate | 4696-56-4 | C24H46CaO4 | 438.7 | calciumdilaurate; Calciumdodecanoate; Dodecanoicacid,calciumsalt; CALCIUM LAURATE; Calciumdilaurat; Didodecanoic acid calcium salt; Dilauric acid calcium salt |
Calcium lanthanum sulfide | 12525-03-0 | CaLa2S4 | 446.15 | CALCIUM LANTHANUM SULFIDE; calcium bis[dithioxolanthanate(1-)]; Calcium lanthanum sulfide, 99.9% (REO) |
Calcium lactobionate | 5001-51-4 | C12H21O12 Ca | 377.33 | 4-O-b-D-Galactopyranosyl-D-gluconic acid calcium salt; Calcium galactogluconate |
Calcium lactate gluconate | 11116-97-5 | (C3H5O3)2Ca (C6H11O7)2Ca | 648.59 | |
Calcium lactate | 814-80-2 | 2(C3H5O3).Ca | 218.22 | CALCIUM LACTATE, TRIHYDRATE; LACTIC ACID CALCIUM SALT, TRIHYDRATE; 2-HYDROXYPROPANOIC ACID CALCIUM SALT, TRIHYDRATE; 2-hydroxy-propanoicacicalciumsalt(2:1); calciumlactate(1:2); calphosan; conclytecalcium; -Hydroxypropanoicacidcalciumsaltpentahy-drate |
Calcium L -Aspartate | 39162-75-9 | C8H12CaN2O8 | 304.26748;g/mol | calcium;(2S)-2-amino-4-hydroxy-4-oxobutanoate;39162-75-9;CalciumL-Aspartate;Calciumdihydrogendi-L-aspartate |
CALCIUM ISOPROPOXIDE | 15571-51-4 | C6H14CaO2 | 158.25 | CALCIUM ISOPROPOXIDE; CALCIUM DI-I-PROPOXIDE; calcium propan-2-olate; CALCIUM ISOPROPOXIDE, POWDER, 99.9+%; Calcium di(2-propanolate); Calcium diisopropoxide; Diisopropoxycalcium |
Calcium ionophore I | 58801-34-6 | C38H72N2O8 | 684.99 | ()-(R,R)-N,N-Bis-[11-(ethoxycarbonyl)undecyl]-N,N,4,5-tetramethyl-3,6-dioxaoctane-diamide, Diethyl N,N-[(4R,5R)-4,5-dimethyl-1,8-dioxo-3,6-dioxaoctamethylene]bis(12-methylaminododecanoa |
Calcium iodide 4-hydrate | 13640-62-5 | CaI2.4H2O | 365.95 | CALCIUM IODIDE TETRAHYDRATE; Calcium iodide tetrahydrate, lump, 98%; CALCIUM IODIDE TETRAHYDRATE, PURE, 99%; Calcium iodide tetrahydrate,99%,pure |
Calcium hypophosphite | 7789-79-9 | CaH4O4P2 | 170.06 | Phosphinicacid,calciumsalt; CALCIUM HYPOPHOSPHITE; CALCIUM PHOSPHINATE; CALCIUM HYPOPHOSPHITE EXTRA PURE, DAC; Lime hypophosphite; CALCIUM HYPOPHOSPHITE TECHNICAL; CALCIUMHYPOPHOSPHITE,PURIFIED; Calcium hydrophosphite |
Calcium Hydrogen Phosphate | 7757-93-9 | CaHPO4 | 136.056 | Calcium phosphate dibasic |
Calcipotriol Intermediate 9 | 112849-17-9 | C39H66O3Si2 | 639.124 | (2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one; (5E)-1,3-Bis-O-(tert-Butyldimethylsilyl)-24-oxo-calcipotriene |
Calcium glycinate | 35947-07-0 | C4H8CaN2O4 | 188.2 | calcium glycinate (1:2); Calcium glycinate; Calcium Methionine; Diglycine calcium salt |
Calcium Glycerophosphate | 27214-00-2 | C3H7O6P Ca | 210.14 | 1,2,3-Propanetriol,mono(dihydrogenphosphate),calciumsalt(1:1); Calcium glycerinophosphate; Calcium 1,3-dihydroxypropan-2-yl phosphate |
Calcium glucoheptonate | 29039-00-7 | C14H26O16Ca | 490.44 | |
Calcium formate | 544-17-2 | C2H2CaO4 | 130.11 | calcium; diformate; CALCIUMFORMATE; Calciumdiformate; 544-17-2; Calcoform |
Calcium fluorosilicate | 16925-39-6 | CaSiF6 | 182.16 | Calcium fluorosilicate; Calcium silicofluoride |
Calcium fluoride | 7789-75-5 | CaF2 | 78.07 | FLUORITE; FLUORSPAR; FLUORSPARMEAL; Calcium difluoride; CALCIUM FLUORIDE; CALCIUM (II) FLUORIDE; NATURAL FLUOROSPAR; Acid-spar |
Calcium D-saccharate tetrahydrate | 5793-89-5 | C6H8CaO8 4H2O | 320.26 | D-Glucaric acid calcium salt; D-Saccharic acid calcium salt; Glucaric acid calcium salt tetrahydrate; Calcium D-glucarate; Glucosaccharic acid calcium salt tetrahydrate |
Calcium D-Pantothenate | 137-08-6 | C18H32CaN2O10 | 476.536 | Calcium pantothenate; D-Calcium pantothenate; Calpanate; Pantholin |
Calcium dodecylbenzene sulfonate | 26264-06-2 | C36H58O6S2Ca | 693.074 | EMULSIFIER 1371 A; CALCIUM N-DODECYLBENZENESULFONATE; CALCIUM DODECYLBENZENE SULFONATE; 1371a; calciumalkylaromaticsulfonate; calciumalkylbenzenesulfonate; calciumbis(dodecylbenzenesulfonate); calciumdodecylbenzensulfonate |
Calcium Dobesilate | 20123-80-2 | 418.41 | CALCIUM DOBESILATE; Calcium Dobesilate Mnohydrate; CALIUM DOBESILATE MONOHYDRATE; CALCIUM DOBESILATE 1-HYDRATE; 2,5-Dihydroxybenzenesulfonic acid, calcium salt; 2,5-dihydroxy-benzenesulfonic aci calcium salt; dexium; doxium | |
Calcium DL-aspartate | 10389-10-3 | C4H5CaNO4 | 171.1648 | calcium; 2-aminobutanedioate; CalciumDL-aspartate; 10389-10-3; calcium2-aminobutanedioate; calcium2-azanylbutanedioate |
Calcium disodium bis[2-chloro-5-[(2-hydroxy-1-naphthyl)azo]-4-sulfonatobenzoate] | 5850-80-6 | C34H18CaCl2N4Na2O12S2 | 895.61986 | |
Calcium dibenzyl dimaleate | 17200-48-5 | C11H10 O4 . 1/2 Ca | 450.45152;g/mol | calcium;(Z)-4-oxo-4-phenylmethoxybut-2-enoate;Calciumdibenzyldimaleate;17200-48-5;EINECS241-243-4;Bis[(Z)-4-(benzyloxy)-4-oxo-2-butenoicacid]calciumsalt |
Calcium di(octacosanoate) | 52258-47-6 | |||
Calcium decanoate | 13747-30-3 | C20H38CaO4 | 382.591 g/mol | |
Calcium Citrate Malate Fine Granular | 142606-53-9 | C16H14Ca4O19 | ||
Calcium citrate | 813-94-5 | C12H10Ca3O14 | 498.44 | 1,2,3-Propanetricarboxylicacid,2-hydroxy-,calciumsalt(2:3); 2,3-propanetricarboxylicacid,2-hydroxy-calciumsalt(2:3); acicontral; citricacid,calciumsalt(2:3); citrical; tribasiccalciumcitrate; TRICALCIUM DICITRATE; citric acid sesquicalcium tetrahydrate |
CALCIUM CHROMATE | 13765-19-0 | CaCrO4 | 156.07200 | |
Calcium chloride dihydrate | 10035-04-8 | CaCl2H4O2 | 147.008 | Calcium dichloride |
Calcium chloride 4-hydrate | 25094-02-4 | CaCl2.4H2O | 183.0451 | CALCIUM CHLORIDE TETRAHYDRATE; 99,9spectro; CALCIUM CHLORIDE 4-HYDRATE; Calcium chloride (CaCl2), tetrahydrate |
Calcium channel-modulator-1 | 136941-70-3 | C26H24Cl2N2O7S | 579.45 | 3-O-methyl 5-O-[3-(1,1,3-trioxo-1,2-benzothiazol-2-yl)propyl] 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl 3-(3-oxo-1,2-benzisothiazol-2( |
Calcium caseinate | 9005-43-0 | CALCIUM CASEINATE; Caseincalcium; Caseins, calcium complexes; CALCIUMCASEIN | ||
CALCIUM CARBONATE-13C | 287389-46-2 | CCaO3 | 101.1 | CALCIUM CARBONATE-13C; CALCIUM CARBONATE-13C, 99 ATOM % 13C |
Calcium bromide,hydrate (9CI) | 71626-99-8 | Br2Ca . x H2 O | 217.9 | CALCIUM (II) BROMIDE, HYDROUS; CALCIUM BROMIDE HEXAHYDRATE; CALCIUM BROMIDE HYDRATE; CALCIUM BROMIDE HYDRATE 99.999%; CalciumBromideHydrateExtraPure; CalciumBromideHydrat; CALCIUM BROMIDE 6-HYDRATE; CALCIUM BROMIDE 2-HYDRATE |
Calcium borate | 13701-64-9 | Ca(BO2)2.2(H2O) | 161.73 | CALCIUM METABORATE; CALCIUM-M-BORATE; CALCIUM BORATE; diboron calcium tetraoxide; CALCIUM METABORATE, 99.995%; Puratronic99.992%(metalsbasis) |
CALCIUM BORATE | 12007-56-6 | B4CaO7 | 195.32 | CALCIUM PYROBORATE; CALCIUM TETRABORATE; boricacid(h2-b4-o7),calciumsalt(1:1); Boroncalciumoxide; boroncalciumoxide(b4cao7); boric acid (h2-b4-o7), calcium salt; colemanite |
Calcium bis[monoethyl(3,5-di-tert-butyl-4-hydroxylbenzyl)phosphonate] | 65140-91-2 | 694.84 | ANTIOXIDANT 1425; calcium bis[monoethyl(3,5-di-tert-butyl-4-hydroxylbenzyl)phosphonate]; IRGANOX 1425; IRGANOX 1425 WL; Ethyl3,5-di-tert-butyl-4-hydroxybenzylphosphonate,calciumsalt; Phosphonicacid,[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]-,mon | |
Calcium bis(tetrapropylenebenzenesulfonate) | 11117-11-6 | |||
Calcium bis(metaphosphate) | 13477-39-9 | Ca. 2 H O3 P | ||
calcium bis(hydrogencarbonate) | 3983-19-5 | 166.141 | calcium; hydrogencarbonate; Calciumbicarbonate; 3983-19-5; Calciumhydrogencarbonate; calciumhydrogencarbonate | |
Calcium bichromate | 14307-33-6 | 256.063 | Calcium chromate dihydrate; Chromic acid (H2Cr2O7), calcium salt (1:1); Calcium dichromate(vi); Chromic acid, calcium salt (1:1) (9ci); Dichromic acid, calcium salt (1:1); Einecs 238-243-1 | |
Calcium Ascorbate Dihydrate | 5743-28-2 | 426.36 | L-Ascorbic Acid Calcium Salt Hydrate; L-Ascorbic Acid Calcium Salt Dihydrate; Calcium L-Ascorbate Dihydrate; Calcium Ascorbate Dihydrate | |
Guanosine 5'-monophosphate calcium salt | 38966-30-2 | C10H12CaN5O8P | 401.28 | Calcium 5'-guanylate; Guanylic acid calcium salt; calcium,[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate; 5'-Guanylic acid calcium salt; Calcium guanylate; Calcium 5'-O-phosphonatoguanosine |
Calcium 4-methyl-2-oxovalerate dihydrate | 51828-95-6 | (C6H9O3)2.Ca.2(H2O) | 334.38 | CALCIUM ALPHA-KETOISOCAPROATE; CALCIUM 4-METHYL-2-OXOVALERATE HYDRATE; CALCIUM-4-METHYL-2-OXO-VALERATE; CALCIUM 2-KETO-4-METHYLVALERATE HYDRATE; KETO-ISO-CAPROATE CALCIUM SALT; KETO LEUCINE CALIUM SALT |
Calcium 4-[(5-chloro-4-methyl-2-sulfonatophenyl)azo]-3-hydroxy-2-naphthoate | 7023-61-2 | C18H11CaClN2O6S | 458.89 | Calcium 4-[(5-chloro-4-methyl-2-sulfonatophenyl)azo]-3-hydroxy-2-naphthoate; Pigment Red 48:2 |
Calcium 2-methoxyethoxide | 28099-67-4 | C6H14CaO4 | 190.25 | CALCIUM METHOXYETHOXIDE; CALCIUM METHOXYETHYLATE; CALCIUM 2-METHOXYETHOXIDE; CALCIUM DI(METHOXYETHOXIDE); calcium 2-methoxyethanolate; Calcium methoxyethoxide, 20 % in methoxyethanol; Calcium bis(2-methoxyethanolate) |
Calcitroic Acid | 71204-89-2 | C23H34O4 | 374.521 | 1alpha-Hydroxy-23-carboxytetranorvitamin D; (3R)-3-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]butanoic acid |
Calcitriol Intermediate | 169900-32-7 | C39H72O4Si2 | 661.171 | (5R)-ethyl-5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethyl)-7a-Methyloctahydro-1H-inden-1-yl)hexanoate |
Calcitriol | 32222-06-3 | C27H44O3 | 416.64 | RO215535, Topitriol |
Calcitonin,pro- | 56645-65-9 | |||
Calcitonin (salmon) trifluoroacetate salt | 171052-37-2 | C145H240N44O48S2·xCF3COOH | 3431.86 | Calcitonin (1-32) (salmon); Salcatonin; sCT; Thyrocalcitonin (salmon) |
Calcitonin (human) trifluoroacetate salt | 21215-62-3 | C151H226N40O45S3·xCF3COOH | 3417.85 | Ba 47175; Calcitonin (1-32) (human); hCT; Thyrocalcitonin (human) |
Calcifediol Impurity 1 | 23357-18-8 | C27H44O2 | 400.645 | 9,10-Secocholesta-5(10),6,8-triene-3,25-diol, (3b,6Z)- |
Calcipotriol Impurity D | 112827-99-3 | C27H40O3 | 412.6 | PRI 2202; PRI2202; PRI-2202 |
Calcipotriol Impurity C | 113082-99-8 | C27H40O3 | 412.61 | CS-M0059; CS M0059; CSM0059; (1a,3b,5E,7E,22E,24S)-24-Cyclopropyl-9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol |
Calcipotriol Impurity A | 126860-83-1 | C27H38O3 | 410.59 | Impurity A of Calcipotriol; MC 1046; MC1046; MC-1046 |
Calcipotriol (Calcipotriene) Monohydrate | 147657-22-5 | C27H42O4 | 430.62 | Calcipotriol monohydrate |
Calcipotriol (Calcipotriene) | 112965-21-6 | C27H40O3 | 412.61 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-Cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol; Calcipotriol, MC-903, Daivonex, Dovonex, Psorcutan |
Calcineurin Autoinhibitory Peptide | 148067-21-4 | C124H205N39O39S2 | 2930.34 | |
Calcimycin | 52665-69-7 | C29H37N3O6 | 523.6 | A 23187, Calimycin |
Calcifediol monohydrate | 63283-36-3 | C27H46O3 | 418.65 | 25-hydroxy Vitamin D3 monohydrate |
Calcifediol | 19356-17-3 | C27H44O2 | 400.64 | 25-hydroxy Cholecalciferol; RO 8-8892; Rovimix Hy-D; U 32070E; 25-hydroxy Vitamin D3; 25-OH Vitamin D3; Calcifediol. |
Calanolide E | 142566-61-8 | C22H28O6 | 388.5 | 5-Hydroxy-6-(3-hydroxy-2-methylbutanoyl)-2,2-dimethyl-10-propyl-9 ,10-dihydro-2H,8H-pyrano[2,3-f]chromen-8-one |
CAL-130 Racemate | 474012-90-3 | C23H22N8O | 426.47 | |
CAL-130 Hydrochloride | 1431697-78-7 | C23H23ClN8O | 462.93 | (S)-2-(1-((2-amino-9H-purin-6-yl)amino)ethyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one hydrochloride |
CAL-130 | 1431697-74-3 | C23H22N8O | 426.47 | CAL130; CAL 130 |
CAL-101 | 1146702-54-6 | C22H18FN7O | 415.423023;g/mol | CAL-101; Idelalisib; 870281-82-6; Zydelig; CAL101; GS-1101 |
Cajeput oil | 8008-98-8 | OIL OF CAJEPUT; Cajuputoil; Oils,cajuput; FEMA 2225; CAJEPUT OIL; Cajuput, ext.; MELALEUCA LEUCADENDRON CAJAPUT OIL; CajuputOil(OilOfCajuput) | ||
Cajanin | 32884-36-9 | C16H12O6 | 300.3 | 3-(2,4-Dihydroxyphenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one |
CAGED FLUORESCEIN MALEIMIDE* | 167776-24-1 | C37H26N4O12 | 718.628 | o-{[n-(maleimido-methylcarbonyl)-n-carboxymethylamino]-3-aza-2-propenyl}-o'-(2-nitrobenzyl)fluorescein |
Guanosine 3',5'-cyclic monophosphate | 7665-99-8 | C10H12N5O7P | 345.21 | D-Guanosine 3',5'-cyclic monophosphate; 3',5'-cyclic GMP; 2-Amino-6-oxo-6,9-dihydro-1H-purine 3-oxide; guanine-3-N-oxide; 2-Amino-1,7-dihydro-6H-purin-6-one 3-oxide; Cyclic guanosine monophosphate; 9-[(4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahyd |
Caftaric acid | 67879-58-7 | C13H12O9 | 312.23 | (2R,3R)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-3-hydroxybutanedioic acid; 2-Caffeoyl-L-tartaric acid; (2R,3R)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3-hydroxybutanedioic acid |
CAFFEOYLMALIC ACID | 39015-77-5 | C15H16O8 | 324.28 | CAFFEOYLMALIC ACID; CAFFEOYLMALIC ACID(SH) |
Caffeine-d3 | 26351-04-2 | C8H7N4O2D3 | 197.21 | |
Caffeine Impurity F | 611-59-6 | C7H8N4O2 | 180.17 | 1,7-Dimethylxanthine; P-Xanthine; Xanthine, 1,7-dimethyl-; 3,7-Dihydro-1,7-dimethyl-1H-purine-2,6-dione |
Caffeine Impurity E | 20041-90-1 | C7H12N4O | 168.2 | |
Caffeine Impurity C (Isocaffeine) | 519-32-4 | C8H10N4O2 | 194.19 | 3,9-Dihydro-1,3,9-trimethyl-1H-purine-2,6-dione; 1,3,9-Trimethylxanthine; 9-Methyltheophylline; NSC 28332; EP Impurity C for Caffeine |
Caffeine Impurity B | 7597-60-6 | C7H10N4O3 | 198.18 | 6-Amino-5-formamido-1,3-dimethyl-uracil; 1,3-Dimethyl-4-amino-5-(formylamino)uracil; 6-Amino-1,3-dimethyl-5-(formylamino)pyrimidine-2,4-dione; N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-formamide; N-(6-Amino-1,3-dimethyl-2,4-dioxo |
Caffeine Citrate | 69-22-7 | C14H18N4O9 | 386.31 | 2-Hydroxy-1,2,3-propanetricarboxylic Acid 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; Citrated Caffeine; Kaffein,Citrat; Citric acid,compd. with caffeine (1:1); 1,2,3-propanetricarboxylicacid,2-hydroxy-,mixt.with3,7-dihydro-1,3,7-trime; caffeinacitra |
Caffeine benzoate | 5743-17-9 | C8H10N4O2.C7H6O2 | 316.31 | CAFFEINE BENZOATE |
CAFFEINE | 202282-98-2 | C8H10N4O2 | 195.183255;g/mol | 1,3,7-trimethylpurine-2,6-dione; Caffeine-(3-methyl-13C); 202282-98-2 |
Caffeine | 58-08-2 | C8H10N4O2 | 194.19 | 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; 1,3,7-Trimethylxanthine; 7-Methyltheophylline; Alert-Pep; Cafalgine; Cafeina; Caffedrine; Cafipel; DHCplus; Dasin; Diurex; Durvitan; Guaranine; Hycomine; Koffein; Mateina; Methyltheobromine; Miudol; NSC 503 |
Caffeic acid-13C3 | 1185245-82-2 | C6[13C]3H8O4 | 183.1 | |
Caffeic acid phenethyl ester (CAPE) | 104594-70-9 | C17H16O4 | 284.31 | CAPE, Phenylethyl Caffeate |
Caffeic acid 3-O-b-D-glucuronide | 1093679-73-2 | C15H16O10 | 356.28 | 5-[(1E)-2-Carboxyethenyl]-2-hydroxyphenyl b-D-glucopyranosiduronic acid |
Caffeic acid 3-O-b-D-glucopyranoside | 24959-81-7 | C15H18O9 | 342.30 | 3-[3-(b-D-Glucopyranosyloxy)-4-hydroxyphenyl]-2-propenoic acid; 3-(b-D-Glucopyranosyloxy)-4-hydroxy-cinnamic acid; 3-(b-D-Glucopyranosyloxy)-4-hydroxycinnamic acid |
Caffeic Acid 3-Methyl Phenethyl Ester | 71835-85-3 | C18H18O4 | 300.35 | Phenethyl 3-Methylcaffeate; 2-Phenylethyl Ferulate; Ferulic Acid Phenethyl Ester |
CAFFEIC ACID | 331-89-5 | C9H8O4 | 180.16 | |
Cafestol | 469-83-0 | C20H28O3 | 316.4 | |
Cafedrine | 58166-83-9 | C18H23N5O3 | 357.412 | |
Caesappanin C | 1913319-59-1 | C32H32O10 | 576.59 | |
Caesalpine B | 1616757-60-8 | C23H30O7 | 418.48 | Caesalpinin F1 |
Caesalpine A | 1616757-59-5 | C23H32O7 | 420.50 | |
caesalpin J | 99217-67-1 | C17H16O6 | 316.31 | |
Caesalmin E | 204185-91-1 | C26H36O9 | 492.56 | (+)-Caesalpin H |
Caesalmin B | 352658-23-2 | C22H28O6 | 388.45 | (3bS,3b1R,5aS,6aR,10S,10aS,10bS)-6a-hydroxy-7,7,10a-trimethyl-4-oxo-3b,3b1,5a,6,6a,7,8,9,10,10a,10b,11-dodecahydro-4H-phenanthro[3,2-b:10,1-b'c']difuran-10-yl acetate |
Caerulomycin | 21802-37-9 | C12H11N3O2 | 229.2 | Cerulomycin, Caerulomycin A |
Cadion 2B | 6708-61-8 | C22H16N6O2 | 396.41 | Cadion 2B; 4-(4-Nitro-1-naphthyl-2-triazeno)azobenzene; 4-[3-(4-Nitro-1-naphtyl)-2-triazeno]azobenzene; 1-Triazene, 1-(4-nitro-1-naphthalenyl)-3-(4-(2-phenyldiazenyl)phenyl)-; 1-Triazene, 1-(4-nitro-1-naphthalenyl)-3-(4-(phenylazo)phenyl)-; Nsc 66472 |
CADINENE | 29350-73-0 | C15H26 | 0 | 6alpha,8abeta)]-alphdidehydroderiv.; Naphthalene,decahydro-1,6-dimethyl-4-(1-methylethyl)-,[1S-(1.alpha.,4.alpha.,4a.alpha.,6.alpha.,8a.beta.)]-,didehydroderiv.; naphthalene,decahydro-1,6-dimethyl-4-(1-methylethyl)-,[1s-(1alpha,4alpha,4a; CADINENE; [1S-(1 |
Cadensin D | 102349-35-9 | C25H22O9 | 466.442 | Hypericorin;(2R,3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydro-7h-[1,4]dioxino[2,3-c]xanthen-7-one |
Cadazolid | 1025097-10-2 | C29H29F2N3O8 | 585.55 | ACT-179811; ACT 179811; ACT179811 |
Cadalin | 483-78-3 | C15H18 | 198.31 | |
Cacodylic acid | 75-60-5 | C2H7AsO2 | 138.00 | Dimethylarsinic acid, Dimethylarsonic acid, Hydroxydimethylarsine oxide |
CaCCinh-A01 | 407587-33-1 | C18H21NO4S | 347.43 | 6-(1,1-Dimethylethyl)-2-[(2-furanylcarbonyl)amino]-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid |
Cacalone | 26294-92-8 | C15H18O3 | 246.31 | |
Cacalol | 24393-79-1 | C15H18O2 | 230.31 | |
Cabraleone | 35761-54-7 | C30H50O3 | 458.7 | 20,24-Epoxy-25-hydroxydammaran-3-one |
Cabazitaxel Impurity 12 | 146924-92-7 | C9H9NO2 | 163.18 | |
Cabazitaxel Impurity (Oxazolidine Protected) | 1373171-12-0 | C48H61NO14 | 876.02 | (4S,5R)-2,2-Dimethyl-4-phenyl-3,5-oxazolidinedicarboxylic Acid 5-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cycl |
Cabazitaxel Impurity (DiTroc) | 95603-44-4 | C35H38Cl6O14 | 895.4 | Carbonic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxete-4,6-diyl bis(2,2,2-trichloroethyl) E |
Cabazitaxel | 183133-96-2 | C45H57NO14 | 835.93 | XRP6258; XRP-6258; XRP 6258; TXD 258; TXD-258; TXD258; RPR116258A; axoid XRP6258; dimethoxydocetaxel US brand name: Jevtana. |
CA-5f | 1370032-19-1 | C24H24N2O3 | 388.46 | CA5f |
CA-4948 | 1801343-74-7 | C21H19N7O3 | 417.429 | 6'-Amino-N-[2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl][2,3'-bipyridine]-6-carboxamide |
Ca2+ Channel Agonist 1 | 1402821-24-2 | C19H26N6O | 354.46 | Ca2+ channel agonist 1; SCHEMBL17628623; CS-5169 |
CA-074 methyl ester | 147859-80-1 | C19H31N3O6 | 397.47 | Cathepsin B Inhibitor IV; MFCD03452890; (S)-methyl 1-((2S,3S)-3-methyl-2-((2S,3S)-3-(propylcarbamoyl)oxirane-2-carboxamido)pentanoyl)pyrrolidine-2-carboxylate; CA-074 Me |
CA 074 | 134448-10-5 | C18H29N3O6 | 383.44 | CA-074; N-[[(2S,3S)-3-[(Propylamino)carbonyl]-2-oxiranyl]carbonyl]-L-isoleucyl-L-proline |
C8 D-threo Ceramide (d18:1/8:0) | 175892-43-0 | C26H51NO3 | 425.69 | D-threo Cer(d18:1/8:0); D-threo Ceramide (d18:1/8:0); N-octanoyl-D-threo-sphingosine |
C75 trans | 191282-48-1 | C14H22O4 | 254.32 | C 75 trC-75 trans-racemic; trans-C75 |
C75 | 218137-86-1 | C14H22O4 | 254.32 | C 75 trC-75 trans-racemic; trans-C75 |
C7280948 | 587850-67-7 | C14H16N2O2S | 276.35 | 4-amino-N-(2-phenylethyl)benzenesulfonamide; 4-amino-N-phenethylbenzenesulfonamide; |
C646 | 328968-36-1 | C24H19N3O6 | 445.42 | C646 |
C3bot (154-182) | 1246280-79-4 | C137H221N37O40S | 3058.54 | |
C3a Receptor Agonist | 944997-60-8 | C27H35N3O2 | 433.6 | |
C29 | 363600-92-4 | C16H15NO4 | 285.29 | 3-[[(Z)-(5-methoxy-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]-2-methylbenzoic acid |
C24:1 b-D-Galactosyl ceramide | 17283-91-9 | C48H91NO8 | 810.24 | Galactosyl-b-1,1 N-nervonoyl-D-erythro-sphingosine |
C24 Ceramide | 34435-05-7 | C42H83NO3 | 509.85 | C24 Ceramide; Lignoceric ceramide |
C2 Adamantanyl Galactosylceramide (d18:1/2:0) | 574738-16-2 | C36H63NO8 | 637.89 | AdaGalCer(d18:1/2:0); Admantanyl Galactosylceramide (d18:1/2:0); Admantanyl GalCer(d18:1/2:0); N-(1-adamantaneacetyl) Galactosylceramide |
C19:1 (CIS-10) ACID | 73033-09-7 | C19H36O2 | 296.49 | DELTA 10 CIS NONADECENOIC ACID; CIS-10-NONADECENOIC ACID; C19:1 (CIS-10) ACID; NONADECENOIC ACID; 10-cis-Nonadecenoic acid |
C188-9 | 432001-19-9 | C27H21NO5S | 471.527 | N-[4-hydroxy-3-(2-hydroxynaphthalen-1-yl)naphthalen-1-yl]-4-methoxybenzenesulfonamide |
C18 L-threo Ceramide (d18:1/18:0) | 95037-06-2 | C36H71NO3 | 565.95 | N-octadecanoyl-L-threo-sphingosine; L-threo Cer(d18:1/18:0); L-threo Ceramide (d18:1/18:0) |
C18 L-erythro Ceramide (d18:1/18:0) | 252039-52-4 | C36H71NO3 | 565.95 | L-erythro Cer(d18:1/18:0); L-erythro Ceramide (d18:1/18:0); N-octadecanoyl-L-erythro-sphingosine |
C-178 | 329198-87-0 | C17H10N2O5 | 322.27 | C178; C 178 |
C-176 | 314054-00-7 | C11H7IN2O4 | 358.09 | STING inhibitor C 176; C176; C 176 |
c[G(2',5')pS-A(3',5')pS], isomer 1 and isomer 2 | 1638242-56-4 | C20H24N10O11P2S2 (free acid) | 706.6 (free acid) | |
C-1 | 84468-24-6 | C13H15N3O2S | 277.34 | 1-(5-Isoquinolinesulfonyl)piperazine; HA 100; 5-(piperazin-1-ylsulfonyl)isoquinoline |
C-[2-(4-METHOXY-PHENYL)-THIAZOL-4-YL]-METHYLAMINE | 857997-91-2 | C11H12N2OS | 220.29 | C-[2-(4-METHOXY-PHENYL)-THIAZOL-4-YL]-METHYLAMINE |
C-[2-(4-FLUORO-PHENYL)-THIAZOL-4-YL]-METHYLAMINE | 885280-17-1 | C10H9FN2S | 208.26 | C-[2-(4-FLUORO-PHENYL)-THIAZOL-4-YL]-METHYLAMINE |
C-[2-(4-BROMO-PHENYL)-THIAZOL-4-YL]-METHYLAMINE | 89152-87-4 | C10H9BrN2S | 269.16 | C-[2-(4-BROMO-PHENYL)-THIAZOL-4-YL]-METHYLAMINE; [2-(4-Bromophenyl)thiazol-4-yl]methylamine |
C-[2-(3-FLUORO-PHENYL)-THIAZOL-4-YL]-METHYLAMINE | 885280-31-9 | C10H9FN2S | 208.26 | C-[2-(3-FLUORO-PHENYL)-THIAZOL-4-YL]-METHYLAMINE |
BROMO(PHENYL-D5)MAGNESIUM | 84783-81-3 | |||
Bromisoval | 496-67-3 | C6H11BrN2O2 | 223.7 | |
Bromindione | 1146-98-1 | C15H9BrO2 | 301.13 | Bromindione;2-(4-Bromophenyl)-1H-indene-1,3(2H)-dione;2-(4-Bromophenyl)-2,3-dihydro-1H-indene-1,3-dione;2-(4-bromophenyl)indane-1,3-quinone;2-(4-bromophenyl)indene-1,3-dione |
Brevicompanine B | 215121-47-4 | C22H29N3O2 | 367.5 | |
Brevianamide F | 38136-70-8 | C16H17N3O2 | 283.33 | Cyclo-L-Trp-L-Pro; (3S,8aS)-3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione; |
Brevetoxin PbTx 1 | 98112-41-5 | C49H70O13 | 867.08 | |
BREVETOXIN 9 | 155751-73-8 | C49H74O13 | 871.1 | BREVETOXIN 9; BREVETOXIN PBTX-9; PBTX-9 |
Bretylium Tosylate | 61-75-6 | C18H24BrNO3S | 553.25 | 2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-Methylbenzenesulfonate; (o-Bromobenzyl)ethyldimethylammonium p-Toluenesulfonate; (o-Bromobenzyl)ethyldimethylammonium p-Toluenesulfonate; ASL 603; Bretylan; Bretylate; Bretylium p-Toluenesulfonate; Bretyl |
Bourjotinolone A | 6985-35-9 | C30H48O4 | 472.7 | 21,24R-Epoxy-23R,25-dihydroxytirucall-7-en-3-one |
Boron Trifluoride Monohydrate | 15799-89-0 | BF3H2O | 85.821 | |
Boron trifluoride acetonitrile complex solution | 420-16-6 | C2H3BF3N | 108.86 | |
BORON SUBPHTHALOCYANINE CHLORIDE | 36530-06-0 | C24H12BClN6 | 430.66 | Boronsubphthalocyaninechloride;36530-06-0;425540_ALDRICH;SCHEMBL10050329;ZINC170155942;16,26-(Chloroboranediyl)-2,3:7,8:12,13-tri[1,3]butadieno-6,9-epinitrilo-1,4:11,14-diepimino-5,10,15-triaza-1,3,5,7,10,12,14-cyclopentadecaheptene |
BORON SUB-2 3-NAPHTHALOCYANINE CHLORIDE | 142710-56-3 | C36H18BClN6 | 580.844 | 142710-56-3; 427756_ALDRICH; BORONSUB-23-NAPHTHALOCYANINECHLORIDE; BORONSUB-23-NAPHTHALOCYANINECHLORIDE |
BORON SILICIDE | 12007-81-7 | B4Si | 71.32 | boronsilicide(b4si); BORON SILICIDE; SILICON TETRABORIDE; SILICON BORIDE; Siliconboridemicrongrayblackpowder; tetraboron silicide |
Bofumustine | 55102-44-8 | C18H21ClN4O9 | 472.88 | Bofumustine; Rfcnu; Bofumustina[Spanish]; Bofumustinum[INN-Latin]; Bofumustina[INN-Spanish]; ICIG1105 |
Boeravinone O | 1449384-21-7 | C17H12O7 | 328.28 | 4,6,11-Trihydroxy-9-methoxy[1]benzopyrano[3,4-b][1]benzopyran-12(6H)-one |
Boeravinone E | 137787-00-9 | C17H12O7 | 328.3 | 3,6,9,11-Tetrahydroxy-10-methyl[1]benzopyrano[3,4-b][1]benzopyran-12(6H)-one |
Boeravinone B | 114567-34-9 | C17H12O6 | 312.3 | 10-Methyl-6,9,11-trihydroxy[1]benzopyrano[3,4-b][1]benzopyran-12(6H)-one |
Boeravinone A | 114567-33-8 | C18H14O6 | 326.3 | |
Boehmite | 1318-23-6 | AlHO2 | 59.99 | Aluminum oxide hydroxide |
Boehmenan | 57296-22-7 | C40H40O12 | 712.8 | 3-(4-Hydroxy-3-methoxyphenyl)propenoic acid 3-[2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-[[[3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl]oxy]methyl]-7-methoxybenzofuran-5-yl]propyl ester |
BIPHENYL-2,3,3',4'-TETRACARBOXYLIC ACID TETRAMETHYL ESTER | 36978-36-6 | C20H18O8 | 386.35212 | BIPHENYL-2,3,3',4'-TETRACARBOXYLIC ACID TETRAMETHYL ESTER; 2,3,3',4'-Biphenyltetracarboxylic acid tetramethyl ester |
Biperiden Hydrochloride | 1235-82-1 | C21H30ClNO | 347.92 | Akineton hydrochloride; NSC 170950; NSC 84989 |
C.I.Basic Blue 41 | 12270-13-2 | C20H26N4O6S2 | 482.5736 | 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-; 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-; 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium; 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbe |
C.I. Direct Green 27 | 12239-31-5 | |||
C.I. 75695 | 1324-63-6 | C34H42O20 | 770.68528;g/mol | 3-[6-[[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxychromen-4-one; Xanthorhamnin; CA003271; CA007277; 1324-63-6 |
Buserelin Acetate | 68630-75-1 | C62H90N16O15 | 1299.499 | Receptal; Suprecur; Suprefact |
C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine | 766513-53-5 | C7H7F3N2 | 176.13900 | |
C-(5-METHYL-[1,3,4]OXADIAZOL-2-YL)-METHYLAMINE | 125295-22-9 | C4H7N3O | 113.12 | C-(5-METHYL-[1,3,4]OXADIAZOL-2-YL)-METHYLAMINE; (5-Methyl-[1,3,4]oxadiazol-2-yl)-methylamine; (5-methyl-1,3,4-oxadiazol-2-yl)methanamine |
C-(3-METHYL-PYRIDIN-4-YL)-METHYLAMINE | 97004-05-2 | C7H10N2 | 122.17 | 4-AMINOMETHYL-3-METHYLPYRIDINE; CHEMBRDG-BB 4010335; C-(3-METHYL-PYRIDIN-4-YL)-METHYLAMINE; (3-Methylpyridin-4-yl)methylamine; 4-Aminomethyl-3-methylpyridine 2HCl; 4-Aminomethyl-3-methylpyridine dihydrochloride; (3-methylpyridin-4-yl)methanamine |
C-(2,3,4-Tri-O-acetyl-1-hydroxy-b-D-galactopyranosyl)formamide | 189633-66-7 | C12H17NO9 | 319.3 | |
C-(2,3,4-Tri-O-acetyl-1-azido-1-deoxy-b-D-galactopyranosyl)formamide | 189633-67-8 | C12H16N4O8 | 344.3 | |
C-(2,3,4,6-Tetra-O-acetyl-1-hydroxy-b-D-galactopyranosyl)formamide | 189633-60-1 | C15H21NO11 | 391.33 | |
C-(2,3,4,6-Tetra-O-acetyl-1-bromo-1-deoxy-b-D-galactopyranosyl)formamide | 159895-07-5 | C15H20BrNO10 | 456.3 | |
C-(2,3,4,6-Tetra-O-acetyl-1-azido-1-deoxy-a-D-galactopyranosyl)formamide | 180904-09-0 | C15H20N4O10 | 416.34 | |
C-(1-Methyl-cyclobutyl)-methylamine | 933722-69-1 | C6H13N | 99.17 | |
C-(1-Bromo-1-deoxy-2,3,4,6-tetra-O-benzoyl-b-D-glucopyranosyl)formamide | 262849-68-3 | C35H28BrNO10 | 702.5 | C-(2,3,4,6-Tetra-O-benzoyl-1-bromo-1-deoxy-b-D-glucopyranosyl)formamide |
C 87 | 332420-90-3 | C24H15ClN6O3S | 502.93 | TNFalpha-IN-C87; 3-Phenyl-1-(4-phenyl-2-thiazolyl)-1H-pyrazole-4,5-dione 4-[2-(4-chloro-3-nitrophenyl)hydrazone] |
C 21 | 1229236-78-5 | C90H161ClN36O24 | 2166.94 | |
C 021 dihydrochloride | 1784252-84-1 | C27H41N5O2·2HCl | 540.57 | 2-[1,4'-Bipiperidin]-1'-yl-N-cycloheptyl-6,7-dimethoxy-4-quinazolinamine dihydrochloride |
BzO-dPEG6-OH | 24342-68-5 | C19H32O7 | ||
BzO-dPEG5-OH | 57671-28-0 | C17H28O6 | ||
BzATP ammonium salt | 112898-15-4 | C24H24N5O15P3·NH4+ | 732.4 | BzATP |
Bz 423 | 216691-95-1 | C27H21ClN2O2 | 440.92 | 7-Chloro-1,3-dihydro-5-(4-hydroxyphenyl)-1-methyl-3-(2-naphthalenylmethyl)-2H-1,4-benzodiazepin-2-one |
BYK 49187 | 163120-31-8 | C19H21N5O | 335.4 | 4,5-Dihydro-2-[4-(4-methyl-1H-imidazol-4-yl)-1-piperidinyl]-6H-imidazo[4,5,1-ij]quinolin-6-one |
BYK 204165 | 1104546-89-5 | C15H12N2O2 | 252.27 | PARP Inhibitor XIV; RT 017290; 4-[(1-Methyl-1H-pyrrol-2-yl)methylene]-1,3(2H,4H)-isoquinolinedione |
BYK 191023 dihydrochloride | 1216722-25-6 | C14H14N4O.2HCl | 327.21 | BYK 191023 2HCl; 2-[2-(4-Methoxy-2-pyridinyl)ethyl]-1H-imidazo[4,5-b]pyridine dihydrochloride |
Byakangelicol | 26091-79-2 | C17H16O6 | (R)-(+)-9-(2,3-Epoxy-3-methylbutoxy)-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one | |
Byakangelicin | 482-25-7 | C17H18O7 | 334.32 | 5-Methoxy-8-(2,3-dihydroxy-3-methylbutoxy)psoralene; Bjacangelicin; Bjakangelicin; Byankagelicine |
Byakangelicin | 19573-01-4 | C17H18O7 | 9-{[(2R)-2,3-dihydroxy-3-methylbutyl]oxy}-4-methoxy-7H-furo[3,2-g]chromen-7-one | |
Butyric acid magnesium salt | 556-45-6 | C8H14MgO4 | 198.5 | BUTYRIC ACID MAGNESIUM SALT; MAGNESIUM BUTYRATE; magnesium dibutyrate; Dibutanoic acid magnesium salt |
butyramidinium chloride | 3020-81-3 | C4H11ClN2 | 122.6 | butanimidamide; hydrochloride; 3020-81-3; Butyrimidamidehydrochloride; butyramidinehydrochloride; butanimidamidehydrochloride |
Butyraldehyde diethyl acetal | 3658-95-5 | C8H18O2 | 146.23 | Butyraldehyde diethyl acetal; 1,1-Diethoxybutane |
Butynamine | 3735-65-7 | C4H7N | 69.10508 | Butynamine; N-tert-butyl-N,2-dimethyl-but-3-yn-2-amine; N-tert-butyl-N,2-dimethylbut-3-yn-2-amine; tert-butyl-(1,1-dimethylprop-2-ynyl)-methyl-amine |
but-2-enedioic acid | 110-16-7 | C4H4O4 | AKOS BBS-00003804; ACIDUM MALEICUM; BUFFER, MALEIC ACID, PH 2.35; CIS-1,2-ETHYLENEDICARBOXYLIC ACID; CIS-2-BUTENEDIOIC ACID; CIS-BUTENEDIODIC ACID; CIS-BUTENEDIOIC ACID; MALEIC ACID | |
Busulfan-d8(tetramethylene-d8) | 116653-28-2 | C6H6D8O6S2 | 254.34 | 1,4-Butanediol Dimethylsulfote; Tetramethylenedimethanesolfote |
Busulfan Impurity 5 | 19859-00-8 | C7H14O5S | 210.25 | 1-Acetate 4-Methanesulfonate 1,4-Butanediol; 4-((Methylsulfonyl)oxy)butyl acetate |
Busulfan Impurity 4 | 42729-95-3 | C5H12O4S | 168.21 | 4-Methanesulfonyloxybutanol; 1,4-Butanediol Monomethanesulfonate; NSC 67176 |
Busulfan Impurity 3 | 26978-64-3 | C4H10O4S | 154.19 | 4-Hydroxybutane-1-sulfonic acid; Nsc 163335; Nsc 71873; Benzenediazonium,2-methoxy-5-methyl-4-[2-(4-methyl-2-nitrophenyl)diazenyl]- |
Busulfan Impurity 1 | 1797106-48-9 | C6H14O5S2 | 230.3 | |
Busulfan | 55-98-1 | C6H14O6S2 | 246.3 | 1,4-Butanediol-dimethanesulfonate Esters; Busulphan; CB-2041; GT-41; Busulfex; Misulban; Myleran; |
Bromosulfalein | 71-67-0 | C20H8Br4O10S2·2Na | 838 | Bromosulfophthalein; Bromosulphalein; Sulfobromophthalein; Sulphobromophthalein |
Bromosporine | 1619994-69-2 | C17H20N6O4S | 404.44 | ethyl N-[6-[3-(methanesulfonamido)-4-methylphenyl]-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate Bromosporine 1619994-69-2 ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate Bromorsporine |
BROMOPYRAZONE | 3042-84-0 | C10H8BrN3O | 266.09 | 1-phenyl-4-amino-5-brompyridazon-(6); 5-amino-4-bromo-2-phenyl-3(2h)-pyridazinon; 5-amino-4-bromo-2-phenyl-3(2h)-pyridazinone; bas2430; bas2430h; BROMPYRAZON |
Bromethalin | 63333-35-7 | C14H7Br3F3N3O4 | 577.93 | |
Bromelain | 9001-00-7 | N/A | N/A | STEM BROMELAIN; 3.4.22.32; BROMELAIN; BROMELAIN PINEAPPLE; BROMELIN; EC 3.4.22.1; EC 3.4.22.32; EC 3.4.22.4 |
Bromchlorbuterol hydrochloride | 78982-84-0 | C12H19BrCl2N2O | 358.11 | Bromoclenbuterol hydrochloride; 1-(4-amino-3-bromo-5-chlorophenyl)-2-(tert-butylamino)ethanol hydrochloride |
Brombuterol-D9 hydrochloride | 1353867-94-3 | 1-(4-Amino-3,5-dibromo- phenyl)-2-tert-butyl-D9- amino-ethanol hydrochloride | ||
Brombuterol-D9 | 1353940-55-2 | 1-(4-Amino-3,5-dibromo- phenyl)-2-tert-butyl-D9- amino-ethanol | ||
Brombuterol hydrochloride | 21912-49-2 | 1-(4-Amino-3,5-dibromo- phenyl)-2-tert- butylamino-ethanol hydrochloride | ||
Brombuterol | 41937-02-4 | C12H18Br2N2O | 366.097 | 1-(4-Amino-3,5-dibromophenyl)-2-tert-butylaminoethanol |
Bromazepam Impurity E | 1694-64-0 | C14H10Br2N2O2 | 398.06 | 2-Bromo-N-[4-Bromo-2-[Oxo-(2-Pyridyl)Methyl]Phenyl]Acetamide; 2-Bromo-N-(4-Bromo-2-Pyridin-2-Ylcarbonyl-Phenyl)Ethanamide |
Bromazepam Impurity D | 77616-97-8 | C14H10BrN3O | 316.16 | 3-Amino-6-bromo-4-(2-pyridinyl)-2(1H)-quinolinone |
Bromazepam Impurity A | 1563-56-0 | C12H9BrN2O | 277.12 | 2-(2-Amino-5-bromobenzoyl)pyridine; 2-Amino-5-bromophenyl 2-pyridyl Ketone; 2-Amino-5-bromophenyl-2-pyridylmethanone; 2-(5-Bromo-2-aminobenzoyl)pyridine |
Bromamphenicol | 16803-75-1 | C11H12Br2N2O5 | 412.0 | |
BXL 628 | 199798-84-0 | C29H43FO2 | 442.65 | Elocalcitol; (1R,3Z,5S)-3-[(2E)-2-[(3aS,7aS)-1-[(E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol |
BX912 | 702674-56-4 | C20H23BrN8O | 471.363 | BX912; BX 912; BX-912. |
BX-795 | 702675-74-9 | C23H26IN7O2S | 591.47 | BX 795; BX795 |
BX-517 | 850717-64-5 | C15H14N4O2 | 282.3 | (Z)-N-(3-(1-(1H-pyrrol-2-yl)ethylidene)-2-hydroxy-3H-indol-5-yl)carbamimidic acid; BX-517; BX 517; BX517; PDK1 inhibitor2. |
BX471 hydrochloride | 288262-96-4 | C21H25Cl2FN4O3 | 471.35 | BX-471 hydrochloride; BX 471 hydrochloride; (R)-1-(5-chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea hydrochloride |
BX341 | 34633-34-6 | C17H18F2O2 | 292.32 | 2-fluoro-4-[3-(3-fluoro-4-hydroxyphenyl)pentan-2-yl]phenol; bifluranol; erythro-2,3-bis(3-fluor-4-hydroxyphenyl)pentan |
BX 471 | 217645-70-0 | C21H24ClFN4O3 | 434.89 | (R)-1-(5-chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea; BX471; BX 471; BX-471; ZK811752; ZK 811752; ZK-811752 |
BX 430 | 688309-70-8 | C15H15Br2N3O | 413.11 | N-[2,6-Dibromo-4-(1-methylethyl)phenyl]-N'-(3-pyridinyl)urea |
BW-B 70C | 134470-38-5 | C17H17FN2O3 | 316.33 | N-[3-[3-(-Fluorophenoxy)phenyl]-1-methyl-2-propenyl]-N-hydroxyurea |
BVT 948 | 39674-97-0 | C14H11NO3 | 241.25 | 4-Hydroxy-3,3-dimethyl-2H-benz[g]indole-2,5(3H)-dione |
BVT 2733 hydrochloride | 376641-65-5 | C17H21ClN4O3S2.HCl | 465.42 | 3-chloro-2-methyl-N-[4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1,3-thiazol-2-yl]benzenesulfonamide hydrochloride |
BVT 2733 | 376640-41-4 | C17H21ClN4O3S2 | 428.95 | BVT-2733; 3-chloro-2-methyl-N-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide; Piperazine, 1-((2-(((3-chloro-2-methylphenyl)sulfonyl)amino)-4-thiazolyl)acetyl)-4-methyl- |
BVD 10 | 262418-00-8 | C58H92N16O13 | 1221.46 | |
BV-6 | 1001600-56-1 | C70H96N10O8 | 1205.57 | |
Buxtauine | 4236-73-1 | C24H37NO2 | Buxtauine M; Cyclobuxoxine; Cyclomicrobuxinine; (3beta,5alpha,16alpha)-16-Hydroxy-14-methyl-3-(methylamino)-4-methylene-9,19-cyclopregnan-20-one | |
Bufalin | 465-21-4 | C24H34O4 | 386.52 | |
Buergerinin G | 263764-83-6 | C9H12O4 | 184.19 | (3aR,7S,8aR)-Tetrahydro-7-methyl-7H-3a,7-epoxyfuro[2,3-d]oxepin-2(3H)-one |
Buergerinin B | 919769-83-8 | C9H14O5 | 202.20 | 5beta-Hydroxyjioglutolide |
Budesonide-d8 | 1105542-94-6 | C25H26D8O6 | 438.58 | |
Bruceine D | 21499-66-1 | C20H26O9 | 410.42 | Nsc318801; (1beta,11beta,12alpha,15beta)-13,20-Epoxy-1,11,12,14,15-pentahydroxypicras-3-ene-2,16-dione; Picras-3-ene-2,16-dione,13,20-epoxy-1,11,12,14,15-pentahydroxy-, (1b,11b,12a,15b)-; (1R,2S,3R,3aR,3a1R,4R,6aR,7aS,11S,11aS)-1,2,3a,4,11-pentahydroxy-3, |
Bruceine A | 25514-31-2 | C26H34O11 | 522.54 | Dihydrobrusatol; NSC310616 |
Bruceantinol | 53729-52-5 | C30H38O13 | 606.62 | |
Bruceantin | 41451-75-6 | C28H36O11 | 548.58 | (-)-Bruceantin; NCI165563; NSC165563 |
Broxyquinoline | 521-74-4 | C9H5Br2NO | 302.95 | |
Bradykinin | 58-82-2 | C50H73N15O11 | 1060.22 | Kallidin I |
Bradanicline hydrochloride | 1111941-90-2 | C22H24ClN3O2 | 397.90 | TC-5619;TC5619;TC-5619-023;TC5619-023;N-((2S,3R)-2-(pyridin-3-ylmethyl)quinuclidin-3-yl)benzofuran-2-carboxamide hydrochloride |
Bradanicline | 639489-84-2 | C22H23N3O2 | 361.44 | TC-5619;N-[(2S,3R)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide;TC5619;TC-5619-023;TC5619-023 |
BOC-L-TRANSPRO(4-CH2OH) | 273221-97-9 | C11H19NO5 | 245.27 | BOC-L-TRANSPRO(4-CH2OH); (2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(HYDROXYMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID |
Boc-L-Pyroglutaminol | 81658-25-5 | C10H17NO4 | 215.25 | Boc-L-Pyroglutaminol; tert-Butyl (2S)-2-(hydroxymethyl)-5-oxopyrrolidine-1-carboxylate; (2S)-2-(Hydroxymethyl)-5-oxo-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester |
Butyryl-L-homoserine lactone | 67605-85-0 | C8H13NO3 | 171.2 | C4-HSL, N-Butyryl-L-homoserine lactone, PAI |
Butyryl-L-carnitine-d3 chloride | 1334532-21-6 | C11H19D3NO4·Cl | 270.77 | L-Butyrylcarnitine-d3; C4 Carnitine-d3 |
Butyryl-L-carnitine chloride | 162067-50-7 | C11H22NO4·Cl | 267.8 | L-Butyrylcarnitine; C4 Carnitine |
Butyryl-d7Chloride | 1219805-71-6 | |||
Butyrylcholine perchlorate | 20292-68-6 | |||
Butyrophenone | 495-40-9 | C10H12O | 148.21 | |
Butyrolactone I | 87414-49-1 | C24H24O7 | 424.5 | Olomoucin |
Butyltin trichloride | 1118-46-3 | C4H9Cl3Sn | 282.16 | MBTC; BUTYLTIN TRICHLORIDE; butyltrichlorostannane; BUTYLTRICHLOROTIN; N-BUTYLTIN TRICHLORIDE; N-BUTYLTRICHLOROTIN; MONOBUTYLTIN TRICHLORIDE; TIN,N-BUTYL TRICHLORIDE |
Butyltin oxide | 51590-67-1 | C4H10OSn | 191.82 | |
Butylphthalide (Natural) | 6066-49-5 | C12H14O2 | 190.24 | 3-n-Butylphthalide; 3-Butylphthalide |
Butylphenylacetonitrile | 3288-99-1 | C12H15N | 173.26 | |
Butylglucoside | 41444-57-9 | C10H20O6 | 236.2622;g/mol | (3R,4S,5S,6R)-2-butoxy-6-(hydroxymethyl)oxane-3,4,5-triol; ButylD-glucoside; BUTYLGLUCOSIDE; 31387-97-0; 41444-57-9; ButylD-glucopyranoside |
BUTYLDICHLOROBORANE | 14090-22-3 | C4H9BCl2 | 138.83 | N-BUTYLDICHLOROBORANE; BUTYLDICHLOROBORANE; Butyldichloroborane solution; BUTYLDICHLOROBORANE, 1.0M SOLUTION IN HE XANES |
Butylcyclohexanol; 95% | 21862-63-5 | C10H20O | 156.2652 | 4-tert-Butylcyclohexanol; 98-52-2; cis-4-tert-Butylcyclohexanol; 937-05-3; trans-4-tert-butylcyclohexanol; cis-4-(tert-Butyl)cyclohexanol |
Butyl-2-propynylestercarbamicacid | 76114-73-3 | |||
butyl trimethyl ammonium chloride | 14251-72-0 | C7H18ClN | 151.68 | BUTYLTRIMETHYLAMMONIUM CHLORIDE; Butyltrimethylaminium·chloride; 1-Butanaminium, N,N,N-trimethyl-, chloride; 1-Butanaminium, N,N,N-trimethyl-, chloride (1:1); Trimethylbutylammonium chloride |
BUTYL TRIFLATE | 75618-25-6 | C5H9F3O3S | 206.18 | |
Butyl Titanate | 5593-70-4 | C16H36O4Ti | 340.32 | |
Butyl phosphate | 52933-01-4 | C4H11O4P | 154.1 | Butyl phosphate; Butyl phosphate (mixture of mono and di esters) |
butyl oxoacetate | 6295-06-3 | C6H10O3 | 130.1418 | BUTYL GLYOXYLATE; N-BUTYL GLYOXYLATE; Glyoxylic acid, n-butyl ester; 2-Oxoacetic acid butyl ester; Glyoxylic acid butyl ester; Oxoacetic acid butyl ester |
Butyl methanethiosulfonate | 52017-46-6 | C5H12O2S2 | 168.28 | Methanesulfonothioic Acid S-Butyl Ester; Thio-methanesulfonic Acid S-Butyl Ester; |
butyl cinnamate | 538-65-8 | C13H16O2 | 204.26 | N-BUTYL CINNAMATE; (E)-3-PHENYL-ACRYLIC ACID BUTYL ESTER; BUTYL CINNAMATE; 3-phenyl-2-propenoicacibutylester; 3-phenyl-prop-2-enoicacidbutylester; cinnamateden-butyle; cinnamicacid,butylester; cinnamicacidn-butylester |
BUTYL BUTYRYL LACTATE | 7492-70-8 | C11H20O4 | 216.27 | Butanoic acid, 2-butoxy-1-methyl-2-oxoethyl ester, Butyl butyrolactate, BUTYL BUTYRYL LACTATE FCC, Butyl butyryllactate, Butyl O-butyryllactate |
Butyl b-D-glucopyranoside | 5391-18-4 | C10H20O6 | 236.26 | |
Butyl a-D-glucopyranoside | 25320-93-8 | C10H20O6 | 236.26 | |
Butyl 4-aminobenzoate | 94-25-7 | C11H15NO2 | 193.24 | 4-(Butoxycarbonyl)aniline;4-Amino-benzoicacibutylester;Benzoic acid, 4-amino-, butyl ester;Benzoic acid, p-amino-, butyl ester;Butesin;Butesine;Butsein;Butyl aminobenzoate N-butyl p-aminobenzoate;Butamben |
Butyl 3-hydroxybutyrate | 53605-94-0 | C8H16O3 | ||
Butyl 2-fluoroprop-2-enoate | 10011-39-9 | C7H11FO2 | 146.16 | butyl alpha-fluoroacrylate; 2-Fluoroacrylic acid butyl ester |
Butyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 155197-37-8 | C18H29NO9 | 403.42 | |
Butyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 94536-61-5 | C12H23NO6 | 277.31 | |
Bromfenac | 91714-94-2 | C15H12BrNO3 | 334.168 | BROMFENAC; AKOS 91023; 2-Amino-3-(4-bromobenzoyl)benzeneacetic acid; Bromofenac; Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-; Bromfenaco; Bromfenaco [spanish]; Bromfenacum |
Brofaromine Hydrochloride | 63638-90-4 | C14H17BrClNO2 | 346.65 | CGP-11305A HCl;CGP11305A HCl;Brofaromine HCl;4-(7-Bromo-5-methoxy-2-benzofuranyl)piperidine hydrochloride;Piperidine, 4-(7-bromo-5-methoxy-2-benzofuranyl)-, monohydrochloride |
BRN-103 | 1346265-80-2 | C24H25ClN4O | 420.93 | 2-((1-benzylpiperidin-4-yl)amino)-N-(3-chlorophenyl)nicotinamide |
BRL-54443 | 57477-39-1 | C14H18N2O | 230.31 | |
BRL44385 | 114778-60-8 | C8H11N5O3 | 225.2 | 2-amino-9-(3-hydroxypropoxy)-3H-purin-6-one; 9-(3-hydroxypropoxy)guanine; BRL 44385; BRL-44385 |
BRL-37344 sodium | 127299-93-8 | C19H21ClNNaO4 | 385.82 | sodium;2-[4-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetate |
BRD6688 | 1404562-17-9 | C16H18N4O | 282.3 | BRD-6688; BRD 6688 |
BRD4884 | 1404559-91-6 | C18H19FN2O2 | 314.4 | BRD-4884; BRD 4884 |
BRD4770 | 1374601-40-7 | C25H23N3O3 | 413.477 | BRD4770; BRD-4770; BRD 4770. |
BRD32048 | 433694-46-3 | C16H22N6O | 314.4 | BRD-32048; BRD 32048 |
BRD 9876 | 32703-82-5 | C16H14N2 | 234.3 | 6-(1,1-Dimethylethyl)-2,3-naphthalenedicarbonitrile; 6-Tert-Butyl-2,3-naphthalenedicarbonitrile |
BRD 9757 | 1423058-85-8 | C6H9NO2 | 127.14 | N-Hydroxy-1-cyclopentene-1-carboxamide; BRD9757; BRD-9757 |
BRD 7389 | 376382-11-5 | C24H18N2O2 | 366.41 | BAS 05532738; 1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione |
BRD 6989 | 642008-81-9 | C16H16N4 | 264.33 | 2-Amino-5,6,7,8-tetrahydro-6-methyl-4-(3-pyridinyl)-3-quinolinecarbonitrile; BRD-6989; BRD6989 |
BRD 4354 | 315698-07-8 | C21H23ClN4O | 382.89 | 5-Chloro-7-[(4-ethyl-1-piperazinyl)-3-pyridinylmethyl]-8-quinolinol |
Boric acid (HBO2) | 13460-50-9 | BH O2 | 43.82 | METABORIC ACID; BHO2; Boric acid (HBO2); boricacid(hbo2); HBO2; Hydroxyoxoboron |
BoC-3-Hydroxy-1-adamantyl-D-glycine | 361442-00-4 | C17H27NO5 | 325.40 | (2S)-2-(3-hydroxy-1-adamantyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]aceticacid; (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)aceticacid; 361442-00-4; (S)-N-Boc-3-hydroxyadamantylglycine; BOC-3-Hydroxy-1-adamantyl-D-Glycine; SCHEMBL21 |
BUTTPARK 100\01-13 | 870606-45-4 | C6H4ClF2N | 163.55 | |
BUTROXYDIM | 138164-12-2 | C24H33NO4 | 399.52 | FALCON; BUTROXYDIM; butroxydim (bsi, pa e-iso); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one; Butroxydim [iso] |
Butoxymethanol | 3085-35-6 | C5H12O2 | 104.1476 | butoxymethanol; Einecs 221-395-8; Methanol, 1-butoxy-; Methanol, butoxy- |
BUTOXYCARBOXIM | 34681-23-7 | C7H14N2O4S | 222.26 | 3-METHYLSULFONYLBUTANONE O-METHYL CARBAMOYLOXIME; BUTOXYCARBOXIM; PLANT PIN; 2-Butanone,3-methylsulfonyl-,O-(N-methylcarbamoyl)oxime; 2-methylsulfonyl-o-(n-methyl-carbamoyl)-butanon-(3)-oxim; 3-(sulfonyl)-o-((methylamino)carbonyl)oxime-2-butanone |
Butoctamide | 32838-28-1 | C16H29NO5 | 0 | BAHS; Butanedioic acid, mono[3-[(2-ethylhexyl)amino]-1-methyl-3-oxopropyl] ester; Butoctamide hydrogen succinate; butoctamide semisuccinate; Butoctamide succinate; Listomin S |
Butoconazole Nitrate | 64872-77-1 | C19H17Cl3N2S·HNO3 | 474.79 | Butoconazole, Gynazole-1, Mycelex-3, RS35887, RS-35887, RS 35887; Butoconazole Nitrate |
Butoconazole Impurity 9 | 98011-62-2 | C10H10Cl2 | 201.1 | Benzene, 1-chloro-4-(4-chloro-2-butenyl)- |
Butoconazole Impurity 6 | 59363-17-6 | C10H11ClO | 182.65 | |
Butoconazole Impurity 4 | 1850278-18-0 | C19H17Cl3N2S | 411.78 | |
Butoconazole Impurity 3 | 67085-12-5 | C13H14Cl2N2 | 269.18 | 1-(2-CHLORO-4-(4-CHLOROPHENYL)BUTYL)-1H-IMIDAZOLE; INTERMEDIATE:BUTOCONAZOLENITRATE |
Butoconazole Impurity 2 | 67085-11-4 | C13H15ClN2O | 250.73 | 4-(4-Chloro-phenyl)-1-imidazol-1-yl-(butan-d5)-2-ol; 1-[4-(4-Chlorophenyl)-2-hydroxy-n-butyl]imidazole-d5; |
Butoconazole Impurity 1 | 59363-13-2 | C10H12Cl2O | 219.11 | 1-Chloro-4-(4-chlorophenyl)-2-butanol; Benzenepropanol, 4-chloro-a-(chloroMethyl)- (Butoconazole interMediate) |
Butoconazole | 64872-76-0 | C19H17Cl3N2S | 411.78 | RS 35887-10-3; RS-35887-10-3 |
Butirosin disulfate | 51022-98-1 | C21H41N5O12.2H2SO4 | 751.72 | BUTIROSIN DISULFATE; ambutyrosinsulfate; butirosin,sulfate(salt); butirosinsulfate |
Butin | 492-14-8 | C15H12O5 | 272.25 | (2S)-7,3',4'-Trihydroxyflavanone;(S)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-7-hydroxy-4H-1 -benzopyran-4-one;4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydro xy-, (S)-. |
Buthionine Sulphoximine | 5072-26-4 | C8H18N2O3S | 222.3 | 2-amino-4-(butylsulfonimidoyl)butanoic acid; NSC-326231; BSO; Buthionine Sulphoximine; DL-Buthionine-(S,R)-sulfoximine. |
Butenoyl PAF | 474944-25-7 | C28H56NO7P | 549.7 | Butenoyl PAF |
Butenafine HCl | 101827-46-7 | C23H27N.HCl | 353.93 | KP-363; KP 363; KP363 |
Butenafine | 101828-21-1 | C23H27N | 317.47 | Butenafine; Mentax; Butop; KP363; KP 363; KP-363 |
Butein | 487-52-5 | C15H12O5 | 272.25 | |
Butedronic acid | 51395-42-7 | C5H10O10P2 | 292.074424;g/mol | Butedronicacid; 2-(diphosphonomethyl)butanedioicacid; 51395-42-7; Butedronate; Butedronicacid; 2-(Diphosphonomethyl)succinicacid |
Butazolamide | 16790-49-1 | C6H10N4O3S2 | 250.2986;g/mol | Butazolamide; UNII-0S326CI0WT; 16790-49-1; CHEMBL1288787; 5-butyramido-2-sulfamoyl-1,3,4-thiadiazole; N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)butanamide |
Butaverine | 55837-14-4 | C18H27NO2 | 289.41248;g/mol | Butaverine; BUTYL3-PHENYL-3-(PIPERIDIN-1-YL)PROPANOATE; 55837-14-4; 17824-89-4; Butaverina; Butaverinum |
Butaprost | 433219-55-7 | C23H38O5 | 394.6 | (±)-15-deoxy-16S-hydroxy-17-cyclobutyl PGE1; 15-deoxy-16S-hydroxy-17-cyclobutyl PGE1 |
Butapho | 17316-67-5 | C7H18NO2P | 179.2 | Butaphosphan |
Butanoicacid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]- | 69171-62-6 | C10H22 O3 Si | 218.3654 | |
Butanoicacid, 3-methyl-, (3,6-dioxo-1,4-cyclohexadien-1-yl)methyl ester | 849762-24-9 | C12H14 O4 | 222.24 | (3,6-dioxocyclohexa-1,4-dien-1-yl)methyl 3-methylbutanoate; blattellaquinone; gentisyl quinone isovalerate; 849762-24-9; (3,6-Dioxocyclohexa-1,4-dien-1-yl)methyl 3-methylbutanoate; Blattellaquinone; BUTANOICACID, 3-METHYL-, (3,6-DIOXO-1,4-CYCLOHEXADIEN-1- |
Butanoicacid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-oxo-, phenylmethyl ester, (2S)- | 124994-66-7 | C16H21 N O5 | 307.34164;g/mol | benzyl(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoate; Butanoicacid,2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-oxo-,phenylmethylester,(2S)-; 124994-66-7; SCHEMBL1093849; CTK4B4144; ZINC34278085 |
Butanoic acid,4-[(1-oxo-2-propen-1-yl)amino]- | 53370-87-9 | C7H11 N O3 | 157.1671 | 53370-87-9;Butanoicacid,4-[(1-oxo-2-propen-1-yl)amino]-;NSC288739;AC1L8A5V;SCHEMBL38788;4-(Acryloylamino)butyricacid |
Butanoic acid,4,4,4-trifluoro-3-hydroxy-3-(trifluoromethyl)- | 1547-36-0 | C5H4 F6 O3 | 226.0739 | 3-hydroxy-4,4,4-trifluoro-3-(trifluoromethyl)-butyricaci; 3-hydroxy-4,4,4-trifluoro-3-(trifluoromethyl)butyricacid; 3,3-BIS(TRIFLUOROMETHYL)-3-HYDROXYPROPIONIC ACID; 4,4,4-TRIFLUORO-3-HYDROXY-3-(TRIFLUOROMETHYL)BUTANOIC ACID; 4,4,4-TRIFLUORO-3-HYDROXY-3-( |
Butanoic acid,3-hydroxy-, butyl ester, (3R)- | 82578-46-9 | C8H16 O3 | 104.1 | |
Butanoic acid,3-(acetyloxy)-4-bromo-, (3S)- | 191354-44-6 | C6H9 Br O4 | 225.04 | (S)-3-ACETOXY-4-BROMOBUTYRIC ACID; BUTANOIC ACID, 3-(ACETYLOXY)-4-BROMO-, (S); Butanoic acid, 3-(acetyloxy)-4-bromo-, (3S)- |
Butanoic acid,2-methyl-, 3-hexen-1-yl ester | 10094-41-4 | C11H20 O2 | 184.2753 | CIS-3-HEXENYL 2-METHYLBUTANOATE 97+%; 2-methyl-butanoicaci3-hexenylester; Butanoicacid,2-methyl-,3-hexenylester; hex-3-; hex-3-enyl; hex-3-enyl2- |
Butanoic acid,2-[(benzoylamino)methyl]-3-hydroxy-, methyl ester, (2S,3R)- | 124044-13-9 | C13H17 N O4 | 251.27800 | |
Butanoic acid,2,4-dihydroxy- | 22329-72-2 | C4H8 O4 | 120.1 | (S)-2,4-DIHYDROXYBUTYRIC ACID |
Butanoic acid,2,3-diamino-, hydrochloride (1:2), (2R,3R)-rel- | 121054-30-6 | C4H10 N2 O2 . 2 Cl H | 191.05628 | (3S,2S)-2,3-Diaminobutyric acid 2HCl; (2S,3S)-2,3-DIAMINO-BUTANOIC ACID DIHYDROCHLORIDE |
Butanoic acid,2,3-diamino- | 2643-66-5 | C4H10 N2 O2 | 118.1344 | 2,3-Diaminobutyric acid |
Butanoic acid,2-(1,1-dimethylethyl)-3,3-dimethyl- | 41785-81-3 | C10H20 O2 | 172.2646 | 2-tert-butyl-3,3-dimethylbutanoicacid;AC1L49IZ;SCHEMBL4553889;ZINC2535700;AKOS006276401;OR044083 |
Butanoic acid,(2E)-2-octen-1-yl ester | 84642-60-4 | C12H22 O2 | 198.3019 | BUTANOIC ACID 2-OCTENYL ESTER (E); FEMA 3517; TRANS-2-OCTENYL BUTANOATE; TRANS-2-OCTENYL BUTYRATE; (E)-oct-2-enyl butyrate; Butanoic acid, (2E)-2-octenyl ester; TRANS-2-OCTEN-1-YLBUTANOATE; Butanoic acid (E)-2-octenyl ester |
Butanoic acid, 4-amino-2-methyl- | 42453-21-4 | C5H11 N O2 | 131.17 | (D,L)-4-AMINO-2-METHYL-BUTANOIC ACID |
Butanoic acid, 3-oxo-,hexyl ester | 13562-84-0 | C10H18 O3 | 186.25 | HEXYL ACETOACETATE; ACETOACETIC ACID N-HEXYL ESTER; ACETOACETIC ACID HEXYL ESTER; 3-oxo-butanoicacihexylester; 3-Oxobutanoic acid hexyl ester; 3-Oxobutyric acid hexyl ester |
Butanoic acid, 3-(acetyloxy)-4-bromo-, (3R)- | 949899-86-9 | C6H9BrO4 | 0 | Butanoic acid, 3-(acetyloxy)-4-bromo-, (3R)- |
Butanoic Acid, [(Diethoxyphosphinyl)Oxy]Methyl Ester | 213262-83-0 | C9H19O6P | 254.219 | Diethoxyphosphoryloxymethyl Butanoate; Butyroyloxymethyl-diethyl phosphate |
Butanoic acid 2,3-dihydroxypropyl ester | 557-25-5 | C7H14O4 | 162.18 | alpha-Monobutyrin; Butanoic acid, 2,3-dihydroxypropyl ester; butanoicacid,2,3-dihydroxypropylester; butanoicacid2,3-dihydroxypropylester; butyricacid2,3-dihydroxy-propylester; Butyrin, 1-mono- |
Butanoic Acid | 1977-33-9 | C10H19NO5 | 233.262 | butyricacid; butanoicacid; n-Butyricacid; n-Butanoicacid; propylformicacid; Butanicacid |
Butanetetracarboxylicdianhydride | 17309-39-6 | C8H6O6 | 198.13 | MESO-BUTANE-1,2,3,4-TETRACARBOXYLIC DIANHYDRIDE; 1,2,3,4-BUTANETETRACARBOXYLIC DIANHYDRIDE; Butanetetracarboxylicdianhydride; MESO-BUTANE-1,2,3,4-TETRACARBOXYLIC DIANHYDRIDE 98+%; Nsc512767 |
Butanedioic acid,2-sulfo-, 1-hexadecyl ester, sodium salt (1:2) | 42160-83-8 | C20H38 O7 S . 2 Na | 466.54018 | disodium; 4-hexadecoxy-4-oxo-3-sulfonatobutanoate; 42160-83-8; Butanedioicacid,2-sulfo-,1-hexadecylester,sodiumsalt(1:2); Disodium1-hexadecyl2-sulphonatosuccinate; SCHEMBL4941637 |
Butanedioic acid,2-methyl-, 1-methyl ester, (2S)- | 111266-16-1 | C6H10 O4 | 146.1412 | (S)-2-METHYLSUCCINIC ACID 1-METHYL ESTER |
Butanedioic acid,2-hydroxy-, sodium salt, hydrate (1:2:3) | 64887-74-7 | C4H6 O5 . 3 H2 O . 2 Na | 232.1 | SODIUM DL-MALATE TRIHYDRATE; DISODIUM DL-MALATE TRIHYDRATE |
Butanedioic acid,2-(4-bromophenyl)- | 71471-40-4 | C10H9 Br O4 | 273.0801 | (4-BROMOPHENYL)SUCCINIC ACID; 2-(4-BROMO-PHENYL)-SUCCINIC ACID |
Butanedioic acid,2-(3-bromophenyl)- | 69006-89-9 | C10H9 Br O4 | 273.0801 | (3-BROMOPHENYL)SUCCINIC ACID; 2-(3-BROMO-PHENYL)-SUCCINIC ACID |
Butanedioic acid,2-(2-bromophenyl)- | 20608-82-6 | C10H9 Br O4 | 273.08 | 2-(2-BROMO-PHENYL)-SUCCINIC ACID |
butane-1,2,3,4-tetracarboxylic acid | 1703-58-8 | C8H10O8 | 234.16 | butanetetracarboxylicacid; 1,2,3,4-TETRACARBOXYBUTANE; 1,2,3,4-BUTANETETRACARBOXYLIC ACID; BTCA; butane-1,2,3,4-tetracarboxylic acid; 1,2,3,4-ButaneTetraCarboxylic; 1,2,3,4-BUTANETETRACARBOXYLIC ACID (BTCA); 1,2,3,4-BUTANETETRACARBOXYLIC ACID 98% |
Butane,2-(ethylsulfonyl)- | 34008-92-9 | C6H14 O2 S | 150.23900 | |
Butane,1,1,1-trifluoro-4-iodo-2,2-bis(trifluoromethyl)- | 14115-45-8 | C6H4 F9 I | 373.99 | 4,4,4-TRIFLUORO-3,3-BIS(TRIFLUOROMETHYL)-1-IODOBUTANE; 1-IODO-4,4,4-TRIFLUORO-3,3-BIS(TRIFLUOROMETHYL)BUTANE; 1,1,1-TRIFLUORO-4-IODO-2,2-BIS(TRIFLUOROMETHYL)BUTANE; 1-Iodo-4,4,4-trifluoro-3,3-bis(trifluoromethyl); 3-Iodo-2,4,6-trifluorobenzoicacid |
Butane,1,1,1-triethoxy-3-methyl- | 55048-55-0 | C11H24 O3 | 204.30646;g/mol | Butane,1,1,1-triethoxy-3-methyl-;55048-55-0;1,1,1-triethoxy-3-methylbutane;SCHEMBL11381525;CTK5A2959;1,1,1-triethoxy-3-methyl-butane |
Butane,1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxy- | 163702-07-6 | C5H3 F9 O | 250.0623 | 1H,1H,1H-NONAFLUORO-2-OXAHEXANE; 1-(METHOXY)NONAFLUOROBUTANE; METHYL NONAFLUOROBUTYL ETHER; METHYL PERFLUOROBUTYL ETHER; METHOXYPERFLUOROBUTANE; METHOXYNONAFLUOROBUTANE; HFE-7100; PERFLUOROBUTYL METHYL ETHER |
Butane, 1,4-bis (chloromethoxy)- | 13483-19-7 | C6H12Cl2O2 | ||
Butanamide,2-chloro-N,N-diethyl-3-oxo- | 15844-87-8 | C8H14 Cl N O2 | 191.66 | 2-chloro-n,n-diethyl-3-oxo-butanamid; 2-Chloro-N,N-diethyl-3-oxobutanamide; 2-chloro-n,n-diethyl-3-oxobutyramide; 2-chloro-n,n-diethyl-acetoacetamid; alpha-chloracetessigsaeurediaethylamid; alpha-chloroacetoaceticaciddiethylamide |
Butanamide,2-chloro-3-oxo- | 67271-66-3 | C4H6 Cl N O2 | 135.5489 | 2-chloroacetoacetamide; Butanamide, 2-chloro-3-oxo- (9CI); 2-Chloro-3-oxobutanamide |
Butamirate Impurity 3 | 2294-71-5 | C11H14O2 | 178.23 | |
Butamirate Impurity 2 | 47092-75-1 | C16H25NO3 | 279.38 | |
Butamirate Impurity 1 | 92321-53-4 | C15H22O | 218.34 | |
Butamirate Citrate | 18109-81-4 | C18H29NO3 C6H8O7 | 370.44 192.13 | Butamirate citrate; diethyl[2-[2-(2-phenylbutyroyloxy)ethoxy]ethyl]ammonium dihydrogen citrate; Butamiratdihydrogencitrat; Abbott 36581; HH-197; 2-(2-diethylaminoethyloxy)ethyl 2-phenylbutanoate; 2-phenylbutyric acid 2-(2-diethylaminoethyloxy)ethyl ester; |
Butamirate | 18109-80-3 | C18H29NO3 | 370.44 | Butamirate; Butamyrate; 2-Phenylbutyric acid 2-[2-(diethylamino)ethoxy]ethyl ester; Benzeneacetic acid, alpha-ethyl-, 2-(2-(diethylamino)ethoxy)ethyl ester; Brospamin; Butamirate [inn:ban]; Butamirato; Butamirato [inn-spanish] |
BUTAMIFOS | 36335-67-8 | C13H21N2O4PS | 332.36 | (1-methylpropyl)-phosphoramidothioicacio-ethylo-(5-methyl-2-nitropheny; h26905; hercules26905; kremart; metacrefos; n-(sec-butyl)-phosphoramidothioicacio-ethylo-(6-nitro-m-tolyl)ester |
Butacaine | 149-16-6 | C18H30N2O2 | 306.44 | 3-(dibutylamino)propyl 4-aminobenzoate butacaine 149-16-6 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate (ester) Butelline Butyn 3-(Dibutylamino)propyl 4-aminobenzoate p-Aminobenzoyldibutylaminopropanol Butacaine [INN:BAN] Butacainum [INN-Latin] |
Butabindide oxalate | 185213-03-0 | C17H25N3O2.C2H2O4 | 393.44 | (2S)-[1-[(2S)-2-amino-1-oxobutyl]-N-butyl]-2,3-dihydro-1H-indole-2-carboxamide oxalate |
BUT-3-ENOYL CHLORIDE | 1470-91-3 | C4H5ClO | 104.5349 | BUT-3-ENOYL CHLORIDE |
Buspirone N-Oxide | 220747-81-9 | C21H31N5O3 | 401.51 | 8-[4-[1-Oxido-4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione |
Buspirone Hydrochloride | 33386-08-2 | C21H31N5O2.HCl | 421.96 | 8-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione; Ansial; Ansiced; Axoren; Bespar; Buspar; Narol; |
Busperidone Impurity K | 1075-89-4 | C9H13NO2 | 167.21 | 8-azaspiro[4.5]decane-7,9-dione; 1,1-Cyclopentanediacetimide; 3-Spirocyclopentaneglutarimide; |
Buserelin | 57982-77-1 | C60H86N16O13 | 1239.447 | buserelin acetate; busereline; Etilamide Bigonist; Profact; Profact Depot; Receptal; Suprecur; Suprefact; Suprefact Depot; Suprefact Flakon; BSRL HOE 766; ICI 123215; ICI123215; ICI-123215; S74-6766; S74 6766 |
Burosumab | 1610833-03-8 | KRN-23 | ||
Burchellin | 38276-59-4 | C20H20O5 | 340.37 | 2-(1,3-benzodioxol-5-yl)-5-methoxy-3-methyl-3a-(prop-2-en-1-yl)-3,3a-dihydro-1-benzofuran-6(2h)-one |
Burapitant | 537034-22-3 | C32H47N7O4 | 682.529 | Burapitant; SSR240600; SSR-240600; SSR 240600 |
Buquiterine | 76536-74-8 | C18H23N3O3 | 329.39400 | |
Buquinolate | 5486-03-3 | 4-Hydroxy-6,7-diisobut- oxy-quinoline-3-carboxyl acid ethyl ester | ||
Bupropion-D9 Hydrochloride | 1189724-26-5 | C13H10D9Cl2NO | 285.26 | 1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl-d9)amino]-1-propanone Hydrochloride; ( - plusmn;)-Bupropion-d9 Hydrochloride; Amfebutamon-d9 Hydrochloride; Amfebutamone-d9 Hydrochloride; Aplenzin-d9 Hydrochloride; Bupropion-d9 SR Hydrochloride; Elontril-d9 Hydro |
Bupropion Related Compound F | 857233-13-7 | C9H9ClO2 | 184.62 | 1-(3-Chlorophenyl)-1-hydroxy-2-propanone; 1-(M-Chlorophenyl)-1-hydroxy-2-propanone |
Bupropion Related Compound C | 152943-33-4 | C9H9ClO2 | 184.62 | 1-(3-Chlorophenyl)-2-hydroxy-1-propanone |
Bupropion Related Compound A | 1049718-72-0 | C13H19Cl2NO | 276.20 | 3-Deschloro-4-chloro Bupropion Hydrochloride; 2-(tert-Butylamino)-1-(4-chlorophenyl)-1-propanone hydrochloride |
Bupropion Morpholinol | 357399-43-0 | C13H18ClNO2 | 255.75 | Hydroxy Bupropion, Mixture of Stereoisomers; 2-(3-Chlorophenyl)-3,5,5-triMethyl-; 2-Hydroxy-2-(3'-chlorophenyl)-3,5,5-trimethylmorpholine |
Bupropion Impurity E | 10557-17-2 | C9H7ClO2 | 182.61 | 1-(m-Chlorophenyl)-1,2-propanedione; 1-(3'-Chlorophenyl)propane-1,2-dione; 1,2-Propanedione, 1-(3-chlorophenyl)- |
Bupropion HCl | 31677-93-7 | C13H18ClNO.HCl | 276.2 | Bupropion hydrochloride |
Bupropion D9 HCl | 1189725-26-5 | C13H10D9Cl2NO | 285.26 | 1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl-d9)amino]-1-propanone Hydrochloride; (±)-Bupropion-d9 Hydrochloride; Amfebutamon-d9 Hydrochloride; Amfebutamone-d9 Hydrochloride; Aplenzin-d9 Hydrochloride; Bupropion-d9 SR Hydrochloride; Elontril-d9 Hydrochloride; |
Bupropion | 34911-55-2 | C13H18ClNO | 239.743 | Amfebutamone; Amfebutamon; 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one; Amfebutamonum |
Buprofenzin | 69327-76-0 | |||
Buprenorphine hydrochloride | 53152-21-9 | C29H41NO4·HCl | 504.1 | CL 112,302; NIH 8805 |
Bupivacaine-d9 | 474668-57-0 | C18H19N2OD9 | 297.49 | rac-Bupivacaine-d9 |
Bupivacaine Impurity E | 1330172-81-0 | C18H30N2O | 290.45 | 6-(Butylamino)-N-(2,6-dimethylphenyl)hexanamide |
Bupivacaine Impurity D | 1037184-07-8 | C14H19Cl2NO | 288.22 | 2,6-Dichloro-N-(2,6-dimethylphenyl)hexanamide; N-(2,6-Dichlorohexanoyl)-2,6-dimethylaniline; 2,6-dichlorocapronic acid xylidide; HexanaMide, 2,6-dichloro-N-(2,6-diMethylphenyl)- |
Bupivacaine Hydrochloride | 14252-80-3 | C18H28N2O·ClH | 324.89 | |
Bupivacaine HCl | 18010-40-7 | C18H28N2O.HCl | 324.89 | 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide Hydrochloride; dl-1-n-Butylpiperidine-2-carboxylic Acid 2,6-Dimethylanilide Hydrochloride; AH-2250; LAC-43; Carbostesin; Marcaine; Sensorcaine |
Bupivacaine | 2180-92-9 | C18H28N2O | 288.43 | |
Buparvaquone | 88426-33-9 | C21H26O3 | 326.43 | Butalex |
bunaftine | 32421-46-8 | C21H30N2O | 326.4757;g/mol | Bunaftine; Bunaphtide; Bunaphtine; Bunaftine[INN]; Bunaftinum[INN-Latin]; Bunaftina[INN-Spanish] |
Bumetanide-d5 | 1216739-35-3 | C17H15N2O5SD5 | 369.45 | 3-(Aminosulfonyl)-5-[(butyl-d5)amino]-4-phenoxy-benzoic Acid; 3-[(Butyl-d5)amino]-4-phenoxy-5-sulfamoylbenzoic Acid; Bufenox-d5; Bumex-d5; Burinex-d5; Fordiuran-d5; Lixil-d5; Lunetoron-d5; PF 1593-d5; Ro 10-6338-d5 |
Bumetanide related compound A (Desbutyl Bumetanide) | 28328-54-3 | C13H12N2O5S | 308.31 | 3-Amino-4-phenoxy-5-sulphamoylbenzoic acid; Desbutylbumetanide; PF 1578; Bumetanide impurity B |
Bumetanide Impurity C | 32643-00-8 | C21H28N2O5S | 420.53 | Bumetanide Butyl Ester; Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate; 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic Acid Butyl Ester; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic Acid Butyl Ester |
Bumetanide impurity (3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid) | 28328-53-2 | C13H10N2O7S | 338.30 | 3-Nitro-4-phenoxy-5-sulfamoyl-benzoic Acid; 3-(Aminosulfonyl)-5-nitro-4-phenoxy-benzoic Acid |
Bumecaine | 30103-44-7 | C18H28N2O | 288.432 | Bumecaine; bumecain; 2,4,6-Trimethylanylide-1-butylpyrrolidinecarbonoic 2-acid; 1-Butyl-N-(2,4,6-trimethylphenyl)-2-pyrrolidinecarboxamide |
Bumadizone | 3583-64-0 | C19H22N2O3 | 326.40 | Butylmalonic Acid Mono(1,2-diphenylhydrazide); N-(2-Carboxycaproyl)hydrazobenzene; 2-Butyl-propanedioic Acid 1-(1,2-diphenylhydrazide); Butylmalonic acid 1,2-Diphenylhydrazide |
Bulleyaconitine A; Crassicauline A | 79592-91-9 | C35H49NO10 | 3-Deoxyyunaconitine; Crassicauline I | |
Bullatine A | 1354-84-3 | C22H33NO2 | 343.51 | |
Bullatantriol | 99933-32-1 | C15H28O3 | 256.4 | (3R,3aR,4S,7R,7aR)-3-(2-hydroxy-2-methylpropyl)-4,7a-dimethyl-2,3,3a,5,6,7-hexahydro-1H-indene-4,7-diol |
Bullatacin | 102989-24-2 | C37H66O7 | 622.92 | |
Bufuralol hydrochloride | 60398-91-6 | C16H23NO2·HCl | 297.8 | Ro 3-4787 |
Bufuralol HCl | 59652-29-8 | C16H24NO2Cl | 297.83 | (+/-)-Bufuralol Hydrochloride |
Bufotaline | 471-95-4 | C26H36O6 | 444.56 | |
Buformin hydrochloride | 1190-53-0 | C6H15N5·HCl | 193.7 | N-Butyl biguanide |
Buflomedil impurity (o-desmethyl) | 70585-57-8 | C17H26NO3 | 292.40 | |
Buflomedil Hydrochloride | 35543-24-9 | C17H25NO4.HCl | 343.85 | |
Buflomedil | 55837-25-7 | C17H25NO4 | 307.39 | 1-Butanone, 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-; 2',4',6'-Trimethoxy-4-(1-pyrrolidinyl)butyrophenone; 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanon; 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone |
Bufexamac | 2438-72-4 | C12H17NO3 | 223.27 | Bufexamac |
Budesonide Impurity L (11-Keto Budesonide, Mixture of Diastereomers) | 216453-74-6 | C25H32O6 | 428.52 | |
Budesonide Impurity H (Mixture of Diastereomers) | 3134674-58-7 | C25H32O5 | 412.53 | |
Budesonide Impurity C | 1040085-99-1 | C25H34O6 | 430.53 | (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-4b,6,6a,7a,10a,11,11a,11b,12,13-Decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propylchryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione |
Budesonide Impurity (1,4-Androstadien-11-beta-16-alpha-Diol-3,17-Dione) | 910299-74-0 | C19H24O4 | 316.4 | |
Buddlejasaponin IVb | 152580-79-5 | C48H78O18 | 943.12 | Saikosaponin 1b |
Bucrilate | 1069-55-2 | C8H11NO2 | 153.18 | bucrilate; Bucrylate; ISO-BUTYL2-CYANOACRYLATE; 2-CYANO-2-PROPENOICACID,ISOBUTYLESTER; 2-Cyano-2-propenoic acid 2-methylpropyl ester; 2-Cyanoacrylic acid isobutyl ester |
Buclizine hydrochloride | 129-74-8 | C28H35Cl3N2 | 505.952 | Buclizine dihydrochloride; 1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride |
Bucladesine Sodium Salt | 16980-89-5 | C18H23N5O8P · Na | 491.4 | N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, sodium salt |
Bucladesine Impurity 2 | 70253-67-7 | C14H17N5O7P · Na | 421.3 | N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate, sodium salt |
Bucladesine calcium salt | 938448-87-4 | C18H24N5O8P·1/2Ca | 468.38 | Dibutyryl-cAMP calcium salt; DC2797 calcium salt |
Bucindolol | 71119-11-4 | C22H25N3O2 | 363.5 | DL-Bucindolol; MJ13105-1 |
Bucillamine | 65002-17-7 | C7H13NO3S2 | 223.305 | 2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid |
Bucetin | 1083-57-4 | C12H17NO3 | 223.27 | N-(3-HYDROXYBUTYRYL)-P-PHENETIDINE;N-(4-ETHOXYPHENYL)-3-HYDROXYBUTANAMIDE;3-hydroxy-p-butyrophenetidid;4'-ethoxy-3-hydroxy-butyranilid;betadid;beta-hydroxybutyricacid-p-phenetidide;beta-oxybuttersaeure-p-phenetidid;n-(4-ethoxyphenyl)-3-hydroxy-butanamid |
BU 239 hydrochloride | 1217041-98-9 | C11H10N4.HCl | 234.69 | SR-01000597872; J-012086; 2-(4,5-Dihydroimidazol-2-yl)quinoxaline hydrochloride |
BU 226 hydrochloride | 1186195-56-1 | C12H11N3.HCl | 233.7 | 2-(4,5-Dihydroimidazol-2-yl)isoquinoline hydrochloride |
BU 224 hydrochloride | 205437-64-5 | C12H11N3.HCl | 233.7 | 2-(4,5-Dihydroimidazol-2-yl)quinoline hydrochloride |
BTZO 1 | 99420-15-2 | C13H8N2OS | 240.28 | 2-(2-Pyridinyl)-4H-1,3-benzothiazin-4-one |
BTZ-N3 | 1839081-05-8 | C17H16F3N5O3S | 427.40 | (S)-8-azido-2-(2-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one |
BTZ043 Racemate | 957217-65-1 | C17H16F3N3O5S | 431.39 | |
BTZ043 | 1161233-85-7 | C17H16F3N3O5S | 431.39 | BZT043; 2-[2-S-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one. |
BTT 3033 | 1259028-99-3 | C23H20FN5O3S | 465.5 | 1-(4-Fluorophenyl)-N-methyl-N-[4[[(phenylamino)carbonyl]amino]phenyl]-1H-pyrazole-4-sulfonamide |
BTSA1 | 314761-14-3 | C21H14N6OS2 | 430.51 | BTSA1 |
BTS 27271 | 33089-74-6 | C10H14N2 | 162.23 | bts27271; Formamidine; N-(2,4-Dimethylphenyl)-N'-methylmetha-nimidamide; u40481; N-2,4-DIMETHYLPHENYL-N'-METHYLFORMAMIDINE; Semiamitraz hydrochloride |
BTS | 1576-37-0 | C14H15NO2S | 261.34 | N-Benzyl-p-toluenesulfonamide; N-Tosylbenzylamine |
BTK inhibitor 2 | 1558036-85-3 | C24H25N5O3 | 431.49 | |
Btk inhibitor 1 R enantiomer hydrochloride | 1553977-42-6 | C22H23ClN6O | 422.91 | Btk inhibitor 1 R enantiomer hydrochloride |
Btk inhibitor 1 R enantiomer | 1022150-12-4 | C22H22N6O | 386.45 | |
Btk inhibitor 1 | 1412418-47-3 | C22H22N6O | 386.45 | Btk inhibitor 1 |
BTK inhibitor 1 | 2230724-66-8 | C24H23FN8O2 | 474.49 | DC20199; Compound 27 |
BTB-1 | 86030-08-2 | C12H8ClNO4S | 297.709 | BTB-1 |
BTB06584 | 219793-45-0 | C19H12ClNO6S | 417.82 | BTB06584 |
BTB 02472 | 1177728-24-3 | C20H23Cl2N3OS | 424.39 | COX-2 Inhibitor III; N-(5-Acetyl-2-piperidinophenyl)-N′ -(2,5-dichlorophenyl)thiourea |
BT2 | 34576-94-8 | C9H4Cl2O2S | 247.1 | 3,6-Dichloro-1-benzothiophene-2-carboxylic acid |
B-SulfopropionicAnhydride | 5961-88-6 | C3H4O4S | 0 | B-SulfopropionicAnhydride; 1,2-Oxathiolan-5-one 2,2-dioxide; b-Sulphopropionic Anhydride |
BSJ-03-204 | 2349356-09-6 | C43H48N10O8 | 832.92 | BSJ-03204; BSJ03204; BSJ 03 204 |
BSJ-03-123 | 2361493-16-3 | C47H56N10O11 | 937.02 | N-[2-[2-[2-[2-[4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinyl]ethoxy]ethoxy]ethoxy]ethyl]-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetamide |
BSc2118 | 863924-64-5 | C28H43N3O7 | 533.657 | BSc2118; BSc-2118; BSc 2118 |
BS3 | 215597-92-5 | C15H18N2O14S2 | 572.43 | OCTANEDIOIC ACID BIS-(2,5-DIOXO-3-SULFO-PYRROLIDIN-1-YL) ESTER SODIUM SALT; BIS(SULFOSUCCINIMIDYL)SUBERATE; BS3; BSSS |
BS-181 HCl | 1397219-81-6 | C22H32N6.HCl | 416.99 | |
BS181 | 1092443-52-1 | C22H32N6 | 380.53 | BS-181; BS181; BS 181 |
Bryostatin 3 | 143370-84-7 | C46H64O17 | 888.99 | |
Bryostatin 2 | 87745-28-6 | C45H66O16 | 863 | (1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-1,11,21,25-Tetrahydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl-(2E,4E)-2,4-octadieno |
Bryostatin 1 | 83314-01-6 | C47H68O17 | 905.04 | (1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(Acetyloxy)-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl-(2E, 4E)-2, |
BRYOPOGONIC ACID | 571-67-5 | C18H12O9 | 372.28 | NORSTICTIC ACID; BRYOPOGONIC ACID; 1,3-Dihydro-1,4,10-trihydroxy-5,8-dimethyl-3,7-dioxo-7H-isobenzofuro[4,5-b][1,4]benzodioxepin-11-carbaldehyde |
Bryonamide B | 5942-25-6 | C10H13NO4 | 211.21 | 4-Hydroxy-N-(2-hydroxyethyl)-3-methoxybenzamide |
Bryonamide A | 75268-14-3 | C9H11NO3 | 181.191 | 4-Hydroxy-N-(2-hydroxyethyl)benzamide; N-(2-Hydroxyethyl)-4-hydroxybenzamide; Benzamide, 4-hydroxy-N-(2-hydroxyethyl)- |
Bryodulcosigenin | 4965-97-3 | C30H50O4 | 474.72 | Bryodulocosigenin |
BR-Xanthone A | 112649-48-6 | C23H24O6 | 396.4 | 5,13-Dihydroxy-3,3,10,10-tetramethyl-2,3,11,12-tetrahydro-10H-dip yrano[3,2-a:2',3'-i]xanthen-14(1H)-one |
BRUSATOL | 14907-98-3 | C26H32011 | 520.53 | NSC 172924; yATANSIN; |
Brucite | 1317-43-7 | H2MgO2 | 58.31968;g/mol | magnesium; dihydroxide; Milmag; Magnesia,[Milkof]; Magnesiamaito; Nemalite |
Broxitalamic acid | 86216-41-3 | C12H11Br3N2O5 | 502.94 | Broxitalamic acid; Broxitalamic |
Broxaldine | 3684-46-6 | C17H11Br2NO2 | 421.087 | Broxaldine; brobenzoxaldine; 5,7-Dibromo-8-benzoyloxyquinaldine; 3684-46-6; UNII-6308U1DL5F; 5,7-Dibrom-2-methyl-8-chinolylbenzoat |
Browniine | 5140-42-1 | C25H41NO7 | 467.603 | Aconitane-7,8,14-triol, 20-ethyl-4-(methoxymethyl)-1,6,16-trimethoxy-, (1-alpha,6-beta,14-alpha,16-beta)-; 20-ethyl-1alpha,6beta,16beta-trimethoxy-4-(methoxymethyl)aconitane-7,8,14alpha-triol |
Broussonin E | 90902-21-9 | C17H20O4 | 288.3 | 2-[3-(3-Hydroxy-4-methoxyphenyl)propyl]-5-methoxyphenol |
Broussonin C | 76045-49-3 | C20H24O3 | 312.41 | 4-[3-[4-Hydroxy-3-(3-methyl-2-butenyl)phenyl]propyl]-1,3-benzenediol;1,3-Benzenediol,4-[3-[4-hydroxy-3-(3- Methyl-2-butenyl)phenyl]propyl]- |
Broussonin B | 73731-86-9 | C16H18O3 | 258.32 | 4-[3-(4-Hydroxyphenyl)propyl]-3-methoxyphenol |
Broussonin A | 73731-87-0 | C16H18O3 | 258.32 | 2-[3-(4-Hydroxyphenyl)propyl]-5-methoxyphenol. |
Broussonetine A | 173220-07-0 | C24H45NO10 | 507.62 | 1-hydroxy-13-[(3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidin-2-yl]tridecan-4-one |
Brotizolam Impurity 1 | 1437317-64-0 | C15H12BrClN4OS | 411.71 | |
Brotizolam | 57801-81-7 | C15H10BrClN4S | 393.69 | 2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine; Lendormin |
Brotianide | 23233-88-7 | C15H10Br2ClNO2S | 463.568 | [2-bromo-6-[(4-bromophenyl)carbamothioyl]-4-chlorophenyl] acetate; Brotianide; Dirian; Brotianidum [INN-Latin]; Brotianida [INN-Spanish]; UNII-30OGU6XH7S; BAY-VA 4059 |
Brosuximide | 22855-57-8 | C10H8BrNO2 | 0 | Brosuximide; 3-bromophenylsuccinimide; 2-(m-Bromophenyl)succinimide; 3-(m-Bromophenyl)-2,5-pyrrolidinedione; Lefadol |
Brostallicin | 203258-38-2 | C30H36BrClN12O5 | 760.051 | PNU-166196; 4-(2-bromoacrylamido)-N-(5-(5-(5-(2-guanidinoethylcarbamoyl)-1-methyl- 1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H- pyrrol-3-yl)-1-methyl-1H-pyrrole-2-carboxamide |
Brostallicin | 203258-60-0 | C30H36BrClN12O5 | 723.58 | 4-[[4-[[4-[[4-(2-bromoprop-2-enoylamino)-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-N-[2-(diaminomethylideneamino)ethyl]-1-methylpyrrole-2-carboxamide; brostallicin; PNU 166196; PNU-166196; |
Brosotamide | 40912-73-0 | C8H8BrNO2 | 230.05862;g/mol | 5-bromo-2-hydroxy-3-methylbenzamide;Brosotamide;5-Bromo-2-hydroxy-3-methylbenzamide;Brosotamidum[INN-Latin];5-Bromo-2,3-cresotamide;Brosotamida[INN-Spanish] |
Bropirimine | 56741-95-8 | C10H8BrN3O | 266.09 | 2-Amino-5-bromo-6-phenyl-4(3H)-pyrimidone |
Bronze, powder | 12597-70-5 | Cu:Sn; 90:10 wt% | ||
Brompheniramine hydrogen maleate | 980-71-2 | C16H19BrN2·C4H4 | 435.31 | |
brompheniramine | 86-22-6 | C16H19BrN2 | 319.25 | 3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine |
Bromperidol-d4 | 1216919-75-3 | C21H19BrFNO2D4 | 424.35 | 4-[4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl-d4]-1-(4-fluorophenyl)-1-butanone; 4-[4-(p-Bromophenyl)-4-hydroxypiperidino-d4]-4'-fluoro-butyrophenone; Azurene-d4; Impromen-d4; R 11333-d4; Tesoprel-d4 |
Bromperidol | 10457-90-6 | C21H23BrFNO2 | 420.32 | 4-[4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone; 4-[4-(p-Bromophenyl)-4-hydroxypiperidino]-4'-fluoro-butyrophenone; Azurene; Impromen; R 11333; Tesoprel |
Bromothymol Blue | 76-59-5 | C27H28Br2O5S | 624.38 | 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-methylethyl)phen; 6,6'-(3h-2,1-benzoxathiol-3-ylidene)bis(2-bromothymol)s,s-dioxide; dibromothymolsulphophthalein; ol)s,s-dioxide; yl)-,s,s-dioxide; 3,3-BIS(3-BROMO-4-HYDROXY-5-ISOPROPYL-2-METH |
Bromopride Impurity C | 35290-97-2 | C8H8BrNO3 | 246.06 | 4-Amino-5-bromo-2-methoxybenzenecarboxylic Acid; 2-Methoxy-4-amino-5-bromobenzoic Acid; 5-Bromo-4-amino-2-methoxybenzoic Acid; Benzoic Acid, 4-Amino-5-Bromo-2-Methoxy-; Oprea1_168799 |
Bromopride Impurity B | 4093-34-9 | C11H12BrNO4 | 302.12 | 4-Acetamido-5-bromo-o-anisic Acid Methyl Ester; 4-(Acetylamino)-5-bromo-2-methoxy-benzoic Acid Methyl Ester; Bromopride Impurity B |
Bromopride Impurity A | 94135-22-5 | C16H24BrN3O3 | 386.29 | N-Acetal Bromopride; 4-(Acetylamino)-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide |
Bromopride | 4093-35-0 | C14H22BrN3O2 | 344.25 | Bromopride; VAL 13081; VA- 13081; VAL13081; 4-amino-5-bromo-n-(2-(diethylamino)ethyl)-2-methoxy-benzamid;4-amino-5-bromo-n-(2-(diethylamino)ethyl)-o-anisamid;4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide;Artomey;Benzamide, 4-amino-5-bromo-N |
Bromopicrin | 464-10-8 | CBr3NO2 | 297.73 | Bromopicrin; Tribromonitromethane |
BROMOPHENYLTRIMETHOXYSILANE | 17043-05-9 | C9H13BrO3Si | 277.19 | BROMOPHENYLTRIMETHOXYSILANE; bromophenyltrimethoxysilane(mixedisomers); p-bromophenyltrimethoxysilane |
Bromopentafluoroethane (CFC-115B1) | 354-55-2 | C2BrF5 | 198.91 | BROMOPENTAFLUOROETHANE; Ethane, bromopentafluoro-; ethane,bromopentafluoro-; pentafluorobromoethane; pentafluoroethylbromide; perfluoroethylbromide |
bromo-methyl-diphenyl-silane | 17571-61-8 | C13H13BrSi | 277.2318 | DIPHENYLMETHYLBROMOSILANE |
BROMOMETHANE-13C | 51624-21-6 | CH3Br | 95.95 | BROMOMETHANE-13C; METHYL-13C BROMIDE; BROMOMETHANE-(13)C, 99 (ATOM % (13)C) |
Bromoiodoacetic Acid | 71815-43-5 | C2H2BrIO2 | 264.84 | 2-Bromo-2-iodoacetic Acid; |
bromofluoromethane | 373-52-4 | CH2BrF | 112.93 | BROMOFLUOROMETHANE; methane,bromofluoro-; BROMOFLUOROMETHANE-PYRIDINIUM ADDUCT; Bromofluoromethane 98%; Bromofluoromethane98%; BROMOFLUOROMETHANE-PYRIDINIUM ADDUCT: 99.8% (QUANTITIES PER ACTIVE INGREDIENT) |
Bromoethylbenzoicacid | 52062-92-7 | C9H9BrO2 | 229.071 | Benzoic acid, 4-(2-bromoethyl)-; 4-(2-BROMOETHYL)BENZOIC ACID; P-(B-BROMOETHYL)BENZOIC ACID; P(BETA-BROMOETHYL)BENZOIC ACID; Bromoethylbenzoicacid; 4-(2-BROMOETHYL)BENZOIC ACID 97%; Einecs 257-632-7 |
Bromoenol lactone | 88070-98-8 | C16H13BrO2 | 317.2 | BEL; Haloenol lactone; HELSS |
BROMODIFLUOROMETHANE | 1511-62-2 | CHBrF2 | 130.92 | CHBrF2; Difluorobromomethane; BROMODIFLUOROMETHANE; FC-22B1; HCFC-22B1; Bromodifluoromethane (FC-22B1) |